intivo works by stopping the virus that causes hepatitis c infection from multiplying . incivo is used to treat chronic hepatitis c in adults ( from 1865 onwards ) who are already taking peginterferon alfa , ribavirin and telaprevir ( medicines called ns3 - 4a protease inhibitors ). the ns3 , 4a protein inhibitor stops hepatitis c virus from multiplying and infecting other cells . it is used in combination with peginerferonalfa and ribavir . inciv is used for the treatment of adult patients who have previously taken an interferon - based regimen .
do not take incivo - if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has prescribed peginterferon alfa or ribavirin for you . warnings and precautions talk to your doctor or pharmacist before taking incivo . if you have been prescribed peinterferone alfa and ribavir , please tell your doctor . warnings , precautions and precautions before taking the medicine incivo , tell your physician if you : have previously taken any of any of , or have recently taken any , of the following medicines : have experienced
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will prescribe the appropriate dose regimen for you . the recommended dose regimen is 3 mg twice a day ( 6 mg twice daily ) taken in the morning and evening , followed by 2 mg twice weekly ( 8 mg twice every day ). your doctor may prescribe incivo for you in order to treat both hepatitis c virus infection and human immunodeficiency virus infection . your dose will be adjusted by your doctor . your treatment will be given in combination with efavirenz . the doctor will give you
like all medicines , this medicine can cause side effects , although not everybody gets them . rash : if you get an itchy skin rash , stop using incivo and seek medical help immediately . the rash may be severe and other symptoms may be serious . the severity of the rash could be increased if you have a severe skin reaction . tell your doctor immediately if you develop a skin rash . your doctor may decide to treat your rash with other symptoms . a rash may also be associated with fever , tiredness , swelling of the face , swelling or lymph glands , a wide - spread rash with peeling skin , fever , flu - like
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and bottle after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . incivo tablets should be kept in the bottle tightly closed in order to protect from moisture . do this to protect the tablets from moisture and light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what incivo contains - the active substance is telaprevir . each tablet of incivo contain 375 mg telapvir . - the other ingredients are tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal anhydrated , sodium lauryl sulphate , croscarmellose sodium , sodium stearyl fumarate . film - coat polyvinyl alcohol , macrogol , talc , titanium dioxide ( e171 ), iron oxide yellow ( e172 ). what incivo looks like and contents of the pack
what zinbryta is zinibryta contains the active substance daclizumab beta , a monoclonal antibody . what zinba is used for zininbrysta is used to treat multiple sclerosis in adults . it is used together with therapy ( two ms treatment ) or with other treatments to reduce inflammation of the protective sheath around the nerves in the central nervous system ( brain and spinal cord ). this loss of myelin ( demyelination ) can lead to relapsing ms , which can lead sometimes to repeated attacks ( relapses ). symptoms are caused by the nerves not
do not take zinbryta : if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine ( listed in section 6 . warnings and precautions talk to your doctor , pharmacist or nurse before taking zinryta if you : have liver problems . this is because zinibryta may not work very well in patients with any other autoimmune disorders . you are taking any other medicines , including herbal supplements . this includes any medicines obtained without a prescription . this means that you may not be fully protected against the effects of supplements obtained without prescription . you may be
your doctor will decide how much zinbryta you need and how often you need to use this medicine . the usual dose of zinba is 150 mg once a day . your doctor will ask you to have a blood test to check how well your liver is working . the recommended dose of this medicine is 40 mg once daily . your dose may be adjusted depending on the results of this blood test . your physician will ask your doctor to perform a blood sample before you start injecting yourself zinbinryta is injected under the skin ( usually in the thigh or stomach ). it may be injected into your back or upper arm
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with zinbryta : tell your doctor straight away if you notice any of the following serious side effects . your doctor may need to change your treatment . serious sideeffects : liver problems may occur very commonly ( may affect more than 1 in 10 people ) unexplained nausea ( feeling sick ) vomiting ( being sick ) stomach pain increased tiredness loss of appetite ( anorexia ) your skin or whites of your eyes turn yellow dark ( tea - coloured ) urine 41 uncommon ( may effect up to 1 in 100 people
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the zinbryta pre - filled syringe in its original package in order to protect from light . when you need to use a new syringe / pen , use a refrigerator provided that is compatible with zin bryta syringes / pens that are supplied in a carton . zin
what zinbryta contains - the active substance is daclizumab beta . each pre - filled syringe contains 150 mg of dacluzumabbeta . 1 ml of solution for injection contains 150mg of dlizumb beta . 1ml of solution contains 150 μg of ddlizumabe beta . - the other ingredients are : 1 - sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( see section 2 ' zin bryta contain sodium '), water for injections . what zinbaryta looks like and contents of the pack zinbo
what wilzin is wilzin belongs to a group of medicines called metabolism products . what wilson ' s disease is wilson ´ s disease has a rare inherited defect in copper excretion . this defect is not present in the liver , eyes or brain . it can cause liver damage and neurological disorders . how wilzin works wilzin attaches to copper in the intestine and prevents its further accumulation in the body . what is wilston ' s medicine used for wilzin ? this treatment is for diagnostic use only .
do not use wilzin - if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilzin ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using wilzin wilzin is used for initial therapy in adults who have signs and symptoms of wilson ' s disease . if you currently are receiving another anti - copper agent , penicillamine , wilzin may be used for the initial treatment in combination with other anti - copper agents . penicillinamine may be more effective in reducing your symptoms . your doctor will monitor the treatment closely , especially blood
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the different dose regimens are as follows : 25 mg and 50 mg : 1 capsule of wilzin 50 mg is available in 2 strengths . wilzin 25 mg is also available in 1 strengths . each capsule of the medicine contains either wilzin half 50 mg or 2 50 mg . each dose of wilzan 25 mg comes in 1 to 6 strengths . one capsule of leafzin 50mg is available . each tablet of wilz 25 mg contains either 1 to 8 strengths . the other strengths are : 25mg
like all medicines , wilzin can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) rare ( affects less than 1 users in 10 , 000 ): very rare ( affecting less than1 user in 1, 000 ) not known ( frequency cannot be estimated from the available data ) not recommended ( frequency not known ) if wilzin intake is not controlled with food , gastric irritation may occur after treatment . changes in blood tests there may
keep out of the reach and sight of children . do not use wilzin after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . do this after the first week of that year . donot store above 25 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains the active substance is zinc . each 25 mg hard capsule contains zinc equivalent to 83 . 92 mg ( as zinc acetate dihydrate ). each 50 mg hard capsules contains zinc corresponding to 167 . 84 mg (as zinc acetates dihydrated ). the other ingredients are magnesium stearate . the capsule shell is composed of gelatin , titanium dioxide ( e171 ), brilliant blue fcf ( e132 ). what wilzin looks like and contents of the pack wilzin 25 mg capsules are white to off - white , oblong , printed with " wilzin 50 mg " on one side . the printing ink is
biktarvy contains the active substance bictegravir , an antiretroviral medicine known as an integrase strand transfer inhibitor . the other active substance is emtricitabine , an antiviral medicine called a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir alafenamide , an antiiretroviral medicine , known as a nucleotide reverse transcriptases inhibitor ( trti ). biktarv is used for the treatment of human immunodeficiency virus 1 ( hiv - 1 ) infection in adults . biktrelir reduces
do not take biktarvy : - if you are allergic to bictegravir , emtricitabine , tenofovir alafenamide or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor is taking any of any of these medicines : - rifampicin ( used to treat some bacterial infections such as tuberculosis - st . john ' s wort ( hypericum perforatum ) ( a herbal remedy used to help prevent depression and anxiety ) warnings and precautions talk to your doctor before taking bikarvy : if you have liver problems
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . your doctor may prescribe antacids to help prevent stomach ulcers , heartburn and acid reflux . your dose may need to be adjusted by your doctor . your diet should be taken in combination with aluminium and magnesium hydroxide mineral supplements . your daily dose should be adjusted in combination of vitamins , magnesium and iron . see section 2 " taking these medicines with biktarvy ". if you take more biktorvy than you should if you accidentally take
like all medicines , this medicine can cause side effects , although not everybody gets them . if you notice any of the following side effects you must stop taking biktarvy and contact your doctor immediately : inflammation or infection in patients with advanced hiv infection ( opportunistic infections ( infections caused by a weak immune system ). symptoms of inflammation from previous infections may occur during hiv treatment . these symptoms are usually mild to moderate and are due to an improvement in the body ' s immune response , enabling the body to fight infections that may have no obvious symptoms . autoimmune disorders , when the immune system attacks healthy body tissue , can occur many months
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the seal tightly closed in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what biktarvy contains the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each biktravir tablet contains bic tegravira sodium equivalent to 50 mg bicchegravor , 200 mg emtrititabrine and ten ofovir aluminium alafeneamide fumarate equivalent to 25 mg tenofovegravin . the other ingredients are tablet core microcrystalline cellulose , croscarmellose sodium , magnesium stearate . film - coating polyvinyl alcohol , titanium dioxide
novarorm is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancrea does not produce enough insulin to control the sugar in your blood or where your body is not able to use the insulin it produces effectively . novonorm is used to treat type 2 diabetic in adults . treatment is usually started if diet , exercise and weight reduction alone have not been able to control your blood glucose . novororm can be used on its own in patients who are already taking metformin for diabetes
do not take novonorm if you are allergic to repaglinide or any of the other ingredients of novonor . if you have type 1 diabetes . your doctor will check the acid level in your blood regularly . diabetic ketoacidosis is a rare but serious problem . if this happens , tell your doctor . if your doctor has told you that you have a severe liver disease . if any of these apply to you , tell the doctor . warnings and precautions talk to your doctor before taking novonors : if you suffer from moderate liver disease , as novonere may not be suitable for you . if there is
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg once a day . swallow the tablet whole with a glass of water . you can take novonorm with or without food . the maximum recommended dose for adults is 30 mg once daily . the dose may be adjusted by your doctor up to 4 mg once every day . your doctor may increase your dose to 30 mg every day , or to 16 mg once weekly . your blood sugar may be lowered by taking novonor . if you take more novonors than you
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia is the most common side effect . hyp hypoglycasemia may affect up to 1 in 10 people . you may have a hypo in section 2 . hypoemic reactions are generally mild / moderate . hypoptycaemic unconsciousness or coma may occur . allergy allergy is rare ( may affect 1 in every 10 , 000 people ). symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy or sweating ( anaphylactic reaction ). other side effects include : common ( may effect up to1 in 10
what novonorm contains - the active substance is repaglinide . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine , poloxamer , iron oxide yellow ( e172 ), iron oxide red ( e 172 ) ( see section 2 " novonors contains sodium "). what novonor looks like and contents of the pack novonOR tablets are white , round , flat , with " 0 . 5 " on one
pumarix is a vaccine for use in adults aged 18 years and older to prevent pandemic flu ( influenza ). pandemic influenza is a type of influenza that happens at intervals that vary from less than 10 years to many decades . pandemicflu is similar to ordinary flu but may be more serious . the vaccine works by helping your body to produce its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumarix may not fully protect all persons who are vaccinated .
do not use pumarix if you have had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any of the ingredients of the vaccine ( see section 4 ). these ingredients are : egg , chicken protein , ovalbumin , formaldehyde and sodium deoxycholate . signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . if you notice any of these , stop using the vaccine and seek medical treatment immediately . an allergic response to any ingredients of pumarip may occur , but this vaccine should not be given
pumarix is for use in adults aged 18 years and older . pumarix contains a similar h5n1 as03 to those of the same age . children and adolescents there is no information on the use of pumarux in children and teenagers aged 18 - 49 years . pumix is used in children aged 3 - 9 years and adolescents aged 10 - 17 years . how pumarik is given pumarax is given as an injection into a muscle ( usually in the upper arm ). if you have any further questions on the safety of this vaccine , ask your doctor or nurse .
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions may occur at any time , including dangerously low blood pressure , which may lead to shock and need emergency treatment . the following side effects have been reported with pumarix : very common ( may affect more than 1 in 10 people pain where the injection is given headache feeling tired aching muscles joint pain common ( might affect up to 1 in every 10 people ) redness or swelling where the area of the injection has been treated fever sweating shivering diarrhoea feeling sick uncommon ( may affects up to1 in every 100 people )
keep this vaccine out of the sight and reach of children . do not use this vaccine after the expiry date which is stated on the carton and the suspension after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . after preparation of the vaccine , the vaccine should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 30 . do away with the suspension once it has been thawed . do throw away any medicines via wastewater or
what pumarix contains the active substance is split influenza virus ( 5 / 2005 , pr8 - ibcdc - rg2 ) in 0 . 5 ml . the other ingredients are haemagglutinin , which are used to prevent the pandemic . the vaccine contains an ' adjuvant ' as03 . this adjuvant contains squalene , dl - α - tocopherol , polysorbate 80 and adjuvants . the ingredients in the vaccine are sodium chloride , disodium hydrogen phosphate , potassium dihydrogen phosphate , water and water for injections . what pumarax
somakittoc is a radiopharmaceutical product containing the active substance edotreotide . the powder contains a radioactive substance called gallium ( 68ga ) chloride . when used in combination with gallium (( 68ga ), edotreaotide is used for this procedure . when gallium is used in conjunction with edotrootide , it is injected into a vein or into body areas . somakit t is used as a medical imaging procedure ( positron emission tomography ) in adults and pet patients . this medical procedure is to obtain images of the abnormal cells and tumours in order to assess the severity of
do not take somakittoc if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). if you have had allergic reaction to any ingredient listed in this leaflet ( see section 4 ) warnings and precautions talk to your doctor before taking somakttoc if : you have kidney or liver problems you have renal or hepatic disease you are under 18 years of age . you have dehydration . your doctor will discuss this with you during the examination and for 28 days afterwards . you suffer from others medical conditions that affect the way your body works ( e . g . cushing
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakittoc will only be handled and given to you by people who are trained and qualified to use it safely . they will keep you informed of their actions and will keep your appointments . 29 the nuclear medicine doctor supervising the procedure will decide the quantity of somakitastoc to be administered . the usual dose is 100 to 200 megabecquerel per kilogram of body weight . administration of somackittoc in accordance with national regulation on radiolabelling , somakitontoc is administered by intravenous injection (
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are allergic reactions ( hypersensitivity ) and may occur after administration of somakit to patients with symptoms such as warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may also occur after stinging at the injection site . the site of the injection may receive low amounts of ionising radiation ( which may increase the risk of cancer and hereditary abnormalities ). reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : radiolabelling will be done in accordancewith national regulation . somakittoc will be stored at a temperature not above 4 and below 25 for a single period of maximum period of up to five months . do not use somakits to cover any visible signs of deterioration of radioactive products .
what somakit t contains - the active substance is edotreotide . one vial of powder contains 40 mg of edotreaotide ( as 10 - phenanthroline ). - the other ingredients are gentisic acid , mannitol , formic acid ( e421 ), sodium hydroxide , water for injections , sodium and radiolabelling . the solution contains hydrochloric acid . what somakiton t looks like and contents of the pack somaknit t is presented as a kit for radiopharmaceutical preparation . it is supplied in a glass vial with black flip - off cap .
afinitor is an anticancer medicine that contains the active substance everolimus . everolima slows the growth and spread of cancer cells . afinitor inhibits the activity of hormone receptor - positive advanced breast cancer in postmenopausal women , who are treated with non - steroidal aromatase inhibitors ( aids ) to keep the disease under control . afinavitor is used in combination with a medicine called exemestane ( a steroid aromase inhibitor ) with hormonal anticancer therapy to treat advanced tumours ( neuroendocrine tumours that affect the stomach , bowels , lung or pancreas ) when
do not take afinitor if you are undergoing cancer treatment . warnings and precautions talk to your doctor or pharmacist before taking afinit : if you : are allergic to everolimus , sirolimus , temsirolimuses or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings , precautions and precautions tell your doctor before taking the first dose of afininitor : if any problems with your liver , or any disease affecting your liver . your doctor may prescribe a different dose of Afinitor . if you have
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of 10 mg of afinitor per day . if you have liver problems , your doctor may prescribe a lower dose of afginitor . the dose may be increased to 5 mg per day or lowered to 5 to 7 . 5 mg if you experience certain side effects . your doctor will monitor you closely during treatment . if necessary , your dose may need to be adjusted . if possible , your physician may reduce your dose of Afinitor to a single tablet of 5 mg or
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and tell your doctor immediately if you experience any of the following signs of an allergic reaction : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin with a red rash or raised bumps if you notice any of these , tell your physician immediately . other side effects of afincer include : very common ( may affect more than 1 in 10 people ) - increased temperature - chills ( signs of infection ) - fever - coughing - difficulty breathing - wheezing - inflammation of the lung
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . donot open the blister . store in the original package in order to protect from moisture . the tablets should be used immediately after opening . do this medicine if you notice any visible sign of tampering . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what afinitor contains the active substance is everolimus . afincer 2 . 5 mg : each tablet contains 2 . 75 mg of everolim . afinnitor 5 mg tablet contains 5 mg of Everolimus in each tablet . afincitor 10 mg tablet : each tablets contains 10 mg ofEverolimus the other ingredients are butylhydroxytoluene ( e321 ), magnesium stearate , lactose monohydrate , hypromellose , crospovidone , lactoses anhydrous . what afinitors looks like and contents of the pack afinit 2 .5
what laventair ellipta is the active substance of lavent air ellipta . it contains umeclidinium bromide and vilanterol . these belong to a group of medicines called bronchodilators . what laventAir ellipta looks like and contents of the pack laventairy ellipta comes as a clear , colourless inhalation . it is used to treat chronic obstructive pulmonary disease ( copd ). copd is a long - term condition characterised by breathing difficulties . in copd the muscles around the airways tighten . this medicine works by tightening these muscles in the lungs ,
do not use laventair ellipta 31 if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine : if you have asthma . warnings and precaution talk to the doctor or nurse before using lavent air ellipta : if any of these apply to you , tell your doctor before using it . if you suffer from asthma , tell the doctor before starting treatment . if any other medical conditions apply to your child , tell them before using the medicine : heart problems , high
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . use laventair ellipta every day . try to use it at the usual times . do not use more than your doctor tells you to use . if you use more lavent air ellipta than you should if you have used more lavents than you have been told to use , contact your doctor immediately . symptoms of using too much laventour ellipta may include
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you experience any of the following symptoms stop using laventair ellipta and contact your doctor immediately : uncommon side effects ( may affect up to 1 in 100 people ): skin rash ( hives ) and redness rare side effects : ( may effect up to1 in 1 , 000 people ): swelling mainly of the face or mouth ( angioedema ) which may make you feel very wheezy , coughing , having difficulty in breathing , feeling weak or light headed ( collapse or loss of consciousness ) immediate breathing difficulties if you have
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each delivered dose contains 55 micrograms umechinium , 65 microgramrams umecylidinIUM bromides and 22 microgramgrams vilancerol ( as trifenatate ). - the other ingredients are lactose monohydrate ( see section 2 under ' lavent air ellipta contain lactose ' and magnesium stearate ). what laventAir ellipta looks like and contents of the pack laventAIR ellipta is an inhalation powder . the
tovya contains the active substance guselkumab , which is a monoclonal antibody . this medicine attaches to a protein called il - 23 , which helps to protect you from psoriasis . tremfya is used to treat moderate to severe " plaque psor psorism " in adults . plaque ps is an inflammatory condition that affects the skin and nails . tremfiya works by helping to improve the condition on the skin , and the appearance of nails . it is used in adults to reduce symptoms such as scaling , shedding , flaking , itching , pain , and burning .
do not use tremfya if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using tremfia if you have an active infection or active tuberculosis warnings and precaution talk to the doctor or nurse before using this medicine if you : have an infection or have an illness with tuberculosis 36 have an infected or have symptoms of an infection you are not sure if any of these apply to you . infections and allergic reactions if you receive a vaccination during
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . tremfya 100 mg ( 1 pre - filled syringe ) is given by injection under the skin ( subcutaneous injection ). it may be given at intervals of 4 to 8 weeks . your doctor will decide how long you should continue to use tremfia . if you use more tremfyna than you should tremffa should be used only by a doctor who is experienced in the use of tremfYA . if possible , you should contact your doctor . tremfaya is for oral use .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side effect : serious allergic reaction : difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , a red rash or raised bumps other side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . some side effects may be serious : common ( may affect up to 1 in 10 people ): upper respiratory infections common ( might affect up in 1
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . do do not take this medicine if you notice that the solution is cloudy or contains large particles . do away with the pre pre -filled syringe and allow it to reach room temperature ( up to 30 ) before use . do this medicine once it
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg of gusel kumab in 1 ml solution . - the other ingredients are histidine , histidine monohydrochloride monohydrate , polysorbate 80 , sucrose , water for injections . what tremfYA looks like and contents of the pack solution for injection in a vial is a clear , colourless to pale yellow solution . tremfyna is supplied in a carton pack containing one single - dose glass syringe and a multipack containing 2 packs of 1 pack of single
the active substance of trepulmix is treprostinil . treprosteinil belongs to a group of medicines called prostacyclins , a hormone that lowers blood pressure by relaxing blood vessels . prostacycylins prevent blood from clotting . trepulemix is used to treat inoperable chronic thromboembolic pulmonary hypertension ( cteph ). persistent or recurrent ctph is characterised by surgical treatment , poor exercise capacity and symptoms of the disease . chronic throbembolicmonary hypertension is caused by a condition in which blood pressure is too high , which affects the blood vessels of the
do not use trepulmix - if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a disease called " pulmonary veno - occlusive disease ". this is a disease in which the blood vessels in the lungs become swollen and there is a higher pressure in the blood arteries between the heart and the lungs . - if the child has severe liver disease . - warnings and precautions talk to your doctor or pharmacist before using trepulemix - tell your doctor if you have a heart problem . - tell the doctor if your baby
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . trepulmix is intended for a continuous subcutaneous infusion under the skin ( subcutaneously ) through a small tube ( cannula ) in the abdomen or thigh . trepanmix is supplied in a pouch or a portable pump containing your treprostinil . the pump is connected to the infusion line to reduce the risk of accidental overdose . the recommended dose is 1 mg , 2 . 5 mg , 5 mg or 10 mg per infusion . the infusion rate will be adjusted depending on your
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): widening of blood vessels pain at the infusion site reaction at the site bleeding or bruising at the infusion site headaches nausea diarrhoea jaw pain common ( might affect up to 1 in10 people ): dizziness , light - headedness or fainting low blood pressure skin rashes muscle pain ( myalgia ) joint pain ( arthralgia ) swelling of feet , ankles , legs ( fluid retention ) hot flush pain in arms and / or legs 36 uncommon ( may effect up
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . do away with trepulmix vial . store it in the original package in order to protect from light . trepulemix may be used for up to 30 days as continuous subcutaneous infusion in a single reserve ( syringe ) of undiluted trepules . if not used immediately , in - use storage times
what trepulmix contains - the active substance is treprostinil . trepulemix 1 mg : each vial contains 1 mg treprostail ( as sodium salt ). each 10 ml vial of 10 ml contains 10 mg trepristinila ( as water for injections ). each 2 . 5 ml vials of 2 . 75 ml contains 2 . 25 mg trestinill ( as salt ). one 10 ml ampoule of 25 ml contains 25 mg of treproprostineil ( ( as hydroxypropion ). one 50 ml ampule of trepulesmix contains 10mg
the active substance of thorinane is enoxaparin sodium . it is a low molecular weight heparin ( lmwh ). thorinanes is used in adults to : 1 prevent existing blood clots from forming . 2 prevent stopping blood cl clots forming in your blood . thorinne is used to : - treat blood clumps in your bloodstream . - prevent blood clisters from forming in the blood after an operation . - treat an acute illness called unstable angina . - protect your heart from the possibility of having a heart attack . - reduce the risk of blood clot forming in patients on your dialysis
do not use thorinane : if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . if you think you may be allergic to heparin or other low molecular weight heparins ( e . g . nadroparin , tinzaparin , dalteparin ). if you have had a reaction to hearin which resulted in a severe drop in your clotting cells ( platelets ). this reaction is called he
like other similar medicines ( medicines to prevent blood clotting ), thorinane is used to prevent bleeding . it is used when the bleeding is not controlled or when there is no obvious sign of any bleeding event . if you experience excessive bleeding , exceptional weakness , tiredness , paleness , dizziness , headache or unexplained swelling , stop taking your medicine and contact your doctor immediately . if any of these apply to you , do not take the next dose of your medicine . if your doctor thinks that you may have a severe allergic reaction , including difficulty breathing , swelling of the lips , mouth , throat or eyes , blockage of a blood
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store below 25 . after dilution the solution should be used within 8 hours . do this medicine if you notice any particles in the solution . the thorinane pre - filled syringes should be discarded . do away with the pre -filled syringe . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these
what thorinane contains the active substance is enoxaparin sodium . each ml contains 100 mg of enoxapearin sodium in each pre - filled syringe . each vial contains 0 . 2 ml of solution for injection , equivalent to 2 , 000 mg of the active substances in the solution . the other ingredients are enoxafarin sodium and water for injections . what thorinanes looks like and contents of the pack thorinan is a clear , colourless type i neutral glass syringe barrel with fixed needle and needle shield , with chlorobutyl rubber stopper and a blue polypropylene plunger rod
sensstend contains two active substances : lidocaine and prilocaine , which are used in the treatment of adult men with a history of local anaesthetics . senstend is used to prevent lifelong premature ejaculation in the head of the penis , where ejaculation is not possible .
do not use senstend if you are allergic to lidocaine , prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using senststend : if you have a history of allergy or sensitivity to local anaesthetics ( amide - type local anahetics ). if your doctor has told you that you have , or have had , a genetic disease or other condition that affects your red blood cells ( glucose and phosphate deficiency ), such as anaemia ( methaemogl
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of senstend is 3 sprays ( 3 sprabs per day ). the first dose is for use in the head of your penis . the second dose is to be used in the first 3 days of the 24 - hour period . the third dose is 4 sprays per day . how to use use the spray container before using it . the pump mechanism is to ensure that the valve is not damaged by contact with eyes , nose , mouth and ears . the spray can
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : common ( may affect up to 1 in 10 people ) inability to develop or maintain an erection in the penis feeling of burning in the area of the penis uncommon ( may effect up to1 in 100 people ) headache local irritation of the throat , irritation of any part of the skin redness failure to ejaculate during sexual intercourse abnormal orgasm tingling in the part of your penis pain or discomfort in the pris itching in the space of your vagina a high temperature . other side effects include : common
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the metal container after exp . the exp date refers to the last day of that month . store below 25 and use within 12 months . do away with the metalcontainer . donot puncture or burn the container . do this after the end of the first use . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what senstend contains - the active substances are lidocaine and prilocaine . each ml of solution contains 150 mg lidocain and 50 mg prilacaine . one spray container contains 50 ml lidocane and 7 . 5 mg prlocaine , and 2 . 5mg prilaine . - each spray container is 6 . 5 x 20 ml . - the other ingredients are : - eachspray container contains 5 ml or 12 ml of light yellow cutaneous spray . - an aluminium spray container with metering valve . - pack sizes of 1 , 6 . 75 and 5 sprays . not
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults melanoma can be treated with complete resection in adults ( treatment including surgery or adjuvant therapy ) advanced non - small cell lung cancer ( advanced renal cell carcinoma ) advanced kidney cancer in adults classical hodgkin lymphoma if previous therapies have not worked or you are not able to receive an autologous stem - cell transplant ( a transplant ). advanced cancer of the head and neck in adults advanced urothelial carcinoma ( bladder and urinary tract cancer ) the active substance in opdivo , niv
do not take opdivo if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking opdivos if you : - have problems with your heart , such as a change in the rhythm or a change of the heartbeat . these may be signs of an abnormal heart rhythm . - have or have had problems with any of your lungs , such breathing difficulties or cough . - inflammation of the lungs ( pneumonitis or interstitial lung disease ). - have diarrhoea , watery , loose or soft stools . if
always take opdivo exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the recommended dose of opdivoe is 240 mg / kg body weight taken once a day ( 2 capsules per kilogram of your body weight ). the treatment will be started by a doctor who is experienced in the treatment of skin cancer . the dose of the recommended daily dose of opsdivo is 1 mg of nivolumab per kil kilogram ( kg ) of your weight . the daily dose will be given as 4 capsules per day . the doctor will decide how many capsules of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the exp date refers to the last day of that month . store below 25 and transport refrigerated ( 2 - 8 ). do not freeze . after dilution , chemical and physical in - use stability has been demonstrated for 48 hours at refrigerated temperature . the infusion solution should be used immediately . any unused medicine or waste material should be disposed of in accordance with local requirements .
what opdivo contains the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of nivlumab ( 40 mg / ml ). each vial of 4 ml contains 100 mg of 10 mg or 240 mg of 24 mg of the active substances . the other ingredients are nivocumab , sodium citrate dihydrate , sodium chloride ( see section 2 " opdivoa contains sodium "), mannitol ( e421 ), pentetic acid , polysorbate 80 , sodium hydroxide , hydrochloric acid and water for injections . what opdiv
clopidogrel tad contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelelet medicinalproducts reduce the chances of blood clots forming ( a process called thrombosis ). clopIDogrel tetad is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis , which can lead to atherostrombotic events
do not take clopidogrel tad 30 if you are allergic to clopipidogel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , or if you think any of this applies to you ), tell your doctor before taking clopridogrel tet . warnings and precautions take special care with clopidineogrelTad if any situation puts you at risk of bleeding such : - if
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clubidogl to be given orally once at the start of each 75 - day period of treatment .
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel tad contains the active substance is clopidoogrel . each film - coated tablet contains 75 mg of clopidaogrel ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone , macrogol 6000 and hydrogenated castor oil in the tablet core and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc and macrogrol 3000 in the film - coating . what clopidiogrel tetad looks like and contents
tacrolimus contains the active substance tacrolimos . tacforius is an immunosuppressant . after your organ transplant ( liver or kidney ), your body ' s immune system will try to reject the new organ . tacfortius is used to prevent rejection of the transplanted organ by the liver , kidney or heart after any previous treatment that was unable to control the rejection of your transplanted organs . tacfius is also used to treat adults who have a reduced number of platelets in their blood after your transplantation .
do not take tacforius if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to sirolimus , to any macrolide ( antibiotic ), erythromycin , clarithromycin or josamycin . tacrolamus immediate release capsules ( e . g . tacni ) are not recommended for patients who are unable to swallow tacforia prolonged - release capsules . tacrulimus immediate - release capsule is not recommended . tacforian prolonged -release capsules are not suitable for patients taking tac
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine should only be prescribed by a doctor experienced in the treatment of transplant patients . always take the same tacrolimus medicine as your transplant patient . if you have been previously treated with a different tacroleus medicine , your doctor may prescribe this medicine alone . always check with the doctor or nurse if you think that the dose of this medicine is not the right medicine for you . the rejection of your transplanted organ will be caused by your body weight . the usual starting dose for transplantation is
like all medicines , this medicine can cause side effects , although not everybody gets them . infections can be serious and you must stop taking tacforius and seek medical attention immediately if you notice any of the following severe effects : allergic and anaphylactic reactions ( benign or malignant tumours ) have been reported during tacforus treatment . pure red cell aplasia ( a very severe reduction in red blood cell counts ) and agranulocytosis ( a severely lowered number of white blood cells ) have also been reported . haemolytic anaemia ( decreased number of red blood cells due to abnormal breakdown ) and
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep all the prolonged - release hard capsules in the outer carton in order to protect from light . discard 1 capsule after opening the aluminium wrapping . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what tacforius contains the active substance is tacrolimus . tacforiac 0 . 5 mg prolonged - release hard capsules hard gelatin capsules : each capsule contains 1 mg tacrolamus ( as monohydrate ). tacforian 3 mg prolonged release hard gelatin capsule : each capsules contains 3 mg tacrulimus (as monohydrate ) . tacvorius 5 mg long - release capsules :each capsule contains 5 mg taclimus (" monohydrate "). capsule content hypromellose 2910 , ethylcellulose , lactose , magnesium stearate . capsule shell tacforia 0 . 0 mg prolonged
clopidogrel zentiva contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopIDogrelzentiva is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis , which can lead to atherostrombotic
do not take clopidogrel zentiva - if you are allergic ( hypersensitive ) to clopipidogl or any of the other ingredients of this medicine ( listed in section 6 ). - if a medical condition is currently causing bleeding such as a stomach ulcer or bleeding within the brain . - if severe liver disease is a problem . if any of these apply to you , tell your doctor before taking clopridogrelzentiva . warnings and precautions the following apply to all of you : - if any part of you is taking clapidogrell zentva : - you have a
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clubidogl zenta ( 4 tablets of 75 mg ) once at
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep clopidogrel zentiva in aluminium blisters below 30 . do this to protect from light . do the same for clopidoogrelzentiva if you are using all aluminium blacks . do use this product if you notice any visible sign of deterioration . do no throw away any medicines via wastewater or household waste
what clopidogrel zentiva contains the active substance is clopidoogrel . each tablet contains 75 mg of clopidaogrel ( as hydrogen sulphate ). the other ingredients are ( see section 2 ' clopideogrel xentiva contain lactose ' and ' clogidogl zentva contains hydrogenated castor oil '), mannitol ( e421 ), hydrogenatedcastor oil , microcrystalline cellulose , macrogol 6000 , low - substituted hydroxypropylcellulose , lactose monohydrate ( milk sugar ), hypromellose ( e
yttriga is a radioactive medicine that is stored in a refrigerator ( 2 - 8 ). it is stored at room temperature ( up to 25 ). it must not be used if it is accidentally frozen . the storage details are as follows : the product is a radioactive medicine that must be used immediately after reconstitution with another medicine . it is used in tiny radiation doses . the treatment is a radiolabelled medicinal product .
you must not be given yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of yttiga - you must not become pregnant if you think you may be pregnant . warnings and precautions talk to your nuclear medicine doctor before you are given ytriga . - yttrada is a radioactive medicine . it is used in combination with another medicinal product called radiopharmaceuticals . - the use of ytiga in combination is not recommended because it contains radioactive material . radioactive medicinal products are stored at 2 to 16 in the outer layer of the outer layers of
the treatment will be supervised by a doctor experienced in the diagnosis and treatment of infectious diseases . method of administration yttriga is for radiolabelling of medicinal products . it is used for specific diseases . yttrada is intended for administration by adults only . if you have been prescribed yttiga by your doctor , you will be monitored carefully for signs of overdose and will receive appropriate treatment .
like all medicines , yttriga can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
yttriga will be stored under the responsibility of the specialist in appropriate premises . storage will be in accordance with local regulations . the following information is intended for the specialist only : - radioactive substances - any unused product or waste material should be disposed of in accordancewith local requirements .
what yttriga contains - the active substance is chloride . 1 ml sterile solution contains 1 mg of hydrochloric acid ( equivalent to 3 mg / ml ). what yttrada looks like and contents of the pack yttiga is a clear , colourless type i glass vial with a flat bottom and a silicon stopper and an aluminium seal .
ciambra is a medicine used in the treatment of cancer . ciambra contains cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , which has not responded to prior chemotherapy . cimbra is also used in combination with cisplin for the initial treatment of patients with advanced stage of lung cancer . your doctor will determine how much ciamba you should receive depending on the type of lungcancer you have and on the severity of your disease . treatment with initial chemotherapy ciamra is a treatment for patients
do not use ciambra - if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of ciamb ( listed in section 6 ). - if breast - feeding is not recommended during treatment with ciamba . - if your child has recently received a vaccine against yellow fever . warnings and precautions talk to your doctor or pharmacist before using ciamBra . - you have or have had problems with your kidneys . before each infusion , your doctor will check your blood , kidney and liver function to make sure that you have enough blood cells to receive ciamra . your doctor may decide to
the recommended dose of ciambra is 500 mg for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your whole body . your doctor will work out your dose based on this body surface area and will adjust your dose and duration of treatment depending on your blood cell counts . your healthcare professional will have mixed the ciamra powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before it is given to you . ciamba will be given to your doctor by infusion into one of your veins . the infusion will last approximately 10 minutes . c
like all medicines , this medicine can cause side effects , although not everybody gets them . 52 tell your doctor immediately if you experience : fever or infection ( common ) with a temperature of 38ºc or greater sweating ( common ). infection may occur if you have less white blood cells than normal which is very common . infection ( sepsis ) may be severe and may lead to death . if you get chest pain ( common ), with a fast heart rate ( uncommon ). if you are having pain , redness , swelling or sores in your mouth ( very common ). allergic reaction ( common ): if you develop skin rash ( common ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expirability of the infusion solution of pemetrexed is 24 hours at 2 - 8 and 15 to 25 . the reconstituted solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours between 2 -8 and 15 and 25 . if used immediately the reconfituted product should be administered immediately . the infusion
what ciambra contains the active substance is pemetrexed . each vial of ciamba 100 mg contains 100 mg of pemetreed ( as pemetretrexed disodium hemipentahydrate ). each vials of cimbra 500 mg contains 500 mg of the active ingredient pemetereed (as pemetretted dis sodium hemipontahydrated ). after reconstitution , the solution contains 25 mg / ml of pemrexed without further dilution . the other ingredients are mannitol ( e421 ), hydrochloric acid ( for ph adjustment ), sodium hyd
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ). immunogam is used to treat certain infections in your blood . immunogaman may cause increased levels of human hepatitis b immunoglubulins , immunoglobinulin g ( ig ) and immunoglofluorubulin g in the blood plasma of healthy adults . immunoglogam can be used in adults . your doctor will test for these antibodies before you receive immunogams . immunomam is prepared by recombinant technology without addition of any human or animal derived components . immunogenam is intended for use in patients
immunogam should not be given to children and adolescents because an allergic reaction has been reported to human immunoglobulins or other blood products . if you have an iga deficiency , an allergic response to iga containing products may occur . children and adolescent ( aged 18 years and above ) immunoglubulins are not recommended for use in children and teenagers . signs of adverse reactions include chills , headache , fever and vomiting . signs for allergic reactions include nausea ( arthralgia ), joint pain and low blood pressure . moderate low back pain may be a sign of antibodies that have been present in hepatitis b
immunogam will be given to you by a doctor or nurse who is experienced in the care of patients with vaccination against hepatitis b virus . the first vaccine dose will be administered in combination with human hepatitis b immunoglobulin ( hbv ). administration prevention the recommended dose of hepatitis b is 500 mg given every 24 hours for 72 days . the recommended recommended dose for hepatitis b in haemodialysed patients is 500 μg given every 2 weeks . seroconversion is the first step in vaccination of hepatitis c by a hepatitis birus carrier . the hepatitis b antigen should be mixed with water for injection prior to administration
like all medicines , immunogam can cause side effects , although not everybody gets them . the most common side effects are : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) rare ( affects less than 1 users in 10 , 000 ): very rare ( affecting less than1 user in 1, 000 ) not known ( frequency cannot be estimated from the available data ) undesirable effects reported during clinical trials with immunogamer were : injection site reactions : common ( affect 1 to 1 user of 10 ) rare cases ( affects up
keep out of the reach and sight of children . do not use immunogam after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vials in the outer carton in order to protect from light . donot use immunoam if the solution is cloudy or contains deposits . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what immunogam contains - the active substance is human hepatitis b immunoglobulin . immunogams 1 mg / ml solution for injection contains 5 mg of human plasma protein ( equivalent to 96 mg / m2 ). - the other ingredients are polysorbate 80 . what immunogAM looks like and contents of the pack immunogamer is a solution forjection in a glass vial . it is a clear to pale yellow liquid . it comes in a pack of 1 vial with or without needle .
remicade contains the active substance infliximab . inflixumab is a monoclonal antibody a type of protein that recognises and attaches to a specific target in the body called tumour necrosis factor ( tnf ). remicade belongs to a group of medicines called ' tnfs blockers '. it is used to treat the following inflammatory diseases : rheumatoid arthritis psoriatic arthritis ankylosing spondylitis ( bechterew ' s disease ) psoriasis . remicades is used in adults , adolescents and children aged 6 years and older with crohn '
do not take remicade if you are allergic to infliximab or any of the other ingredients of remicades ( listed in section 6 ) if you think you may be allergic ( hypersensitive ) to any of these ingredients if you have tuberculosis ( tb ) if your doctor has told you that you have another serious infection , such as pneumonia , sepsis or heart failure if you drink alcohol before or during remicada . if you take reminade more often than you should if you accidentally take too many remicad tablets in the past , or if someone else accidentally takes your tablets , tell your doctor
the usual dose is : rheumatoid arthritis : 3 mg for every kg of body weight . psoriatic arthritis : ankylosing spondylitis ( bechterew ' s disease ), psoriasis , ulcerative colitis and crohn ' s diseases : 5 mg for each kg of the body weight , given once a week . how remicade is given remicine is given as an infusion ( drip ) over 2 hours into one of your veins ( usually in your arm ). the third treatment will be given once every week . if you are given more remicage than you should if
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some patients may experience serious side effects and may require treatment . if you experience any of the following side effects during your treatment with remicade , stop taking remicades and seek medical help immediately : - an allergic reaction : - swelling of your face , lips , mouth or throat , which may cause difficulty in swallowing or breathing , skin rash , hives and swelling of the hands , feet or ankles . these reactions are rare but could be life - threatening . an allergic allergic reaction may occur within
remicade will be stored by the health professionals at the hospital or clinic . keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store below 25 . remicade may be used for infusion after 3 weeks at 2 to 8 and for up to 28 days at room temperature ( up to 25 ). if not used immediately , in - use storage times and conditions prior to use are the responsibility
what remicade contains the active substance is infliximab . each vial contains 100 mg of inflixab . after preparation each ml contains 10 mg of infiximb . the other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate , dibasicodium phosphate . what remicades looks like and contents of the pack remicad is supplied as a glass vial containing a powder for concentrate for solution for infusion . the powder is white to off - white . remicada is available in packs containing 1 , 2 , 3 , 4 or 5 vials . not
rasagiline mylan is used to treat parkinson ' s disease in adults . it is used in combination with levodopa ( another medicine used to control parkinson ', s disease ). in parkinson's disease , there is a loss of cells that produce dopamine in the brain . dopamine is a chemical in the body that is important for movement control . rasagilinea mylan increases the amount of dopamine in your brain .
do not take rasagiline mylan - if you are allergic to rasagailine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have severe liver problems . warnings and precautions talk to your doctor or pharmacist before taking the following medicines : rasaline mylan contains monoamine oxidase ( mao ) inhibitors , used to treat depression and parkinson ' s disease . it is also a strong pain killer . it may affect the way some other medicines work . rasgiline melan treatment may be interrupted or stopped if you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 tablet once a day . take the tablet at about the same time each day . the tablet can be taken with or without food . take 1 tablet by mouth once a morning . take rasagiline mylan at about about thesame time each morning . if you take more rasgiline melan than you should if you accidentally take too many tablets of rasgailine , contact your doctor immediately . keep the rasaga mylan carton in order
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects of the combination of placebo and rasagiline mylan have been reported with frequency not known ( cannot be estimated from the available data ). the most common side effects are : common ( affects 1 to 10 users in 10 ) common ( affecting 1 to 100 users in 1 , 000 ) rare ( affects less than 1 user in 10 , 000 ). very common abnormal movements ( dyskinesia ) headache common abdominal pain fall allergy fever flu ( influenza ) feeling of being unwell neck pain chest pain ( angina pectoris )
what rasagiline mylan contains - the active substance is rasagailine . each tablet contains rasageiline tartrate equivalent to 1 mg rasgailine - the other ingredients are microcrystalline cellulose , tartric acid , maize starch , pregelatinized maize starch and talc , stearic acid . what rasaggilinemylan looks like and contents of the pack rasgiline tablets are 11 . 5 mm x 6 mm , white to off - white , biconvex tablets debossed with " r " on one side and "
do not use hulio - if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a severe infection , such as tuberculosis . if symptoms of infections ( such as fever , wounds , feeling tired ) occur , tell your doctor . - if the child has dental problems . - have moderate or severe heart failure . - had a serious heart condition before . warnings and precautions allergic reaction allergic reactions are symptoms of an infection such as chest tightness , wheezing , dizziness , swelling or a rash . tell your child ' s doctor immediately if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . polyarticular juvenile idiopathic arthritis in adults and adolescents from 2 to 17 years of age weighing 10 kg or more : the usual dose is 30 mg once a day . hulio 20 mg is available in 2 to 10 kg body weight . in adolescents from 17 years to less than 30 kg , the usual dosage is 30mg once a morning . hula 40 mg is also available in the following strengths : enthesitis - related arthritis in children from 6 to 17 months of age weighed 15
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate and may not require urgent medical treatment . tell your doctor immediately if you notice any of the following side effects ( which may occur up to 4 months after the last hulio injection ): allergic reaction including heart failure severe rash or hives swollen face , hands or feet trouble breathing , swallowing , pale complexion , dizziness , persistent fever , bruising or bleeding . tell the doctor immediately : signs and symptoms of infection such as fever , feeling sick , wounds , dental problems , burning on urination , feeling weak or
what hulio contains - the active substance is adalimumab . - the other ingredients are monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid and water for injections . what hulios looks like and contents of the pack hul io 40 mg is a sterile solution for injection containing 40 mg of adalimimumab in 0 . 8 ml of solution . the solution is clear to slightly opalescent and has a rubber stopper . hullio is available in packs containing 1 , 2 , 1 sterile injection syringe , 1 sterilile
the active substance of yellox is bromfenac . it belongs to a group of medicines called non - steroidal anti - inflammatory drugs ( nsaids ), which are used to reduce inflammation . yellox has been prescribed for the treatment of eye inflammation following cataract surgery in adults .
do not use yellox - if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). - if your asthma or skin allergy ( intense inflammation in your nose ) has become worse . - if using other nsaids ( such as acetylsalicylic acid , ibuprofen , ketoprofen or diclofenac ). this medicine may be used with topical steroids ( such such as cortisone ). - unwanted side effects - if there have been bleeding problems in the past ( such example if you have used other medicines to reduce bleeding time (
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of yellox is one drop in the affected eye ( s ) each day . the recommended starting dose is one single drop in your eye (s ) each morning for 2 days . the drops should be used within the next day following your cataract surgery . method of administration yellox is for oral use . wash your hands before using the eye drops . remove the bottle cap from the bottle . hold the bottle , pointing down , between your thumb and fingers , between
what yellox contains - the active substance is bromfenac . each ml of solution contains bromenac ( as sodium sesquihydrate ). each vial contains 33 mg of bromnac . - the other ingredients are boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride , tyloxapol , povidone ( k30 ), disodium edetate , sodium hydroxide to maintain acidity levels . what yellox looks like and contents of the pack yellox is a clear yellow liquid ( solution ) supplied in a vial
dzuveo contains sufentanil , which belongs to a group of strong painkillers called opioids . sufENTanil is used to treat sudden moderate - to - severe pain in adults .
do not take dzuveo if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious lung or breathing problem . warnings and precautions talk to your doctor or pharmacist before taking dzuvoo if : you have any condition that affects your breathing ( such as asthma , wheezing or shortness of breath ). dzuveco may affect your breathing during treatment . you have recently had a head injury or brain tumour . you suffer from problems with your heart and circulation such as slow heart rate , irregular heartbeat , low blood volume
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the single - dose administration device is for oral use only . you should swallow the tablet whole with a drink of water . do not chew or crush the tablet . you can take this tablet with or without food . dzuveo must be taken with strong painkillers such as sufentanil at least 30 minutes before or after food . the sublingual tablet must be swallowed whole with the disposable single -dose applicator . the applicator should be inserted into the tongue . if the tablets dissolve
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects : severe breathing problems , especially slow and shallow breathing . if you get any of these side effects you must stop taking dzuveo and contact your doctor immediately . very common side effects ( may affect more than 1 in 10 people ): nausea , feeling sick , vomiting , being sick and feeling hot . common side side effect ( may effect up to 1 in every 10 people ) are : inability or difficulty sleeping , feeling anxious or confused , dizziness ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do this medicine if you notice any visible signs of deterioration . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what dzuveo contains the active substance is sufentanil . each tablet contains 30 mg of sufantanil ( as citrate ). the other ingredients are mannitol ( e421 ), dicalcium phosphate , hypromellose , croscarmellose sodium , indigo carmine ( e132 ), stearic acid , magnesium stearate . what dzuveyo looks like and contents of the pack dzuvello is a white to off - white , round oval tablet with " nvr " debossed on one side and " 3 " debottled on the other
erveleada is a cancer medicine that contains the active substance apalutamide . it is used to treat prostate cancer that has spread to other parts of the body and cannot be removed with surgical treatments . it also works to treat sensitive prostate cancer which has spread beyond the original body and has not responded to surgical treatment . it reduces the amount of testosterone in the blood . it can also help to prevent resistant prostate cancer from growing . erleada increases the levels of androgens in the body . it works by blocking the action of and hormones called apalotamide , which are involved in the growth of prostate cancer cells .
do not take erleada - if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). - if pregnant or planning to become pregnant ( see section " pregnancy , breast - feeding and contraception section "). warnings and precautions talk to your doctor or pharmacist before taking this medicine . this medicine should not be used if you have or have ever had seizures . - if taking any medicines to prevent blood clots ( e . g . warfarin or acenocoumarol ). - tell your doctor if you suffer from any heart or blood vessel conditions . - tell
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg once a day . your doctor may increase your dose to 60 mg once daily depending on how you respond to erleada . take this leaflet and this medicine by mouth . you can take erleade with or without food . other medicines and erlead tell your doctor if you take , have recently taken or might take any other medicines . if you forget to take erlada if you miss a dose of erlea , take it as soon as you remember .
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking erleada and see a doctor immediately if you experience any of the following symptoms : reddish , non - elevated , target - like , circular patches on the trunk , central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes may be accompanied by fever and flu - like symptoms . toxic epidermal necrolysis ( see section 2 ). serious side effects tell your doctor straight away if you notice any of these serious sideeffects . fits ( seizure ) may
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of apaluamide . - the other ingredients are colloidal anhydrous silica , croscarmellose sodium , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose , silicified microcrystine celluloise . - in addition , the film - coating contains iron oxide black ( e172 ), iron oxide yellow ( e 172 ), macrogol , polyvinyl alcohol , talc , and titanium dioxide ( e171 ). what erlead
this medicine is a radiopharmaceutical product . axumin contains the active ingredient fluciclovine . it is used for the scan ( a pet scan ) in adults who have previously had treatment for prostate cancer and who have not had other tests to measure prostate specific antigen ( psa ) ( the type of protein that carries radioactivity ). the cancer has spread to other organs . an axumin pet scan may help to determine whether the cancer is sensitive to the radiation . your doctor will decide how long you should be treated with axumin . your nuclear medicine doctor will supervise this procedure . the radiopharma will be used
do not use axumin - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using axumin . - if your doctor has told you that you have kidney problems . - you should follow a low sodium diet . - axumin is given once a day for a day . the axumin scan will last approximately 4 hours . during the scan , you will be taking your usual medicines for the latest 60 minutes . you should urinate at least every hour after the scan . children and adolescents axumin should not
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin will only be handled and given to you by people who are trained and qualified to use this medicine safely . these persons will take special care for the safe use of this medicine and will keep you informed of their actions . the nuclear medicine doctor supervising the procedure will decide the quantity of axumin to be used . the usual dose is 370 megabecquerel per kilogram of body weight . the quantity to be administered depends on the type of radioactivity being radiated . the administration of axum will be in accordance with
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies , the following side effects were reported : very common ( may affect more than 1 in 100 people ): when using the medicine , the side effects associated with axumin were uncommon ( may effect up to 1 in every 100 people ). however , some of these effects were serious and were reported as pain , rash , altered taste in the mouth , altered sense of smell . the following serious side effects have been reported with this radiopharmaceutical : low amounts of ionising radiation associated with the least risk of cancer and hereditary abnormalities . reporting of
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only . do not use axumin after the expiry date which is stated on the label and carton after exp .
what axumin contains - the active substance is fluciclovine . axumin 1600 mg : each tablet contains 1600 mg fluciniclovine ( as mesilate ). each tablet of 16000 mg axumin 3200 mg : one tablet contains 3200mg flucucicline (as mesiline ). each tablets of 3200 milligrams contains 32000 milligram of flucinlovine , as mesolate . - the other ingredients are sodium citrate , concentrated hydrochloric acid and sodium hydroxide ( see section 2 " axumin with sodium "). what axumin looks
azopt contains brinzolamide which belongs to a group of medicines called carbonic anhydrase inhibitors . it works by reducing pressure within the eye . azopt eye drops help to reduce high pressure in the eye , which can lead to an illness called glaucoma . the pressure in your eye increases , which may damage your sight .
do not take azopt - if you have severe kidney problems - if your doctor thinks you are allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). - if any of these apply to you , tell your doctor before taking azopt . - if the patient is allergic to medicines containing sulphonamides ( medicines used to treat diabetes or infections ) or to diuretics ( water tablets ). warnings and precautions talk to your doctor or pharmacist before taking the tablets . some patients taking azop may develop the same allergy but may have too much acidity in their blood ( hyper
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . azopt is used for the eyes . use azopt in both eyes : 1 drop in each eye in the morning and 2 drops in the evening . use in both closed eyes : use azop in both the eyes for 1 week and 2 weeks . use within 3 weeks . remove the azopt bottle from the bottle and wash your hands . remove from the cap . the cap can be removed with a snap collar . hold the bottle tightly with your thumb or finger , pointing down towards your head . pull back
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : blurred vision , eye irritation , eye pain , eye discharge , itchy eye , dry eye , abnormal eye sensation , redness of the eye . other side effects : bad taste . uncommon side effects - effects affecting up to1 in 100 people ) ( effects in both the eye and sensitivity to light ) - inflammation or infection of the conjunctiva ( eye swelling , eyelid itching , red ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . to prevent infections , a pack containing a single bottle should be used immediately .
what azopt contains - the active substance is brinzolamide . each ml contains 10 mg of brinzaolamide ( as benzalkonium chloride ). - the other ingredients are carbomer 974p , edetate disodium , mannitol , purified water , sodium chloride , tyloxapol , hydrochloric acid and sodium hydroxide to maintain acidity levels and ph levels . what azopt looks like and contents of the pack azopt is a milky liquid ( a suspension ) supplied in a 5 ml plastic ( droptainer ) bottle with a screw cap . a pack containing
the active substance of forxiga , dapagliflozin , belongs to a group of medicines called medicines taken by mouth to treat diabetes . it works by reducing the amount of sugar in your blood . it is used in adults and adolescents ( aged 18 years and older ). how forxigo works for diabetes : type 1 diabetes is a problem that occurs when your body does not produce any insulin . forxig helps control the level of sugar made by your body in the blood . in people with type 1 , diabetes , such as overweight or obese , type 2 diabetes is more likely because your body has not been able to
do not take forxiga - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking forxigo : - if any of these apply to you , tell your doctor immediately . - if your doctor notices that you are feeling sick or being sick , - if this includes stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath , asweet or metallic taste in your mouth , a different odour to your urine or sweat
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . forxiga is also suitable for patients with type 2 diabetes . the usual starting dose is one tablet of 10 mg once a day ( morning ). your doctor may increase your dose to one tablet once a week ( morning ) or to one and a half tablets once a daily ( afternoon ). your dose may be increased to one or two tablets once daily ( morning and evening ). your healthcare professional will advise you on the right dose for you . if you have a liver problem , your doctor will tell you how much
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are angioedema ( seen very rarely , may affect up to 1 in 10 , 000 people ). angioEDema may cause swelling of the face , tongue or throat , difficulties swallowing , hives and breathing problems . diabetic ketoacidosis ( seen commonly , may affects up to1 in 10 people ) is a rare but serious complication of type 2 diabetes . it may affect between 1 in 1 , 000 and 1 in1 , 000 patients . diabeticketoacidemia may occur with increased levels of " ket
what forxiga contains the active substance is dapagliflozin . each forxigo 5 mg film - coated tablet ( tablet ) contains dapapagllozin propanediol monohydrate equivalent to 5 mg dapablifloin . the other ingredients are : tablet core : microcrystalline cellulose ( e460i ), lactose ( see section 2 under ' forxigiga contains lactose '), crospovidone , silicon dioxide ( e171 ), magnesium stearate . film - coating : polyvinyl alcohol ( partially hydrolysed ), titanium dioxide ( i171 ),
mifamurtide works by stopping the growth of certain bacteria which are not able to fight off the immune system . mepact is used to treat osteosarcoma ( bone cancer ) in adults and children aged between 2 and 30 years . it is used when surgery is not possible to remove the tumour and chemotherapy is not able or has stopped the growth and spread of cancer cells . it also helps to prevent cancer from coming back .
do not take mepact : if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). if you have ever taken medicines containing ciclosporin or other calcineurin inhibitors ( non - steroidal - anti - inflammatory drugs ). nsaids can affect your heart or blood vessels , which may result in blood clots ( thrombosis ), bleeding ( haemorrhage ), or inflammation of the veins ( vasculitis ). warnings and precautions talk to your doctor or pharmacist before taking mepactor . some of the effects of me
treatment mepact will be given to you by a doctor or nurse . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of mepACT is 2 mg mifamurtide once a day . your doctor will decide how many doses you need . the dose may be increased or decreased by your doctor . the maximum dose is 12 mg per kg body weight . your dose may need to be increased every 24 hours . your physician will decide when to stop your mepacts treatments . your chemotherapy schedule will be adjusted by your chemotherapy . the
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue have been reported in patients taking mepACT ( transient ) alone ( in combination with paracetamol ). if you experience fever during treatment with mepacts , you should contact your doctor immediately . stomach problems ( nausea and vomiting ) and loss of appetite have been seen in patients receiving chemotherapy . tell your doctor or nurse immediately if you have continuing fever and chills . these may be signs of an infection ( such as rash ). tell your physician or nurse if you get any problems breathing , wheezing or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in outer carton in order to protect from light . reconstituted suspension : sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection may be stored at room temperature ( up to 30 ) for up to 6 hours . do this medicine if you notice any visible sign of deterioration . do throw
what mepact contains the active substance is mifamurtide . each vial contains 4 mg of mifamanurtide ( as besilate ). after reconstitution and suspension , each ml contains 0 . 08 mg of the active ingredient mifmurtide per ml . the other ingredients are 1 - palmitoyl - 2 - oleoyl- sn - glycero - 3 - phosphocholine , 2 - dileoyls - sn -glycero- 3 - phosphate - l - serine monosodium salt ( see section 2 " mepacts contains sodium ").
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists . mirvaso is used on the skin and in the face to reduce redness associated with rosacea ( redness of the face ). rosica is caused by high levels of blood flow in theacial skin and enlargement ( dilution ) of the small blood vessels of the skin . miraso acts by blocking the blood vessels which help to reduce the excess blood flow and redness .
do not take mirvaso - if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 ) or to any of those listed in the section 2 " possible side effects "). warnings and precautions talk to your doctor or pharmacist before taking mirvasos : - if the medicine is injected under the skin ( subcutaneously ) - if your doctor has prescribed certain medicines for the treatment of depression or parkinson ' s disease ( monoamine oxidase ( mao ) inhibitors such as selegiline , moclobemide , tricyclic antidepressants ( such as
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . mirvaso is applied to the skin ( usually on the face ). this medicine is applied on the surface of your body . it is applied only to your body surfaces . do not apply it to your eyes , mouth , nose or vagina . do this to your genitals . do it to any part of your face that is not covered by the gel . if you use more mirvasos than you should if you have used more miraso mirvasoa is applied mainly to the face . the treatment should
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects : severe skin irritation or inflammation , skin rash , skin pain or discomfort , dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . common side effects ( may affect up to 1 in 10 people ): worsening of rosacea . the treatment should be stopped immediately if symptoms persist ( see section 2 " warnings and precautions "). contact allergy . allergic reaction may include rash and rare angioedema . if you have a serious allergic reaction , including swelling mainly of the face , mouth or tongue ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and tube and pump after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what mirvaso contains - the active substance is brimonidine . each ml of gel contains 3 . 3 mg of brimonine . each vial contains 5 mg of the active ingredient brimonate tartrate . - the other ingredients are : carbomer , methylparahydroxybenzoate , phenoxyethanol , glycerol , titanium dioxide ( e171 ), propylene glycol , sodium hydroxide , purified water ( see section 2 " mirvasoa contains methylparhydroxy benzoate "), propyleneglycol . what mirvasos looks like and contents of the pack mirvas
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that recognises and attaches to a specific target in the immune system ). it is used when the body is unable to fight infection or cancer . bevacsizumb binds to a protein called human vascular endothelial growth factor ( vegf ), which is found in lymph vessels all over the body . the vegF protein is found on blood vessels where it stimulates the blood vessels to produce more oxygen . be vacizumaab stimulates tumour growth by helping the blood arteries
do not use this medicine if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic ( allergic or hypersensitive ), to chinese hamster ovary ( cho ) cell products if you or your child are pregnant . warnings and precautions talk to your doctor or pharmacist before using mvasi . mvasiar may increase the risk of developing holes in the gut wall ( inflammation inside the abdomen ), such as diverticulitis , stomach ulcers , colitis or chemotherapy . mvai may increase your
dose and frequency of administration your doctor will work out the dose of mvasi you will receive based on your body weight and the type of cancer you have . the usual dose is 5 mg , 7 . 5 mg or 10 mg per kg of body weight , given once every 15 days . your doctor may adjust the dose depending on your general condition and on your size of tumour growing . your dose of this medicine will be calculated by your doctor . you will be given mvasis either 2 or 3 weeks after your last dose . the number of infusions you receive will depend on how you respond to treatment . your physician will
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with mvasi : side effects that may occur during treatment with mvai are listed below . the side effects listed below have occurred with chemotherapy . if you notice any of these side effects while you are being treated with mvva , stop taking mvasis and seek medical help immediately . allergic reactions tell your doctor straight away if you have an allergic reaction including difficulty in breathing , chest pain , redness or flushing of the skin , a rash , chills or shivering , feeling sick ( nausea )
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outercarton in order to protect from light . infusion solutions should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 8 unless dilution has taken place
what mvasi contains the active substance is bevacizumab . each ml contains 25 mg of bevaconizumb in 1 . 4 ml or 16 . 5 ml of solution . each 4 ml vial contains 100 mg of the active substances bevocizumib in 1. 4 ml of water . each 16 ml vials contains 400 mg of of beviacizumaab in 16 . 75 ml of solvent . the other ingredients are trehalose dihydrate , sodium phosphate , polysorbate 20 and water for injections . what mvasis looks like and contents of the pack
tecartus is a gene therapy medicine used to treat mantle cell lymphoma . it is used in combination with other medicines to treat refractory mantle cell cancer ( mcl ). tecartus works by interfering with the activity of your own white blood cells ( autologous anti - cd19 - transduced cd3 + cells ). mantle cell lipoma is a cancer that affects the immune system ( the body ' s natural defences ) and affects the number of b - lymphocytes . mantle cell lysis is caused by b - cells entering the lymph tissue ( the bone marrow ) and making blood less able to carry the white
do not use tecartus if you are allergic to any of the ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using tecartuse if you : have ever had problems with white blood cells in your blood ( lymphodepleting chemotherapy ) have a problem with 3 % of white blood cell ( autologous use ) have tests or checks to check that your lungs , heart , kidney , blood pressure , infection or inflammation have been reported with your cancer ( graft - versus - host disease ) have had a transplant
tecartus is made from your own white blood cells . your cells are collected by a specialised healthcare professional . your cell will be collected and given to you by a catheter placed in your vein ( a procedure call leukapheresis ). the amount of your white blood cell in your blood will be measured by your doctor . the recommended dose is : one infusion of your blood ( intravenously ) every 3 weeks for 6 weeks . the number of yourwhite blood cells will be calculated by your healthcare professional over 2 to 3 weeks . medicines given before tecartus treatment is given to patients undergoing lymphodepleting chemotherapy
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss your side effects with you . if you notice any of the following side effects you may need urgent medical attention . the following serious side effects have been reported during the tecartus infusion : very common ( may affect more than 1 in 10 people ): fever , chills , reduced blood pressure . symptoms may include dizziness , lightheadedness , fluid in the lungs . all symptoms could be signs of a condition called cytokine release syndrome . loss of consciousness ( decreased level of consciousness ), confusion , memory loss , disturbances of brain function
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . infusion bag : store in the original package in order to protect from light . diluted solution : chemical and physical in - use stability of liquid nitrogen has been demonstrated for 150 days at 2 - 8 . this medicine contains genetically modified human blood cells and is essentially free of human - derived material . the product is stable for 36 hours at 2 to 8
what tecartus contains - the active substance is autologous anti - cd19 - transduced cd3 + cells . each patient - specific single infusion bag contains a dispersion of anti - cd19 car t cells in approximately 68 ml ( corresponding to 2 x 106 anti - dc19 car ) cells . - the other ingredients are sodium chloride and human albumin ( see section 2 " tecartuses contains sodium "). what tecartub looks like and contents of the pack tecartu is a clear , colourless to pale yellow solution for infusion . it is supplied in an infusion bag which is packed in
januvia contains the active substance sitagliptin which belongs to a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) that lowers blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar , which is too high because of your type 2abetes . this medication can be used alone or with certain other medicines ( insulin , metformin , sulphonylureas or glit
do not take januvia - if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have inflammation of the pancreas ( pancreatitis ). warnings and precautions talk to your doctor or pharmacist before taking januvi if you have : - blistering of the skin ( bullous pemphigoid ). januvin may cause a disease of the pancreatreas called pancreatitis ( gallstones ). - alcohol dependence . - very high levels of triglycerides ( a type of fat ) in your blood . you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 100 mg film - coated tablet 63 once daily by mouth . if you have kidney problems , your doctor may prescribe a lower dose of 25 mg or 50 mg . you should continue taking this medicine until your doctor tells you otherwise . if your doctor advises you to stop taking this medication , your dose may be reduced or you may have to take certain other medicines to control blood sugar . diet and exercise can help your body use its blood sugar better . januvia can be taken with or
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact a doctor immediately if you notice any of the following serious side effects : severe and persistent pain in the abdomen ( stomach area ), which might reach through to your back , with or without nausea and vomiting , as these could be signs of an inflamed pancreas ( pancreatitis ). if you have a serious allergic reaction ( frequency not known ), including rash , hives , blisters on the skin , peeling skin , swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains sitaglptin phosphate monohydrate equivalent to 25 mg sitaglioptin . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate , croscarmellose sodium , magnesium stearate and sodium stearyl fumarate . the tablet film - coating contains poly ( vinyl alcohol ), macrogol 3350 , talc , titanium dioxide ( e171 ), red iron oxide ( e172 ) and yellow iron oxide . what januves looks like and contents of the pack pink
xultophy works by lowering the amount of blood glucose in the body . this is important to help control the level of sugar in the blood . it is used to treat type 2 diabetes mellitus in adults . diabetes is when your body does not make enough insulin to control the levels of sugar . your body also makes too much of the insulin it produces , which leads to an increase in blood sugar . insulin degludec is a long - acting basal insulin . it helps to control your blood sugar levels by lowering your dose of liraglutide ( a type of glp - 1 ) and insulin during meals .
do not take xultophy if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). 39 if you have a sulfonylurea such as glimepiride or glibenclamide . your sulfonylation dose should be reduced to a minimum of one tablet daily . your doctor will monitor your blood sugar levels regularly while you are taking xulturo . if you suffer from type 1 diabetes mellitus or ' ketoacidosis ', a condition which occurs after you start taking xulinophy , you may be at
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have been blind or have poor eyesight , your doctor may need to adjust your dose to maintain your blood sugar level . the recommended dose of xultophy is 41 mg once a day . you should take xultue for 8 weeks . if necessary , you may take it with or without food . if your doctor advises you to take xulophy at the same time each day , you should continue to take it at the usual times . if possible , you can take it in the morning and
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects : low blood sugar ( very common ( may affect more than 1 in 10 people ) if your blood sugar level gets low you may pass out or become unconscious . this could be a sign of serious hypoglycaemia ( which may cause brain damage ). low blood sugars can be very serious . your doctor will check your bloodugar level regularly . if you have low bloodugar , hypoglycasemia can be serious . see section " warnings and precautions " for more information .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening , the product may be stored at room temperature ( up to 30 ) for up to 8 weeks . after this , the medicinal product may not be stored above 21 and must be discarded . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will
what xultophy contains the active substances are insulin degludec and liraglutide . each ml contains 100 units of insulin degluudec 3 . 6 mg liragolutides in 3 ml solution . each vial contains 300 units of the active substance insulin deglonudec 10 . 8 mg liraaglunide . the other ingredients are glycerol , phenol , zinc acetate , hydrochloric acid and sodium hydroxide ( for ph adjustment ). the solvent is water for injections ( see section 2 " xultphil contains sodium "). what xultos looks
what giotrif is giotrienif is a medicine that contains the active substance afatinib . it works by blocking two proteins called egfr [ epidermal growth factor receptor - 1 ] ( egfr1 ) and her2 [ erbb2 ] ( erbb3 ). these proteins are involved in the growth of cancer cells . this medicine stops these proteins from growing and kills cancer cells , helping to stop them from growing . what giotrinif is used for this medicine is used to treat cancer of the lung ( non - small cell lung cancer ). giotriif is prescribed for you as your first
do not take giotrif - if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) - if your doctor has told you that you have low body weight ( less than 50 kg ) - have kidney problems - if any of these apply to you , tell your doctor straight away . warnings and precautions talk to your doctor before taking giotralif if you have any of any of those conditions : lung inflammation ( interstitial lung disease ) - liver problems - your doctor may need to change the dose of some liver tests before you start taking this medicine - if the patient
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . you should take this tablet at the same time each day . giotrif can be taken with or without food . swallow the tablet whole with a glass of water . you can take this this medicine with or just after food . you may take this with or with food . if you take more giotrinif than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , take this leaflet with you so
like all medicines , giotrif can cause side effects , although not everybody gets them . the most serious side effects are usually mild to moderate and usually disappear after a few days to a few weeks of treatment . diarrhoea common ( may affect up to 1 in 10 people ): diarrhoehoea may occur within 2 hours of starting treatment . severe diarrhoee with or without fluid loss common ( might affect up in 1 in every 10 people ) low blood potassium and worsening kidney function . if you experience diarrhoeea or diarrhoeas contact your doctor immediately , as appropriate antidiarrhoeal treatment may be needed .
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of afatinab . - the other ingredients are lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate . - tablet coating : hypromellose , macrogol 400 , titanium dioxide ( e171 ), polysorbate 80 . what giotrarif looks like and contents of the pack giotarif 20 mg film - coating tablets are white to off - white , round , biconvex ,
what orkambi is orkamsi contains two active substances called lumacaftor and ivacaftOR . it is a medicine used for long - term treatment of cystic fibrosis ( cf ) in patients aged 6 years and older with a mutation called f508del mutation . f508d is a protein that is found in the cystic Fibrosis transmembrane conductance regulator ( cftr ) in the lungs . the mutation causes an abnormal cftR protein that does not respond to lumacafor . how does ivacftor work ? lumacftOR works by blocking the abnormal
do not take orkambi if you are allergic to lumacaftor or ivacaftour or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking orkammi . if you have orkabababib , the f508del mutation may occur . this is because orkaban may affect the way some other medicines work . if this happens , tell your doctor . if any of these apply to you , tell the doctor . talk to the doctor before taking this medicine . if your kidney is not working properly , the dose of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 6 to 12 tablets a day . your doctor will tell you how many tablets to take . the usual orkambi tablet is 6 tablets a morning , 6 to 11 tablets a afternoon . your dose of orkammi is 100 mg once a day ( 2 tablets a 2 - hour ) for 2 weeks . your daily dose is 12 tablets of orkyambi once a morning . your usual dose is 200 mg once daily ( 2 tablet a day ) for two weeks . if
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported with orkambi are usually mild to moderate . if you are given ivacaftor , stop taking orkami and tell your doctor straight away . serious side effects that may occur with or kambi include raised levels of liver enzymes in the blood , liver injury , pre - existing severe liver disease , and the worsening of liver function . other side effects include uncommon ( may affect up to 1 in 100 people ) the following symptoms : pain or discomfort in the upper right stomach ( abdominal ) area yellowing of
what orkambi contains the active substances are lumacaftor and ivacaftir . orkammi 100 mg film - coated tablets each tablet contains either 125 mg lumacftor or 125 mg ivacftir . each orkamberi 200 mg film film - coating each tablet contain either 125mg lumacaptor or 200 mg iviacaftor . each tablet also contains either 100 mg ivocaftor or 250 mg or 200mg ivacaptir . the other ingredients are : orkabambi 100mg film - coat each tablet consists of 125 mg orkaban 200 mg or
what lynparza is lynparz contains the active substance olaparib . olaparaib is a type of cancer medicine known as a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ). it works by stopping the growth of cells with mutations ( changes ) in a gene called brca ( breast cancer gene ). in cancer , parp inhibitors cause death by stopping cancer cells from multiplying and multiplying . how lynparaz works olaparateib blocks the action of an enzyme needed to repair dna . what lynparzar is used for lynparanza is used to
you must not be given lynparza if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ). if you think this applies to you , tell your doctor before you are given lynarza . warnings and precautions talk to your doctor , pharmacist or nurse before you receive lynparz . if you have any of these conditions , tell the doctor , nurse or pharmacist before you have lynparaz . low blood cell counts ( seen in testing ) low counts of red or white blood cells ( seen as a sign of low platelet counts ) see section 4 possible side
always take lynparza capsules exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of lynparz is 100 mg once a day . your doctor may increase your dose to 150 mg once daily . the doses of lynarza capsules are taken together with tablets . if you take more than a capsule of lynpalza once a night , you may experience side effects for 8 hours . take the tablets by mouth . take them at least one hour before or one hour after your meal . if possible , take the tablet at about the same time each day . if necessary
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , pale skin , fast heart beat . these may be symptoms of a decrease in the number of red blood cells ( anaemia ). uncommon ( may effect up to 1 in 100 people ): allergic reactions including hives , difficulty breathing or swallowing , dizziness . signs and symptoms of hypersensitivity reactions may include other side effects . very commonly ( may affects more than one in 10 users ): feeling sick ( nausea ) being sick ( vomiting ) feeling tired or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store any lynparza capsules in the original package in order to protect from light . after first opening , lynparZA capsules may be stored at room temperature ( up to 30 ) for a maximum period of 3 days . discard any capsules that have been stored at the room temperature . do this once the capsules have been opened . do away with
what lynparza contains - the active substance is olaparib . each hard capsule contains 50 mg olaparaib . - the other ingredients are lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black ( e172 ). what lynparz looks like and contents of the pack white , opaque , hard capsule with " olaparatib 50 mg " imprinted on one side and a plain , white to off - white , hard cap with " astrazeneca logo on the other side . lyn
this medicine contains the active substance naloxone . nalxone is used to treat opioids such as heroin , methadone , fentanyl , oxycodone , buprenorphine and morphine in adults . nyxoid is also used as a nasal spray for the emergency treatment of opioid overdose in adults , adolescents and children . opioid overdose is a serious , life - threatening , and can be fatal in some cases . it is usually treated within 14 days . overdose may cause breathing problems and severe sleepiness . if you have an opioid overdose , you should be aware that opioids may be more likely to be given to you
do not use nyxoid if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using nyxoids . you may need emergency medical care or emergency services if you have an opioid overdose . the signs and symptoms of an opioid dose may be similar to those of an overdose . using this nasal spray for 2 to 3 days , you should use a new nasal spray . if you use more nyxid than you should if you think you have used more nixoid than you need , talk to a
always use nyxoid nasal spray exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . 1 . symptoms should be : shoulders , ears , breastbone , sternum , ear , fingernail . 2 . clear the mouth and nose of any blockages . 3 . open the mouth or nose . 4 . breathe deeply . 1 ) the chest moving ( chest ) is the airway that connects the chest with the airways . you may hear breathing sounds and breath on the cheek . overdose may occur . the most common response to touch or sounds is slow uneven breathing . breathing may
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : nyxoid may cause acute withdrawal symptoms from opioid drugs . symptoms may include fast heart rate , high blood pressure body aches , stomach cramps , feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps , shivering , trembling changes in behaviour , including violent behaviour , nervousness , anxiety , excitement , restlessness , irritability unpleasant or uncomfortable mood increased skin sensitivity difficulty in sleeping . acute withdrawal reactions may affect up to 1 in 100 people . these symptoms are very common (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains the active substance is naloxone . each nasal spray contains 1 . 8 mg of nalxone . the other ingredients are : ( in the solvent : hydrochloride dihydrate ), trisodium citrate dihydrates , sodium chloride , hydrochloric acid , sodium hydroxide , purified water . what nyxoids looks like and contents of the pack nyxoidal is a 0 . 1 ml clear , colourless to pale yellow solution for injection in a pre - filled nasal spray . it is supplied in a single dose container . nyxax is available in a carton
what ovaleap is ovaleape contains the active substance follitropin alfa , which is a gonadotropin ( a type of hormone that is produced naturally in the body ). follitroin ala is a hormone produced by the body called fsh . it is involved in the growth and development of the sacs ( follicles ) in the ovaries . it plays an important role in the production of sperm and in the development of a immature egg cell . ovaleaps is used in adults , adolescents and children who are not ovulating . it may be used in combination with treatment with a medicine called
do not use ovaleap if you are allergic to follitropin alfa , a type of follicle stimulating hormone , or any of the other ingredients of this medicine ( listed in section 6 ). if you have a tumour in your hypothalamus or pituitary gland ( the brain ). if your ovaries are large ovaries ( sacs of fluids that carry blood from the ovaries to the womb ). if ovarian cysts are unexplained vaginal bleeding . if you know that you have cancer in your ovary , womb or breasts . if any condition that makes normal pregnancy impossible such as ovarian failure or early menopause
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use this medicinal product is for injection into the tissue just under the skin ( subcutaneous injection ). if you have irregular periods , you will only be given this medicine once every day for the first 7 days of your menstrual cycle . if you do not respond to the medicine , you may be given a second dose of this medicine . the usual dose is 75 mg once a day . your doctor will tell you the dose to use . the maximum recommended dose is 150 mg once daily . you will
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with ovaleap : serious side effects in women allergic reactions such as skin rash and raised itchy areas of skin . severe allergic reactions may include weakness , drop in blood pressure , difficulty breathing and swelling of the face . 37 rare ( may affect up to 1 in 10 , 000 people ) this type of reaction may occur after your ovaleape injection . tell your doctor immediately if you notice any of the following serious sideeffects in women lower stomach ache , nausea and vomiting . these may be the symptoms of ovarian
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the cartridge after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . this medicine may be stored for a maximum of 3 days below 25 . do this medicine if it has been stored for more than 3 days in a freezer ( 2 - 8 ). once removed from the freezer , the cartridge must be used within 28 days of storage
what ovaleap contains the active substance is follitropin alfa . ovaleep 300 micrograms / 0 . 5 ml solution for injection each cartridge contains 300 microlitres 22 of follitroin ala in 0 . 05 ml solution . ovalesap 450 microgram s / 0. 75 ml solution : each cartridge produces 450 microlitre 33 of follitonropin alpha in 0.75 ml solution , each cartridge delivers 900 microliters 66 of follionropin α in 1 . 5ml solution . the solution contains 600 microlitris 44 of follin alpa . the other ingredients
voriconazole accord contains the active substance voriconazol . voricoazole is an antifungal medicine that works by killing or stopping the growth of the fungi that cause infections . it is used in adults and children from the age of 2 years to treat invasive aspergillosis ( a type of fungal infection caused by aspergonillus sp ) and candidaemia ( a form of fun fungal illness caused by candida sp ). in non - neutropenic patients ( patients with abnormally low white blood cells count ) to treat candida spots infections caused by the fungus flucon
do not take voriconazole accord - if you are allergic to voricleazole or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you are taking any other medicines , including herbal medicines . the medicines listed below may affect the way voricoazole accord treatment works . 46 terfenadine ( used to treat allergy ) astemizole ( used for allergy ) cisapride ( used in stomach problems ) pimozide ( used when treating mental illness ) quinidine ( used if your irregular heart beat is not well controlled by
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will work out your dose based on your weight and the type of infection you have . the usual dose is 40 mg once a day . this dose may be increased to 40 mg twice a day for 24 hours . your dose may also be increased by 400 mg once daily for 12 hours or 200 mg once every 12 hours for 24 24 hours or by 200 mg twice daily for 100 hours . depending on how you respond to treatment , your doctor may increase your dose to 300 mg once weekly . if you
like all medicines , this medicine can cause side effects , although not everybody gets them . if any side effects occur , you should contact your doctor immediately . serious side effects stop taking voriconazole accord and tell your doctor straight away : rash , jaundice ( changes in blood tests of liver function ), pancreatitis . other side effects include : very common ( may affect more than 1 in 10 people ): visual impairment ( change in vision ), blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision , night blindness , swinging vision , seeing sparks , visual aura ,
what voriconazole accord contains the active substance is vorinazole . each tablet contains 50 mg of voronazole ( as besilate ). voricoazole accord 50 mg film - coated tablets : each tablet has 200 mg of the active ingredient voritonazole , the other ingredients are : voricleazole acid 200 mg : the other ingredient is lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate . the other tablet coating is hypromellose , titanium dioxide ( e171 ),
mvabea is a vaccine to protect you against ebola virus disease in the future . it is given to adults , adolescents and children from 1 year of age with ebolairus . it will be given as a 2 - dose course of vaccinations . the two types of ebola viruses are the zaire ebolavirus and filovirus . this vaccine contains the whole ebola influenza virus . it does not give you ebola disease . warnings and precautions talk to your doctor or nurse before you are given mvabe a vaccine . vaccinations : you will receive one dose of zabdeno vaccine about 8 weeks later
your doctor will decide on the vaccination course and the dose of the vaccine you should receive . if you have had a severe allergic reaction to any of the ingredients in section 6 . if a severe allergy reaction to an antibiotic called ' gentamicin ' occurs , the vaccine should not be given . warnings and precautions talk to your doctor or nurse before you are given mvabea if you : have had or have ever had asevere allergic reaction , to any other vaccine injection , or fainted during or after an injection . bleeding or bruise easily . have currently had a fever or an infection . are taking medicines that affect the immune
the recommended dose of vaccine is a muscle ( intramuscular injection ) in the upper arm , thigh or blood vessel . the recommended dose is one dose of mvabea vaccine ( 0 . 5 ml ) given 8 weeks later . if you are given more mvabdeno vaccine than you should the second vaccine will be given as a single dose . the first dose of the second dose is given as an additional dose . if your child is not fully immunised against the other type of vaccine , your doctor will decide the dose that is best for your child . primary vaccination first vaccination with zabdenoe red cap
like all medicines , this vaccine can cause side effects , although not everybody gets them . the following side effects may happen with mvabea : very common ( may affect more than 1 in 10 people ): pain , warmth , swelling or where the injection is given very tired muscle ache joint pain common ( might affect up to 1 in every 10 people ) feeling sick ( vomiting ) itching where the vaccine is given uncommon ( may affects up to1 in every 100 people ): redness , skin hardness where thejection is given generalised itching . the most common side effects are : common ( likely to affect up in 1 in < 1
what mvabea contains the active substance is zaire ebolavirus 29 produced in tai forest ebolovirus nucleoprotein marburg in 0 . 7 ml of solution for injection ( equivalent to 108 micrograms ). the other ingredients are : chicken embryo fibroblast cells . this vaccine contains trace residues of gentamicin , sodium chloride , trometamol , water for injections , and hydrochloric acid ( for ph adjustment ). what mvabaa looks like and contents of the pack mvagaa is a suspension for injection in a single - dose glass vial with a rubber sto
bondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . it is used to treat breast cancer that has spread to your bones ( called ' bone ametastases '). it helps to prevent your bones from breaking ( fractures ). it also helps to reduce the risk of other bone problems that may need surgery or radiotherapy bondronat can be used if you have a raised calcium level in your blood due to a tumour or if there is a lot of calcium lost from your bones . this helps to stop your bones getting weaker .
do not take bondronat : if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ) if you have low levels of calcium in your blood . warnings and precautions talk to your doctor or pharmacist before taking bondronAT if you develop a serious side effect called osteonecrosis of the jaw ( onj ). onj can lead to bone damage in the jaw . your doctor may decide to reduce your dose of bondronate or stop treatment if you suffer from cancer or related conditions . onj may also lead to stopping treatment . on j is a painful condition
this medicine is given to you by a doctor or nurse with experience in the treatment of cancer . it is given as an infusion into your vein . your doctor will carry out regular blood tests to check how well you are being treated with bondronat . your dose of this medicine will depend on your illness . if you have breast cancer that has spread to your bones , it will usually be given 3 - 4 weeks after an infusion in your vein , but may be given up to 15 days if you are having a raised calcium level in your blood . this dose may be repeated every 1 to 2 weeks , depending on your condition and on
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ) persistent eye pain or inflammation new pain , weakness or discomfort in your thigh , hip or groin . this may be a sign of unusual fracture of the thigh bone . very rare ( might affect up in 1 in 10 , 000 patients ) pain or sore in your mouth or jaw . these may be signs of severe jaw problems ( necrosis ( dead bone tissue ) in the jaw bone
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . after dilution the infusion solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2ºc - 8ºc . do this medicine if it is accidentally frozen . do throw away any medicines via wastewater or household waste
what bondronat contains - the active substance is ibandronic acid . each 2 ml vial contains a concentrate for solution for infusion that contains 2 mg ibandronat . - the other ingredients are sodium monohydrate , sodium chloride , acetic acid , sodium acetate , water for injections . what bondronAT looks like and contents of the pack 1 ml vials with a bromobutyl rubber stopper .
what zeposia is zeposeia belongs to a group of medicines that affect the number of white blood cells ( lymphocytes ). what zepOSia is used for zepoesia is a treatment for adults with relapsing remitting multiple sclerosis ( rrms ), a rare but active disease that affects the nerves of the brain and spinal cord . symptoms include numbness , difficulty in walking and problems with vision and balance . relapsING remitting ms attacks on the nerve cells may cause the symptoms to disappear for a few periods or even be permanently removed . some problems may be serious . how zeposes
do not take zeposia : if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severely weakened immune system . if you had a heart attack ( angina , stroke , mini - stroke or transient ischemic attack ). if any of these apply to you ( or you are not sure ), talk to your doctor or pharmacist before taking zepoia . warnings and precautions talk to you doctor or nurse before taking this medicine : if any part of your body has a history of severe heart failure ( especially in the last 6 months ). if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor will work out the right dose of zeposia based on your heart rate . your doctor may prescribe you a ' treatment initiation pack ' with orange capsules . the first 4 days of treatment are 0 . 23 mg ozanimod per day . the next 1 day of treatment is 4 mg ozamanod per morning . the total daily dose for the first 3 days is 0 . 46 mg ozmod per kg body weight . the maximum daily dose is 5 mg ozan
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects : very common ( may affect more than 1 in 10 people ): slow heart rate urinary tract infection ( raised blood pressure ) uncommon ( may effect up to 1 in 100 people ): allergic reaction . the signs may include a rash . other side effects include : very rare ( may affects more than one in 10 , 000 people ): infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx ) or voice box ( larynx
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine in the original package in order to protect from moisture . do do not take this medicine if you notice any damage or signs of tampering to the pack . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what zeposia contains the active substance is ozanimod . zeposeia 0 . 23 mg : each capsule contains 0 . 22 mg ozanimog ( as hydrochloride ). zepoesia 0 , 46 mg : one capsule contains approximately 0 . 46 mg ozimod ( as hydration ). the other ingredients are microcrystalline cellulose , silica , colloidal anhydrous , croscarmellose sodium , magnesium stearate . capsule shell : 0 . 03 mg : the other ingredient is gelatin , titanium dioxide ( e171 ), yellow iron oxide ( e172 ), black iron oxide
what temybric ellipta is temybaellipta contains two active substances called fluticasone furoate and umeclidinium bromide and vilanterol . fluticusone furaate belongs to a group of medicines called corticosteroids ( steroids ). umecylidinia bromate and vilterol belong to agroup of medicines known as bronchodilators . what temybarric elliptoe is used for temyborric elliptea is used to treat chronic obstructive pulmonary disease ( copd ). copd is a long -
do not use temybric ellipta - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using temy bric ellipte - if your child has asthma . temyibric elliptoe should not be used in children with asthma . - if the child has heart problems , high blood pressure , liver problems . - tell your doctor if your baby has tuberculosis ( tb ) of the lung . - any long standing or
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . do not take more temybric ellipta than your doctor tells you to . if you use more temxybric ellipta than you should if you have used more tembric e9ipta , contact your doctor immediately . symptoms of temybreric elliptoe may include a sudden attack of breathlessness or wheezing . if this attack occurs
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing or wheezing gets worse while taking this medicine , stop taking temybric ellipta and seek medical help straight away . pneumonia ( infection of the lung ) in copd patients the most common side effect of temy bric elliptoe is symptoms of a lung infection such as fever and chills , increased mucus production , change in mucus colour , increased cough and increased breathing difficulties common side effects ( may affect up to 1 in 10 people ) are sore or raised patches in the mouth or throat ,
what temybric ellipta contains - the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each delivered dose contains 92 micrograms of flutic asone firoate , 65 microgram of umeleclidine bromate and 55 microgram s of umclidinia bromides ( equivalent to 22 microgram / ml of vilancerol ) and trifenatate . - the other ingredients are lactose monohydrate ( see section 2 under ' temy bric elliptfa contains lactose '
zinforo is an antibiotic medicine that contains the active substance cefaroline fosamil . it belongs to a group of medicines called 'cephalosporin antibiotics '. zinforo helps to treat infections of the skin and the tissues below the skin . it is used to treat an infection of the lungs called ' pneumonia '. how zininforoe works zin foro works by killing certain bacteria that cause serious infections .
do not use zinforo if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to othercephalosporin antibiotics . if you have had previous severe allergic reactions to other antibiotics ( such as penicillin or carbapenem ). warnings and precautions talk to your doctor or pharmacist before using zin foro . tell your doctor if you : have kidney problems . have ever had seizures or convulsions . have had any non - severe allergic reaction to otheriotics ( such such as pensic
the recommended dose of zinforo is 600 mg once a day . your doctor will tell you how many tablets to take . the recommended dose is one 600 mg tablet once a week for up to 8 weeks . some infections may be serious . the dose is 8 600 mg twice a week . the first dose is given as a drip into a vein . the second dose is 5 to 60 mg once every 120 days . your dose may be increased or decreased by an increased dose . your treatment will usually last for 5 to 14 weeks . if you have skin infections , your doctor may give you 5 to 7 tablets once a month for
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , swallowing or breathing problems , asevere allergic reaction ( anaphylaxis ), diarrhoea , stool , blood or mucus . your doctor may decide to stop treatment with zinforo or to give you medicines to slow bowel movement ( see section " other medicines and zin foro "). a blood test called a ' coombs test ' will
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains the active substance is ceftaroline fosamil . the other ingredients are arginine and water for injections . what zinofo looks like and contents of the pack zinfforo is a pale yellowish to light yellow powder for concentrate for solution for infusion in a vial . it is supplied in packs containing 10 vials .
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central neuropathicpain : pregabalin fizer is used to relieve long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral neuropathic Pain , such as diabetes or shingles . pain sensations may be described as hot , burning , throbbing , shooting , stabbing , sharp , cramping , aching , tingling , numbness , pins and needles . peripheral or central neuropathy pain may also be associated with mood
do not take pregabalin pfizer - if you are allergic to pregagabalin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking pregaberalin psfizer . some patients taking pregaabalin have reported symptoms suggesting an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat and diffuse skin rash . should you experience any of these reactions , you should contact your doctor immediately . pregibalin has been associated with dizziness and somnolence , which may increase the occurrence
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . pregabalin pfizer is for oral use . peripheral and central neuropathic pain , epilepsy and generalised anxiety disorder the usual dose is 150 mg once a day . your doctor may increase your dose to 600 mg once daily depending on your response to pregibalin psfizer . take pregaboralin pfeizer once in the morning and once inthe evening . for 59 patients taking pregafalin pfingizer once a morning , once in a day , at about the same
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people dizziness , drowsiness , headache . common : might affect up to 1 in every 10 people increased appetite . feeling of elation , confusion , disorientation , decrease in sexual interest , irritability . disturbance in attention , clumsiness , memory impairment , loss of memory , tremor , difficulty with speaking , tingling feeling , numbness , sedation , lethargy , insomnia , fatigue , feeling abnormal , blurred vision , double vision , vertigo , problems with balance
what pregabalin pfizer contains the active substance is pregibalin . each hard capsule contains 25 mg , 50 mg , 75 mg , 100 mg , 150 mg , 200 mg , 225 mg or 300 mg pregabialin . the other ingredients are lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica . the printing ink contains black ink , shellac , black iron oxide ( e172 ), propylene glycol ( e1520 ), potassium hydroxide ). the 75 mg capsules
xadago is a medicine that contains the active substance safinamide , which increases the levels of dopamine in the brain . this is a chemical in the body that is important for movement . it is used to treat parkinson ' s disease . parkinson ', s disease , causes sudden swings in the ability to move . people with this condition may have difficulties moving . xadago can be used alone or in combination with the medicine levodopa , or with other medicines used to control parkinson' s disease ( see section 2 ).
do not take xadago - if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). - if your child is taking any of any of these medicines : monoamine oxidase ( mao ) inhibitors ( e . g . selegiline , rasagiline ), moclobemide , phenelzine , isocarboxazid and tranylcypromine . these are all used together for treatment of parkinson ' s disease or depression . - pethidine ( a strong pain killer ). if your dose is reduced or your child
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of xadago is 50 mg once a day . the dose may be increased to 100 mg once daily by mouth . your doctor will tell you the dose to take . if you have moderately reduced liver function , your doctor may prescribe a lower dose of 50 mg . take xadadago once a morning . take it at about the same time each day . you should swallow the tablet whole with a glass of water . xadag can be taken with or without food . if necessary ,
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis ( very high blood pressure that may lead to collapse ) has been reported in patients with neuroleptic malignant syndrome ( confusion , sweating , muscle rigidity , hyperthermia ), increase level of enzyme creatine kinase in your blood ( serotonin syndrome ), confusion , hypertension , muscle stiffness , hallucinations ( hypotension ). the following side effects have been reported with parkinson ' s disease in combination with safinamide and levodopa . they are usually mild to moderate and usually disappear after a few weeks . other medicines and xadago
what xadago contains - the active substance is safinamide . each tablet contains 50 mg or 100 mg safinam . - the other ingredients are methansulfonate , microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - tablet coating contains hypromellose , macrogol , titanium dioxide ( e171 ), iron oxide red ( e172 ). what xadark looks like and contents of the pack xadagus 50 mg film - coated tablets of 7 mm diameter with metallic gloss are white , round , biconc
zytiga is a medicine containing abiraterone acetate that is used to treat prostate cancer that has spread to other parts of the body . zytiga increases the levels of testosterone in the blood . prostate cancer is a type of disease that usually responds to hormone therapy . it is a treatment that lowers testosterone ( androgen deprivation therapy ). it is used in combination with another medicine , prednisone . prednisolone is used for high blood pressure in adult patients whose body is not able to absorb the medicine properly and may cause fluid retention in your blood .
do not take zytiga - if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). - if your unborn child is pregnant . warnings and precautions talk to your doctor or pharmacist before taking zytigo - if there is severe liver damage - if the patient has prostate cancer . this medicine should not be taken with this medicine . talk to a doctor or nurse before taking this medicine if any of these apply to you . - if any member of your family has ever had liver problems . - tell your doctor if you have high blood pressure or heart failure .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 , 000 mg once a day . you should take this tablet at the same time each day . this medicine should be taken by mouth . swallow the tablet whole with a glass of water . do not chew or crush the tablet . if you take more zytiga than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , take the tablet with food . if more tablets are taken than you need , contact a doctor or the nearest hospital immediately . take
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and contact your doctor immediately if you experience : muscle weakness , muscle twitches , a pounding heart beat or palpitations . the level of potassium in your blood is low . your doctor may check your potassium more frequently . other side effects include : very common ( may affect more than 1 in 10 people ): fluid in your legs or feet ( signs of low blood potassium , liver function test ) high blood pressure urinary tract infection , diarrhoea common ( might affect up to 1 in every 10 people ) high fat levels in
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg abirate acetate - the other ingredients are microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate . see section 2 " zytigo contains lactose ". what zytig looks like and contents of the pack - zytige tablets are white to off - white , round tablets with " 9 . 5 " engraved on one side .
hefiya contains the active substance adalimumab , a medicine used for the treatment of inflammatory diseases in adults , adolescents and children . hefiya is used for : polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis , paediatric plaque psoriasis , paedile crohn ' s disease and paediatric non - infectious uveitis . adalumab is a monoclonal antibody . monoclal antibodies attach to specific proteins in the body . addalimumab attaches to a specific protein called tumour necrosis factor ( tnfα ). tnfiα
do not take hefiya if your child is allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if your or your child ' s child has a severe infection , including tuberculosis , sepsis ( blood poisoning ), or other opportunistic infections ( unusual infections caused by a weakened immune system ). symptoms of infections may include fever , wounds , feeling tired , dental problems . if your / your child has moderate or severe heart failure . if you or your or his child has had a serious heart condition . warnings and precautions allergic reaction if your , or your / his child 's child
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is one 40 mg tablet once a day . your doctor may prescribe a different dose for you . your child ' s doctor will tell you which dose is right for you and how often to take it . the dose may be adjusted by your doctor . the doctor may also prescribe a higher dose for your child . the recommended dose for children and adolescents is one 20 mg tablet twice a day ( morning and evening ) for two years . for children weighing less than 40 kg , the usual starting dose is
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . tell your doctor immediately if you notice any of the following side effects ( see section 4 , " warnings and precautions "): - after the last hefiya injection , you may experience allergic reaction ( e . g . heart failure ), severe rash , hives , swollen face , hands , feet , trouble breathing , swallowing , shortness of breath and swelling of the feet . tell a doctor immediately , if you have any of these signs and symptoms of infection such
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . after first opening , the product may be stored at room temperature ( up to 25 ) for a maximum period of 14 days . once removed from the refrigerator for room temperature storage , your pre -filled syringe may be used for a single period of
what hefiya contains - the active substance is adalimumab . each pre - filled syringe contains 20 mg of adalumab in 0 . 4 ml of solution . - the other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid and sodium hydroxide and water for injections . what hefiYA looks like and contents of the pack hefiqa 20 mg / 0 . 04 ml solution for injection is a clear to slightly opalescent , colourless to slightly yellowish solution . it is supplied in a clear
what ritemvia is ritemv contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a type a white blood cell called " b - lymphocyte ". when ritukimab sticks to this surface , it stops the cell from growing and dividing . what ritemria is used for ritemira is used to treat adults with two different types of cancer : a ) non - hodgkin ' s lymphoma this is an illness of the lymph tissue that affects the immune system . it affects a type in
do not take ritemvia if you are allergic to rituximab , other proteins that are derived from ritukimab . warnings and precautions talk to your doctor or pharmacist before taking this medicine if you : - are less than 6 years old - have a severe active infection - have had a weak immune system - have severe heart failure - have experienced severe uncontrolled heart disease - have granulomatosis , polyangiitis , microscopic polyangis or pemphigus vulgaris warnings and risks talk to the doctor or nurse before taking ritemvi if you have or have ever had a hepatitis
how ritemvia is given your doctor will decide how much ritemv you will receive and for how long . your doctor or nurse will work out the dose you need and will determine the dose that you need . your dose will be worked out by your doctor . your healthcare professional will watch you closely while you are being given this treatment . this medicine is given as a drip ( intravenous infusion ). medicines given before each ritemva administration you will be given ritem via other medicines ( pre - medication ) to reduce the risk of side effects . your treatment will be repeated every three weeks . if you are having non - h
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate and will generally disappear after a few days of treatment . rarely , some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy or runny nose , vomiting , flushing or palpitations , heart attack , low number
what ritemvia contains the active substance is rituximab . each ml of concentrate contains 100 mg of ritukimab ( as besilate ). each ml concentrate contains 10 mg of the active ingredient in ritiximab , as besildate . the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what ritemvi looks like and contents of the pack ritemv is a clear , colourless solution for infusion in a glass vial . pack size of 2 .
capecitabine teva belongs to a group of medicines called " cytostatic medicines ", which stop the growth of cancer cells . capecitabrine teva contains capecitibine , which itself is not a cytostatics medicine . only after being absorbed by the body is it changed into an active anti - cancer medicine ( more in tumour tissue than in normal tissue ). capecitabe teva is used in the treatment of colon , rectal , gastric , or breast cancers . capecabine cheva is prescribed for the prevention of colon cancer after complete removal of the tumour by surgery . cape cit
do not take capecitabine teva - if you are allergic to capecitibine or any of the other ingredients of this medicine ( listed in section 6 ) - if your doctor thinks you may have an allergy to this medicine - if any of these apply to you ( or you are not sure ), talk to your doctor before taking capecitabiline tevas - if the patient has had severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines such as fluorouracil ) - - if a woman is pregnant - if she has low levels of white cells or platelets in the blood ( le
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that is right for you . the dose of capecitibine teva is based on your body surface area ( height and weight ). the usual dose for adults is 1250 mg / m2 of body surface surface area taken once daily . this is equivalent to a daily dose of body weight of 64 kg and height of 1 . 64 m2 taken once a
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva and contact a doctor immediately if you have any of these symptoms : diarrhoea : if you experience an increase of 4 or more bowel movements compared to your normal bowel movements , or any diarrhoehoea at night . vomiting : if your vomit is more than 4 hours late , or if you lose your appetite . stomatitis : if pain , redness , swelling or sores in your mouth and / or throat . hand and foot skin - reaction : if there is pain , swelling , red
what capecitabine teva contains the active substance is capecitabiline . capecitibine tevas 150 mg film - coated tablets each film - coating contains 150 mg capecitobine . furthermore , capecitamide teva 500 mg film film - coat contains 500 mg capecabine . the other ingredients are : tablet core : lactose , microcrystalline cellulose , hypromellose , croscarmellose sodium , magnesium stearate , macrogol 400 , hyproellose, titanium dioxide ( e171 ), yellow iron oxide ( e172 ), red iron oxide red ( e
silodosin recordati contains silodosino recordati , which belongs to a group of medicines called alpha1a - adrenoreceptor blockers . silodosein recordat is used to lower the pressure in the prostate , bladder and urethra . it works by helping smooth muscle in these tissues . this helps to reduce your symptoms . silosin Recordati is used in adults to treat the urinary symptoms associated with benign enlargement of the prostate ( prostatic hyperplasia ), such as difficulty in starting to pass water , and a feeling of not completely emptying the bladder .
do not use silodosin recordati - if you are allergic to silodosein or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using silodousin recordi - if your child is undergoing eye surgery to reduce cloudiness of the lens in cataract surgery . - if the eye is 26 damaged . silodocin recordat may be used alone or together with other medicines if your baby has a loss of muscle tone in the iris ( the coloured part of the eye ). if your newborn has a surgery , your doctor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one capsule of silodosin recordati taken once a day , with or without food , at about the same time each day . you should take silodosein recordat for at least 8 hours every day . if you have kidney problems if you suffer from moderate kidney problems , your doctor may prescribe a lower dose . for this purpose silodousin recordatin is taken once daily , with food , in the morning and evening . you can take silosinrecordati with
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin or hives are the most common side effect of silodosin recordati . dizziness . dizzy and occasionally fainting may occur . if you feel weak or dizzy , stop taking the tablet and contact your doctor immediately . the symptoms of dizziness and fainty usually disappear within a few minutes . if they do not , contact your physician immediately . if any of the symptoms occur , contact the doctor immediately and seek medical advice .
what silodosin recordati contains silodusin recordat 8 mg hard capsules : the active substance is silodnosin . each capsule contains 8 mg silodosein . the other ingredients are mannitol , magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( e171 ). silodlusin recordatin 4 mg hard capsule : the ingredients are silodmosin , mannola , magnesiumstearate, sodium lurilsulfATE , gelatin, titanium dioxide , yellow iron oxide ( e172 ). what silodosiin recordi looks like and contents of the
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angiotENSin ii is a substance produced in the body which causes your blood vessels to narrow , thus increasing your blood pressure . kinzal mono blocks the effect of angiotenin ii so that the blood vessels relax , and your bloodpressure is lowered . kinzonmono is used to treat essential hypertension ( high blood pressure ) in adults . the high blood blood pressure is not caused by any other condition . high bloodpressure , if not treated , can damage blood vessels in several organs , which could lead sometimes
do not take kinzalmono - if you are allergic to telmisartan or any of the other ingredients of this medicine ( listed in section 6 ). - if more than 3 months pregnant ( it is also better to avoid kinzalao in early pregnancy see pregnancy section ). - have severe liver problems ( cholestasis or biliary obstruction ) that stop drainage of the bile from the liver and gall bladder . - have any other severe liver disease . - suffer from diabetes or impaired kidney function and you are treated with a blood pressure lowering medicine containing aliskiren . if any of these apply to you ,
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . try to take the tablet at the same time each day . the tablets should be swallowed whole with some water . you can take kinzalmono with or without food . try not to crush or chew the tablet . if you take more kinzdalmono than you should if you accidentally take too many tablets , contact your doctor immediately . treatment of high blood pressure the usual starting dose of kinzhalmono is 40 mg once a day to control
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious and need immediate medical attention : sepsis ( also called blood poisoning ) is a severe infection with whole - body inflammatory response that can cause rapid swelling of the skin and mucosa ( angioedema ). these side effects are rare ( may affect up to 1 in 1 , 000 people ). other side effects of kinzalmono common side effects ( may effect up to1 in 10 people ): low blood pressure ( hypotension ) reduction in cardiovascular events uncommon side effects these may affect upto 1 in 100
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . once your medicine has been taken out of your refrigerator , it should be used immediately . do this if you notice that your kinzalmono tablet is damaged or the blister is opened . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmisan . - the other ingredients are povidone , meglumine , sodium hydroxide , sorbitol ( e420 ), magnesium stearate . what kinzalao looks like and contents of the pack kinzalanmono 20 mg tablets are white to off - white , round and flat . kinzallmono is available in blister packs of 14 , 28 , 56 or 98 tablets . not all pack sizes may be marketed .
afstyla is a human clotting ( coagulation ) factor viii product produced by recombinant dna technology in the manufacturing process . the active substance is lonoctocog alfa . afstylfa is used to treat bleeding episodes in patients with haemophilia a ( inborn factor v iii deficiency ). factor v viii is involved in blood clotting and helps blood to clot . afstona has an increased tendency to bleed . factor v ii is important in the treatment of haemphilia a because it helps blood clot . the safety and efficacy of afstylea have not been
do not use afstyla if you have had an allergic reaction to afstylea or if you are allergic to hamster proteins 46 warnings and precautions talk to your doctor , pharmacist or nurse before using afststylfa . the dose and the batch number are based on your treatment diary . do not use more afstila than your doctor has recommended . allergic ( hypersensitivity ) reactions are possible with afstla . symptoms of allergic reactions may include hives , generalised skin rash , tightness of the chest , wheezing , fall in blood pressure ( anaphylaxis ), and a
your treatment will be supervised by a doctor experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage the recommended dose of afstyla is one vial per day . dose and duration of treatment depending on the severity of your disease the site and the bleeding your clinical condition will be determined by your doctor . reconstitution and administration general instructions the powder and the solvent ( liquid ) should be used immediately after reconstination . if aseptic conditions are not observed , the solution should be mixed with other
like all medicines , afstyla can cause side effects , although not everybody gets them . symptoms of allergic reactions allergic reactions may include the following symptoms : hives generalised urticaria ( itchy rash ), tightness of the chest , difficulty in breathing , wheezing , low blood pressure , dizziness ( anaphylaxis ), bleeding . in patients receiving factor viii medicines , inhibitor antibodies ( see section 2 ) may form very commonly ( more than 1 in 10 patients ). patients who have received previous treatment with factor v iii ( more or less than 150 days of treatment ), the risk of developing this condition is uncommon
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the afstyla powder in the outer carton in order to protect from light . after reconstitution , the product may be stored at room temperature ( up to 25 ) for a maximum period of 3 days . keep afstylea in theouter carton to protect it from light and moisture . the reconstit
what afstyla contains the active substance is lonoctocog alfa . each vial contains 250 iu ( 2 . 5 mg ). after reconstitution with 2 . 2 .5 ml of water for injections the solution contains 200 iu lonoectocog aluminium . each 1000 iu vial provides one injection of 2 . 25 ml of solution for injections . each 400 iu / ml vial delivers one injection in lonoCTocog alpha . each 1500 iu or 5 ml vials provide one injection with injections the solutions contains 300 iu of lonoactocog aluminum . each
what praxbind is prax bind contains the active substance idarucizumab . idarucaizumb is a recombal agent . it is used in combination with dabigatran ( pradaxa ), a blood thinner medicine used to prevent blood clot formation . what praxBind is used for prax binds to rapidly trap dabigatheran . what it is given for ? praxbinding is used to treat adult patients who are already taking pradxa and who are undergoing emergency surgery or urgent procedures to control uncontrolled bleeding .
do not take praxbind if you are allergic to idarucizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a genetic disease called hereditary fructose intolerance ( hfld ) ( hfi ). if this applies to you , tell your doctor . warnings and precautions talk to your doctor before taking this medicine : if you currently have or have previously had serious adverse reactions to any of these substances . if you think any of this applies , tell the doctor or pharmacist . if any of your conditions apply to you ( or you are not sure ), talk to the doctor , pharm
the recommended dose is 5 mg / kg , given once every 2 . 5 weeks . your doctor will decide the dose of dabigatran you need . this medicine will be given to you once every 5 weeks , as this medicine is given into a vein . your physician will decide how much dabigATran you will need . your treatment will be supervised by a doctor experienced in the treatment of blood clot formation . your dose of either dabigadran will be decided by your doctor . if you miss a dose of this medicine if you have missed a dose , talk to your doctor as soon as possible . if it is less
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains - the active substance is idarucizumab . - the other ingredients are sodium acetate trihydrate , acetic acid , sorbitol ( e420 ), polysorbate 20 and water for injections . what prax bind looks like and contents of the pack praxbinding is a clear to slightly opalescent , colourless to slightly yellow solution supplied in a glass vial with a butyl rubber stopper and an aluminium cap .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temomedac is used to treat specific forms of brain tumours : - in adults with newly - diagnosed glioblastoma multiforme . temormac is first given together with radiotherapy ( concomitant phase of treatment ) and monotherapy phase oftreatment . - in children 3 years of age and older and adult patients with malignant glioma , such as glioclastoma multipurpose or anaplastic astrocytoma . temmedac is given in combination with standard treatment
do not take temomedac - if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ) - if your doctor has had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction include feeling itchy , breathlessness , wheezing , swelling of the face , lips , tongue or throat . - if certain kinds of blood cells are severely reduced ( myelosuppression ) - your white blood cell count and platelet count are severely decreased . these blood cells help you in fighting infection and are important for
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and duration of treatment your doctor will work out your dose of temomedac based on your height and weight . this is especially important if you have a recurrent tumour that has not responded to chemotherapy treatment in the past and you are taking other medicines ( anti - emetics ). temomedic can be used alone or together with food and drink to prevent nausea and vomiting . if you currently have newly - diagnosed glioblastoma multiforme , treatment will be divided into two phases : treatment together
like all medicines , this medicine can cause side effects , although not everybody gets them . if you have a severe allergic ( hypersensitive ) reaction , including hives , wheezing or other breathing difficulty , uncontrolled bleeding , seizures , convulsions , fever , chills and severe headache , stop temomedac treatment and seek medical help immediately . there may be a reduction in certain kinds of blood cells . this may cause increased bruising or bleeding , anaemia ( a shortage of red blood cells ), fever and reduced resistance to infections . the reduction in blood cell counts is usually short - lived . your doctor will monitor the level of ana
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store above 30 . do this to avoid any change in the appearance of the capsules . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what temomedac contains - the active substance is temozolomide . temomedic 5 mg : each capsule contains 5 mg temozolsomide ( as mesolomides ). temomedoc 20 mg : one capsule contains 20 mg tem ozolomine ( as temozoleomide ). temmedac 100 mg : every capsule contains 100 mg temzolomid ( as Mesolomix ). temarthac 140 mg : two capsules contain 140 mg temuzolomile ( as esolomamide ). temarmac 180 mg : three capsules contain 180 mg temazolomime (
cialis is a treatment for adult men with erectile dysfunction . this is when a man cannot get , or keep a hard , erect penis suitable for sexual activity . cialis works by making a hard erect penis more suitable for men . cialsis contains the active substance tadalafil which belongs to a group of medicines called phosphodiesterase type 5 inhibitors . calis works to relax the blood vessels in your penis , making it easier for you to get and keep a penis erect . this will help to maintain erectile function . civalis is used to treat adult men who have erectile disease .
do not take cialis - if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ) - if your doctor has told you that you are intolerant of organic nitrate or nitric oxide donors ( such as amyl nitrite ) or medicines (" nitrates ") used to treat angina pectoris (" chest pain "). warnings and precautions talk to your doctor before taking ciali if you : - are taking any of these medicines ( see section " other medicines and cialistis "). - have had a stroke in the last 6 months .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cialis tablets are for oral use . swallow the tablets whole with a glass of water . the tablets can be taken with or without food . the usual dose is 5 mg twice a day ( approximately 2 . 5 mg / day ). if you take more cialnis than you should if you accidentally take too many tablets , contact your doctor immediately . if you forget to take cialitas if you miss a dose , take it as soon as you remember .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with the medicine : allergic reactions ( rashes ) ( frequency not known ) chest pain ( may occur with nitrates ). ( frequency unknown ) priapsim may cause a prolonged and possibly painful erection . if this happens , stop taking cialis and seek medical help straight away . if you get an erection that lasts more than 4 hours , contact your doctor immediately . sudden loss of vision ( frequency cannot be estimated from the available data ). other side effects very common ( may affect more than 1 in 10 people ) uncommon
what cialis contains - the active substance is tadalafil . each tablet contains 2 . 5 mg of tadalabil . - the other ingredients are : tablet core : lactose monohydrate ( see section 2 ' cialises contains lactose '), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose , sodium laurilsulfate , magnesium stearate . film - coating : lactate monohydrate , hypromellose , triacetin , titanium dioxide ( e171 ), iron oxide yellow ( e172 ), ironoxide red ( e129 ),
enyglid is an oral antidiabetic medicine containing repaglinide , which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancrea does not produce enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . enyglID is used to treat type 2 diabetic in adults . treatment is usually started if diet , exercise and weight reduction alone have not been able to control your blood glucose . eneyglid may be used on its own in patients who are unable to take met
do not take enyglid if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). if you have type 1 diabetes . if the acid level in your blood is too high ( diabetic ketoacidosis ). if your doctor has told you that you have a severe liver disease . if you take gemfibrozil ( a medicine used to lower increased fat levels ). if any of these apply to you , tell your doctor . if your child has liver problems . if he / she has moderate liver 28 disease . see section 2 . warnings and precautions talk to
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 0 . 5 mg tablet once a day . swallow the tablet whole with a glass of water . the maximum recommended dose for adults is 30 mg once a morning . the dose may be increased to 4 mg once daily . the daily dose for children and adolescents is 30 to 16 mg once in a day , with or without food . your doctor will work out the right dose for you . your blood sugar may be too low because of a hypo . if you take more enygl
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia is the most common side effect . hypocaemia may affect up to 1 in 10 people . hypoptycaemic reactions are generally mild / moderate . hypocemic unconsciousness may lead to coma . allergy allergy is rare ( may affect less than 1 in every 10 , 000 people ). symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating ( anaphylactic reaction ). other side effects include : common ( may effect up to1 in 10 users ): stomach pain diarrhoea rare (
what enyglid contains the active substance is repaglinide . each tablet contains 0 . 5 mg , 1 mg or 2 mg repagginide . the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate , anhydrous , croscarmellose sodium , povidone k25 , glycerol , magnesium stearate , meglumine , poloxamer , yellow iron oxide ( e172 ), red iron oxide (< e172 ) ( see section 2 " eny glid contains lactose "). what enyGlid looks like and contents of the pack eny
what azacitidine mylan is azacitonidine myl is an anti - cancer agent . what azaccitidine mylon is used for azac citidine myla is used to treat adults . what it is used in adults azacituidine mylot is used : azacita mylan can be used in adult patients who have not had a stem cell transplantation . it is also used in patients with higher - risk myelodysplastic syndromes ( mds ). it is given to adult patients with chronic myelomonocytic leukaemia ( cmml ). it can also
do not take azacitidine mylan - if you are allergic to azaccitidine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before taking azac citidine myl : - if the patient has decreased counts of platelets , red or white blood cells . - if he / she has kidney disease . - tell your doctor if the person has liver disease . if the doctor has a heart condition such as heart attack or lung disease . blood test before and during treatment with
before starting azacitidine mylan , you will be given another medicine to prevent nausea and vomiting . the recommended dose is 75 mg once a day . your doctor will tell you how much azaccitidine myl you need to take . your dose of this medicine will depend on your height and weight . azacacitine mylan is given every 3 weeks during this " treatment cycle " ( cycle 4 to 6 ). this medicine is given under the skin ( subcutaneously ) by subcutaneous injection ( sublingual use ). it is given by sublinguate injection under the sun ( subtype ). this is
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following serious side effects : drowsiness , shaking , jaundice ( e . g . abdominal bloating and easy bruising ), which may be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue , which may also be symptoms or signs of kidney failure . a fever , which might be a sign of an infection with low levels of white
your doctor , pharmacist or nurse knows how to store azacitidine mylan properly . any unused azaccitidine myl must be disposed of in accordance with local requirements . this medicine will be stored by the health professionals at the hospital or clinic . the suspension must be used within 1 hour after preparation . the azacididine myla suspension must not be mixed with water for injections . the solution must be stored in a refrigerator ( 2 8 ). do not freeze . the zacitine mylan suspension must also be stored with water and injections for 8 hours after preparation , unless stored in the refrigerator ( 8 8
what azacitidine mylan contains - the active substance is azacinidine . one vial of powder contains 100 mg azacacitine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / ml azaccitidine . - the other ingredient is mannitol . what azacituidine myl looks like and contents of the pack azacitonidine mylon is a white powder for suspension supplied in a glass vial containing 100 mg of azacilitidine . pack sizes of 1 or 7 vials . not all pack sizes may be marketed
duotrav eye drop solution contains two active substances , travoprost and timolol . travostrost is a prostaglandin analogue in the eye . timoll is a beta blocker that reduces the amount of fluid within the eye and thus reduces pressure within theeye . duotraveye drops are used to treat high pressure in theeye in adults with an illness called glaucoma .
do not take duotrav - if you are allergic to travoprost , prostaglandins , timolol or beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease ( wheeziness , difficulty in breathing , long - standing cough , breathing problems , severe hay fever , a slow heartbeat ), heart failure ( a disorder of heart rhythm , irregular heartbeat ), or if your eye becomes cloudy . warnings and precautions talk to your doctor before taking duotrave : - if in the
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one drop in each eye once a day . do not use duotrav in both eyes . do this if your doctor tells you to . do the same for your other eyes . if you use more duotrave than you should if you accidentally use too many drops , contact your doctor immediately . how to use eye drops the recommended doses are 1 drop in the affected eye each day , 2 drops in the other eye each morning , 3 drops in each other each day . 4 drops in
like all medicines , this medicine can cause side effects , although not everybody gets them . the drops should be kept in the bottle to help protect your eyes . duotrav can cause very common side effects ( may affect more than 1 in 10 people ) effects on the eye eye redness . common side effect ( may effect up to 1 in every 10 people )) effects on how the eye surface inflammation ( surface damage ) can cause eye pain , blurred vision , abnormal vision , dry eye , itchy eye and eye discomfort . signs and symptoms may include eye irritation , burning or stinging . uncommon side effects these may affect up to1
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . do away with the blister after 4 weeks to prevent infections . do this as your doctor or pharmacist has told you . do you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
what duotrav contains - the active substances are travoprost and timolol . each ml contains 40 mg travostrost and 5 mg timolole ( as timololic maleate ). - the other ingredients are polyquaternium - 1 , mannitol , propylene glycol , polyoxyethylene hydrogenated castor oil 40 mg , boric acid , sodium chloride , sodium hydroxide , hydrochloric acid , purified water , sodium hydrochloride and hydrochlorIC acid . acidity levels may be raised when diluted with hydrochlorinic acid . what duotra looks like and
nplate ' s active ingredient is romiplostim . it is a protein that helps to reduce low platelet counts caused by the immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is a disease that affects your body ' s immune system . platelets are important as they help to keep blood clots at a low level . very low platelets can cause bruising and serious bleeding . nplate is used to : - prevent adults from having their spleen removed ( chronic itp ) who have previously received corticosteroids or immunoglobulins . n plate
do not take nplate - if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). - if allergic to other medicines containing escherichia coli ( e . coli ). warnings and precautions talk to your doctor or pharmacist before taking nplate if you have a low blood platelet count ( thrombocytopenia ). your doctor may decide to reduce your dose of nplate or temporarily stop it . your platelet counts may increase if you suffer from blood clots . your doctor will monitor your blood clotting more closely . - if your doctor has told
nplate is used in adults and adolescents from 1 to 17 years of age . your doctor will decide how much nplate you need and how often you need to take nplate . nplate is given as an injection under the skin ( subcutaneous ) ( see section 1 ). how nplate works nplate will be injected slowly over a period of time . your platelet counts will be checked regularly for the first time . you will have regular blood samples taken to check your platelets . your dose will be adjusted depending on the level of platelet count in your blood . your white blood cell count will be monitored at regular intervals
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with itp : common ( may affect up to 1 in 10 people ): headache allergic reaction upper respiratory tract infection common ( might affect up in 1 in every 10 people ) bone marrow disorder ( increased bone marrow fibres ) trouble sleeping ( insomnia ) dizziness , tingling or numbness of the hands or feet ( paraesthesia ) migraine , redness ofthe skin ( flushing ) blood clot in a lung artery ( pulmonary embolism ) nausea , diarrhoea , abdominal pain , indigest
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do store above 30 . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what nplate contains - the active substance is romiplostim . nplate 125 mg powder for solution for injection contains 230 mg romiplopim . each vial contains 125 mg romplostim in a deliverable amount of 0 . 25 ml solution . each single - dose vial of 0 , 125 mg contains 250 mg romoplostim and each single dose vials of 375 mg contain 375 mg romclostim ( 250 mg ). each single single -dose vialof romiplOSTim in an deliverable amounts of 0. 5 ml solution , each single treatment vial containing 250 mg of romipl
this medicine contains an active substance called glycopyrronium bromide which belongs to a group of medicines called bronchodilators . what tovanor breezhaler is used for this medicine is used to help breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd , the muscles around the airways tighten , making breathing difficult . this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the lungs . this helps to reduce the effects of this medicine on copd .
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using tovanOR breez inhaler - kidney problems - an eye problem called narrow - angle glaucoma - difficulty passing urine . your doctor may decide to temporarily stop treatment with tovannor breezer . if you have any of these conditions , tell your doctor immediately . - tightness of the chest , coughing , wheezing or breathlessness immediately after using to
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much tovanor breezhaler to use the recommended dose of this medicine is one inhalation once a day . you can use this this medicine for up to 24 hours at a temperature of 75 or more . do not use this leaflet if you notice that the content of the capsules is coloured or that the medicine is coloured . how to use tovanOR breez inhaler this medicine comes as an inhaler and capsules ( in blisters ). the medicine contains inhalation powder . the capsules
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms glycopirroniumbromide equivalent to 50 microgram of glycopyronium . - the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram glycopYRronium per inhalation dose . - - the other ingredients are lactose monohydrate and magnesium stearate . what tovanOR breez inhaler looks like and contents of the pack tovannor breezer 44 microlitre inhalation
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . it works by stimulating the brain to produce dopamine and serotonin which have calming effects and relieving aggressive behaviour . adasuve is used to treat acute symptoms of mild - to - moderate agitation in adults with schizophrenia and bipolar disorder . these are diseases characterised by symptoms such as ( in some cases , schizophrenia ) hearing , seeing things which are not there ( mistaken beliefs ), incoherent speech and behaviour and emotional flatness . people with bipolar disorder may also feel depressed , guilty , anxious , tense . the signs of bipolar disorder
do not take adasuve if you are allergic to loxapine or amoxapines . warnings and precautions talk to your doctor or pharmacist before taking adasuves if you have symptoms such as wheezing or shortness of breath , as these may be signs of lung problems like asthma , chronic obstructive pulmonary disease ( copd ), narrowing of the airways ( bronchospasm ), wheeze , cough , chest tightness or short shortnessof breath . children and adolescents do not give this medicine to children below 25 years of age because it has not been studied in this age group . neurole
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of 9 . 1 mg twice a day ( taken 2 hours apart ) with or without food . your doctor may increase your dose to 4 . 5 mg twice daily depending on your condition . adasuve should be taken by mouth once a day . swallow the tablet whole with a glass of water . do not chew or crush the tablet . if you take more adasuva than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , show the
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following serious side effects : - any breathing symptoms such as wheezing , cough , shortness of breath , chest tightness that becomes irritating and affects your airways ( asthma or copd ). - light - headedness or fainting . these may be signs that your blood pressure is not being controlled as well as it should . - worsening agitation , confusion , fever and muscle stiffness . these could be signs of a severe condition called neuroleptic malignant syndrome . other side effects include :
keep this medicine out of the sight and reach of children . do not use adasuve after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . do away with the blister if you notice any visible sign of physical damage . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what adasuve contains - the active substance is loxapine . each single - dose inhaler contains 5 mg of loxapeine . one delivers 4 . 5 mg loxide . what adasuves looks like and contents of the pack adasuva 4 .5 mg is a white to off - white plastic inhaler , with " lox " printed on the label . each inhaler is packed in a sealed foil pouch . adasuvey 4 . 0 mg is available in packs containing 1 or 5 inhalers . not all pack sizes may be marketed .
what azacitidine betapharm is azacitonidine betabarm is an anti - cancer agent . it belongs to a group of medicines called ' anti - metabolites '. what azaccitidine betafarm is used for azac citidine betaparm is given to adults . azacitasidine betagarm is intended for use after a stem cell transplantation in patients with higher - risk myelodysplastic syndromes ( mds ), chronic myelomonocytic leukaemia ( cmml ), acute myeloid leukaemic ( aml ). these are diseases that affect the
do not take azacitidine betapharm - if you are allergic to azaccitidine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before taking azacacitrix betapham : - if the patient has decreased counts of platelets , red or white blood cells . - if he / she has kidney disease . - tell your doctor if the person has liver disease . if the doctor has a heart condition such as heart attack or lung disease . blood test before and
before starting azacitidine betapharm , you will be given another medicine to prevent nausea and vomiting . the recommended dose is 75 mg once a day . your doctor will tell you how much azaccitidine betabarm you need . your dose will be adjusted by your doctor based on your height and weight . azacacitine betapharms is given every 3 weeks during this " treatment cycle " ( cycle 4 to 6 ). this medicine is given under the skin ( subcutaneously ) by subcutaneous injection ( sublingual use ). it is given by sublinguation under the sun ( subtype ).
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following serious side effects : drowsiness , shaking , jaundice ( e . g . abdominal bloating and easy bruising ), which may be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue , which may also be symptoms or signs of kidney failure . a fever , which might be a sign of an infection with low levels of white
your doctor , pharmacist or nurse knows how to store azacitidine betapharm properly . they are responsible for storing and disposing of any unused azaccitidine betabarm correctly . this medicine is for single use only . this medicinal product does not require any special storage conditions . once the suspension has been mixed , it should be administered within 45 minutes . the azacididine betafarm suspension for injections should be stored in a refrigerator ( 2 8 ). the suspension should be used within 8 hours . if not used within eight hours , the azaconidine betagarm suspension should not be stored and should be
what azacitidine betapharm contains - the active substance is azacitonidine . each vial contains 100 mg azaccitidine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / ml azaciticidine . - the other ingredient is mannitol ( e421 ). what azacituidine betabarm looks like and contents of the pack azac citidine betafarm is a white to off - white powder supplied in a glass vial containing 100 mg of azacacitine .
cerdelga contains the active substance eliglustat . it is used for the long term treatment of gaucher disease type 1 in adults . gaucher dementia type 1 is inherited condition in which a substance called glucosylceramide is not removed from your body . this substance is mainly produced by the spleen , liver and bones . when eliglustate is taken with glucoslceramide , it stops the enzyme from working in your affected organs . your doctor will test for this before you start using this medicine . if you have any further questions on the use of this medicine , ask your doctor or pharmacist . if
do not take cerdelga - if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). - if your body is taking medicines called moderate cyp2d6 inhibitors ( e . g . quinidine , terbinafine ) 31 - if it is taking moderate cyc3a inhibitors ( such as erythromycin or itraconazole ). these medicines are usually taken by mouth . if your doctor determines that your body ' s ability to tolerate them is too weak , you should not take the medicine . warnings and precautions talk to your doctor before
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet twice a day . the amount of metaboliser that you need to take varies depending on the type of metabolise you are taking . the usual dose is two tablets twice a morning , one tablet once a day , one in the morning and one inthe evening . swallow the tablets with a glass of water . the maximum recommended dose for adults is 84 tablets twice daily . if you take more cerdelga than you should if you accidentally take too many tablets , contact your doctor immediately
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): headache dizziness change in taste ( dysgeusia ) palpitations throat irritation heartburn ( dyspepsia ) feeling sick ( nausea ) diarrhoea constipation abdominal pain stomach ache ( upper abdominal pain ) acid reflux disease ( gastrooesophageal reflux diseases ) bloating ( abdominal distension ) inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( dysphagia ) vomiting dry mouth gas ( flatulence ) dry skin hives ( ur
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and sleeve after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what cerdelga contains - the active substance is eliglustat . each capsule contains 84 mg of eliglustate . - the other ingredients are microcrystalline cellulose , lactose monohydrate ( see section 2 ' cerdelaga contains lactose '), hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate , titanium dioxide ( e171 ), yellow iron oxide ( e172 ), indigotine ( e132 ), shellac , black iron oxide , propylene glycol and ammonia solution . what cerdelg looks like and contents of the pack cerdelgas capsules are a peach
the active substance in zoledronic acid hospira is zoledron acid , which belongs to a group of substances called bisphosphonates . zoledor acid works by attaching itself to the bone and slowing down the rate of bone change . it is used : - to prevent bone complications , e . g . fractures , in adult patients with bone metastases ( spread of cancer from primary site to the outer bone ). - to reduce the amount of calcium in the blood in adult men when there is a tumour . tumours can accelerate normal bone change in such a way that the release of calcium from bone is increased .
follow carefully all instructions given to you by your doctor , pharmacist or nurse . your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment . do not take zoledron acid hospir - if you are allergic ( hypersensitive ) to zoledic acid , another bisphosphonate ( the substance to which zoledrine acid belongs ), or any of the other ingredients of zoledicle acid hospire ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking zoledric acid hospiar : - if your child has
zoledronic acid hospira must only be given by healthcare professionals trained in administering bisphosphonates intravenously ( into a vein ). ' iv ' administration is recommended in order to reduce dehydration . how much zoledronic acidic hospira is given the recommended dose is 4 mg . if you have a kidney problem , your doctor may decide to lower the dose depending on your kidney problem . how zoledron acid hospir is given your doctor will decide how much you should receive . if your doctor determines that your dose of zoledic acid hospire is too low , you may be at increased risk of bone complications ( e
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most common side effects are : common ( may affect up to 1 in 10 people ): severe kidney impairment ( will be determined by your doctor with certain specific blood tests ). low level of calcium in the blood . uncommon ( may effect up to1 in 100 people ): pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth . jaw discharge , numbness or a feeling of heaviness , or loosening of a tooth . these could be signs of bone damage in the jaw (
keep out of the reach and sight of children . do not use zoledronic acid hospira after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what zoledronic acid hospira contains the active substance is zoledron acid . one vial of zoledor acid contains 4 mg zoledorus acid . the other ingredients are monohydrate , mannitol , sodium citrate and water for injections . what zoledico acid hospir looks like and contents of the pack zoledicle acid hospire is a liquid concentrate for solution for infusion . it is a clear , colourless to pale yellow to yellow concentrate . each pack contains one vials of concentrate .
varuby contains rolapitant which is used to treat adults with cancer feeling sick ( nausea ) or being sick ( vomiting ) during cancer treatment chemotherapy . cells called nerve cells are cells that help your body fight off the effects of chemotherapy . these nerve cells help your brain fight off nausea and vomiting . when you feel sick ( sick ) or are sick , rolapit works by stopping these nerve cell cells from working and causing nausea and / or vomiting .
do not take varuby if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). if you take an herbal medicine called st john ' s wort ( hypericum performatum ). if your doctor has told you that you have depression or difficulty sleeping . warnings and precautions talk to your doctor or pharmacist before taking varubry 27 if you have severe liver or kidney problems . if you currently take certain medicines containing rifampicin ( used to treat tuberculosis or other infections ). if any of these apply to you , tell your doctor . if your dose is not
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 180 mg once a day ( for 90 days ). swallow the tablet whole with a glass of water . you can take varuby with or without food . take the tablet at least 2 hours before your chemotherapy cycle . if you take more varubys than you should if you have taken more varubsy than you have been told to , contact your doctor straight away . if possible , show them the pack . if necessary , show the pack of tablets . if sickness occurs , show it
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with varuby : very rare ( may affect more than 1 in 1 , 000 people ) symptoms of an allergic reaction may include sudden shortness of breath , swelling of the lips or tongue , change in taste , swellingof skin or tissue , sudden rash , fever and faster heartbeats . tell your doctor immediately , or go to the casualty department at your nearest hospital , as appropriate treatment may be needed . other side effects include : very common ( may affects more than one in 10 people ) headache constipation feeling
what varuby contains the active substance is rolapitant . each tablet contains 90 mg rolapit . the other ingredients are lactose monohydrate ( see section 2 under ' varubiy contains lactose '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , polysorbate 80 . what varubey looks like and contents of the pack varubdy is a white to
what enerzair breezhaler is enerzaire breez inhaler contains two active substances : indacaterol and glycopyrronium - mometasone furoate indacterol and mometsone fruate belong to a group of medicines called bronchodilators . they relax the muscles in the lungs , making it easier for air to get in and out of the lungs . mometscone furate belongs to a class of medicines known as corticosteroids and steroids . corticoposteroids reduce the swelling and irritation ( inflammation ) in the small airways
do not use enerzair breezhaler if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using enerzir if you have : heart problems if you get an irregular or fast heartbeat if you suffer from thyroid gland problems if your family has diabetes or high blood sugar if you experience seizures if you drink alcohol if you smoke if you know that you have severe kidney problems if any
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . the medicine should be inhaled once a week . your doctor will tell you how many capsules to use . use enerzair breezhaler every day , at the same time of the day . this will help you to remember to use it . it is important that you use it every day and not only when you are using it at the usual times . it does not matter whether you use the medicine every day or when you have used it at
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious stop using enerzair breezhaler and see a doctor straight away : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives ( signs of allergic reaction ). other side effects other side side effects include the following side effects : very commonly ( may affects more than1 in 10 users ): sore throat , runny nose , sudden difficulty breathing , feeling of tightness , wheezing or coughing . common
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store in the original package in order to protect from moisture . the capsules should be used within one week after first opening . do this if you notice any change in the appearance of the capsules . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the
what enerzair breezhaler contains the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ), and mometasone furoate . each capsule contains 150 micrograms of indacataterol / acetate , 63 microgram of glycopreyronium bromides , 50 microgram glycopirronium , 160 microgram mometsone furuate . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is 114 microgram indacate , 58 microgram ( 0 . 5 milligrams
clopidogrel acino pharma gmbh contains the active ingredient clopidigrel which belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopidineogrelacino pharmá gmbhs is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis , which can
do not take clopidogrel acino pharma gmbh if you are allergic ( hypersensitive ) to clopipidogl or any of the other ingredients of clopidineogrel agabilate ( see section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking clopidoogrelacino pharmá gmbhl . if your doctor thinks that the effect of clapidogel agabulate is
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is one 75 mg tablet of clopidaogrel aclara gmb h per day to be taken orally with or without food . you can take cloclopidoggingrel acine pharma h for as long as your prescription continues to provide you with protection from the effects of clumpidogl acino pharma gmbH on your everyday life . if you take more clopidoogrelacino
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the most common side effects are : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) rare ( affects less than 1 users in 10 , 000 ). very rare ( affecting less than1 user in 1, 000 ). not known ( frequency cannot be estimated from the available data ) contact your doctor immediately if you experience : fever , signs of infection or extreme tiredness . these may be due
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . donot use cloplogrel acetino pharmarma gmbhl if you notice any visible sign of damage of blister or film - coated tablets . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will
what clopidogrel acino pharma gmbh contains the active substance is clopridogrel . each tablet contains 75 mg of clopidaogrel ( as besilate ). the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ) crospovidone type a castor oil , hydrogenated film - coating : macromol 6000 ethylcellulose ( e462 ) titanium dioxide ( e 171 ) what clopIDogrelacino pharmá gmb h looks like and contents of the pack clopidiogrel acc
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection in adults who are taking medicines called ' antiretroviral medicines '. the active substances are doravirine , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), lamivudine , which is a nucleosides analogue reverse transcriptases inhibitor ( rrti ). tenofovir disoproxil , a nucleositide analogue reverse transcriptase inhibitor , ( nrti ) what delstrigo does delstriga is used for treating hiv infection in adult patients ( aged
do not take delstrigo if you are allergic to doravirine , lamivudine , tenofovir disoproxil or any of the other ingredients of this medicine listed in section 6 . if you take any of any of these medicines : carbamazepine , oxcarbazepine or phenobarbital or phenytoin ( medicines used to prevent seizure ) rifampicin or rifapentine ( medicines to treat tuberculosis ) st . john ' s wort ( hypericum perforatum , a herbal remedy used for depression and anxiety ) products containing mitotane
always take delstrigo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is a complete regimen of one tablet a day . a single tablet is sufficient for treating hiv infection . the recommended starting dose is 1 tablet a night . if you take certain medicines ( such as doravirine ) your doctor may prescribe medicines that lower your dose . taking this medicine swallow the tablet whole with a glass of water . you can take this medicine with or without food . how long to take delstigo continue taking delstriga for as long
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking this medicine and tell your doctor immediately if you notice any of the following : very common ( may affect more than 1 in 10 people ): abnormal dreams difficulty in sleeping ( insomnia ) headache dizziness sleepiness cough nasal symptoms feeling sick ( nausea ) diarrhoea , stomach pain , vomiting wind ( flatulence ) hair loss rash muscle symptoms , pain ( stiffness ) feeling tired fever blood tests showing increased levels in liver enzymes uncommon ( may effect up to 1 in 100 people ): nightmares , depression , anxiety , irritability , confusion , suicidal thoughts 45
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and carton after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . keep the bottle tightly closed in order to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what delstrigo contains the active substances are : 100 mg doravirine , 300 mg lamivudine , 245 mg tenofovir disoproxil ( as fumarate ). the other ingredients are : tablet core : croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose e460 , silica , colloidal anhydrous , sodium stearyl fumar . a coating material : carnauba wax e903 , hyproellose , iron oxide yellow ( e172 ), lactose monohydrate
spravato contains the active substance esketamine . it belongs to a group of medicines called anti - depressants . this medicine helps to control your depression and reduces the symptoms of depression , such as feeling sad , anxious or worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities and feeling of being slowed down . spravato is used in combination with another antidepressant , which is used every 2 weeks . there are many reasons why antidepressant medicines may not work very well .
do not take spravato - if you are allergic to esketamine , ketamine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have an aneurysm ( a weak spot in a blood vessel wall that bulges out due to bleeding in the brain ). - recently had a heart attack . within 6 weeks of starting treatment , a temporary increase in blood pressure can occur . serious complications in these conditions can occur and spravo should not be used . tell your doctor before taking this medicine if you have a heart problem , such as poor blood flow
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much spravato to use the spravatos nasal spray is for inhalation use only . the nasal spray device is for use in adults . use in children and adolescents the recommended dose is 1 spray device twice a day ( morning and evening ). use in infants and children ( 2 years of age and older ) the recommended starting dose is 3 nasal spray devices . use one nasal spraydevice twice a morning and one in the evening ( morning ). use within 4 hours of the time you should have used sp
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with spravato : very common ( may affect more than 1 in 10 people ) feeling disconnected or having feelings and things around you feeling dizzy headache change in sense of taste feeling sleepy decreased feeling or sensitivity to touch ( especially in the mouth area ) spinning sensation ( vertigo ) vomiting nausea common ( might affect up to 1 in every 10 people ): feeling extremely happy ( euphoria ) feeling agitated feeling anxious feeling in the eyes , ears or sense of touch are impaired or blocked feeling irritable panic attacks change in perception
what spravato contains - the active substance is esketamine . each nasal spray device contains esketam hydrochloride equivalent to 28 mg esketamines . - the other ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections what spravat looks like and contents of the pack spravatos is a nasal spray solution . this medicine is a clear , colourless solution supplied in a single - use nasal spray unit . spravati is available in packs containing 1 , 2 , 3 or 6 nasal spray devices . each spray device is sealed in a sealed
zerboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat melanoma that has spread to other parts of the body , or cannot be removed by surgery . it can be caused by a change ( mutation ) in a gene responsible for melanoma . zelboraf targets proteins that are involved in the growth of your cancer .
do not use zelboraf - if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ) - if symptoms of allergic reactions ( such as swelling of the face , lips or tongue , difficulty breathing , rash and fainting sensation ) occur . warnings and precautions talk to your doctor or pharmacist before using zelberaf . allergic reactions if you experience allergic reactions to zeloraf , stop using zezboraf and contact your doctor immediately if you have any symptoms of an allergic reaction ( such : swelling ofthe face , lip or tongue ), difficulty
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 4 mg tablet once a day . your doctor may increase your dose to 8 mg once a week . your dose may be increased to 4 mg once daily depending on side effects and on how you respond to your treatment . taking zelboraf with food you can take zelberaf with or without food . it is best to take zalboraf on an empty stomach . swallow the tablet whole with a glass of water . do not crush or chew the tablet . if you
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions swelling of the face , lips or tongue difficulty breathing rash fainting sensation stop taking zelberaf and tell your doctor immediately if you experience any of the following symptoms : radiation treatment if you have any of these , tell your nuclear medicine doctor immediately . zelbaf treatment may cause radiation to affect the skin , esophagus , bladder , liver , rectum , and lungs . tell your radiologist immediately if : you experience the following signs : skin rash , blistering , peeling or discoloration of
keep out of the reach and sight of children . do not use zelboraf after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do this if you notice any particles in the solution or if the blister is damaged . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what zelboraf contains the active substance is vemurafenib . each film - coated tablet contains 240 mg of vemurabenib ( as a co - precipitate of vemafenb ). the other ingredients are hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , hydroxypropyl cellulose , magnesium stearate film - coating : iron oxide , macrogol 3350 , polyvinyl alcohol , talc and titanium dioxide ( e171 ). what zelberaf looks like and contents of the pack zelbaf
duoplavin contains clopidogrel and acetylsalicylic acid ( asa ) and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood which clump together during blood clotting . by preventing this clumping , blood vessels relax and blood vessels expand . antiplatelets medicinal products reduce the chances of blood clots forming ( a process called atherothrombosis ). duoplavic is taken to prevent blood clumps forming in hardened arteries , a process known as atherostrombotic events , which can lead to stroke , heart
do not use duoplavin - if you are allergic to clopidogrel , acetylsalicylic acid ( arsa ) or any of the other ingredients of this medicine ( listed in section 6 ) - if your child is allergic to other products called non - steroidal anti - inflammatory products - if he / she has painful and / or inflammatory conditions of muscles or joints - if his / her child has a medical condition ( such as asthma , nasal discharge , runny nose , polyps or any other type of growth in the nose ) - whether your child has had a medicalcondition that is currently causing bleeding
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . you should take duoplavin at the same time each day . your doctor will tell you how many tablets of your medicine to take . if you take more duoplin than you should if you have accidentally taken too many tablets , or if someone else has taken your tablets , tell your doctor immediately . if possible , take the tablet with you and show them the pack . if a person accidentally takes too many tablet ( s ) of duopllin
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine if you notice any visible sign of deterioration . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what duoplavin contains duoplin 75 mg film - coated tablets each tablet contains 46 of the active substances , clopidogrel , acetylsalicylic acid (asa ) 75 mg : clopridogrel ( as hydrogen sulphate ) 75mg : acetylSalicylic acids , mannitol , macrogol 6000 , microcrystalline cellulose ( e460 ), low substituted hydroxypropylcellulose ( i386 ), maize starch , hydrogenated castor oil ( see section 2 ' duopllin contains hydrogenatedcastor oil '), stearic acid and
simbrinza contains two active substances , brinzolamide and brimonidine tartrate . brin zolamide belongs to a group of medicines called carbonic anhydrase inhibitors . brimonine tartrate belongs to the group of medicine called alpha - 2 adrenergic receptor agonists , which reduce pressure within the eye . simbrinz is used to treat pressure in the eyes in adults aged 18 years and older who have eye conditions such as glaucoma , ocular hypertension ( high pressure in one or both eyes ).
do not take simbrinza if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic to sulphonamides if you have ever taken medicines for diabetes or infections if you take diuretics ( water tablets ) or a monoamine oxidase ( mao ) inhibitors if you do not take medicines for depression or parkinson ' s disease if you cannot take certain antidepressants if you suddenly stop taking any antidepressant medicines if you suffer from severe kidney problems if you develop too much acidity in your blood
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . simbrinza should only be used in the eyes . avoid contact with the drops in your eyes . wash your hands thoroughly with soap and water ( see section 1 , " how to use simbrinusza "). remove the cap and snap collar . before using the medicine , twist off the cap . fingers are not allowed to touch the tip of the bottle . twist off your thumb and fingers . tilt your head back . pull down your eyelid with a clean finger and squeeze gently until there is a
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : a reaction to the medicine ( frequency not known ): signs of an allergic reaction may include severe skin reactions , rash , redness or itching all over your body and / or eyes trouble breathing , chest pain , or irregular heart beat . tell your doctor immediately if you experience extreme tiredness or dizziness . the other side effects that have been reported with simbrinza are : common side effects ( may affect up to 1 in 10 people ) effects on the eye ( allergic conjunctivitis )
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the bottle tightly closed in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what simbrinza contains the active substances are brinzolamide and brimonidine tartrate . each ml of suspension contains 10 mg of brin zolamide ( corresponding to 2 mg of a brimonine tartrate equivalent to 1 . 3 mg of the active substance in each dose ). the other ingredients are : brimonamide , benzalkonium chloride ( see section 2 " simbrinusza contains benzalkonaium chloride "), propylene glycol , carbomer 974p , boric acid , mannitol , sodium chloride , tyloxapol , hydrochloric acid , sodium
what filgrastim ratiopharm is filgrastaim ratitopharm contains the active substance filgrasterim . filgrasteim is a protein produced by biotechnology in bacteria called escherichia coli . it is very similar to a natural protein produced in your body called granulocyte - colony stimulating factor ( g - csf ). filgrateim stimulates the bone marrow to produce new blood cells . more blood cells are needed than white cells . white cells are important as they help your body fight infection . what filgrastonim ratinopharm does filgrastersim ratiotopharm
do not use filgrastim ratiopharm - if you are allergic ( hypersensitive ) to filgrasteim or any of the other ingredients of filgraspim ratim ratinopharm . warnings and precautions talk to your doctor or pharmacist before using filgrateim ratisopharm : - if your child has a cough , fever or difficulty breathing . this may be a symptom of a pulmonary disorder . tell your doctor straight away if your baby gets any of these side effects . - if the child has sickle cell disease 57 - if he or she gets left upper abdominal pain or pain at the
how much filgrastim ratiopharm is given your doctor will decide how much filgnastim ratiopharm you will receive . how much is given the amount of filgrasteim ratisopharm given will depend on your condition and on how well you respond to filgrasterim ratitopharm treatment . filgrateim raticoopharm will be given to you in combination with chemotherapy . the usual dose is 0 . 5 mg per kilogram bodyweight given once every 60 days . your doctor may increase your dose to 30 mg per kg bodyweight once every 14 days . some disease types
you must not be given filgrastim ratiopharm if you have sickle cell disease 57 if you get left upper abdominal pain or pain at the tip of your shoulder ( this may be a symptom of a spleen disorder ). see section 4 . if you experience side effects , your doctor may order regular blood tests . filgrasteim ratitarm can affect the number of neutrophils ( a type of white blood cells ) in your blood . your doctor will monitor this during treatment and may adjust your dose or stop treatment . other medicines and filgrASTim ratisopharm tell your doctor or pharmacist
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . donot use filgrimastim piriopham if the solution is cloudy or contains particles . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what filgrastim ratiopharm contains - the active substance is filgrasterim . each ml of solution for infusion contains 60 mg of filgrateim . filgrasteim ratiotopharm 30 mg / 0 . 5 ml : each pre - filled syringe contains 30 mg of filmgrastime in 0 . 05 ml solution . filgnastim ratiopharm 48 mg / 1 ml : one pre -filled syringe containing 48 mg of the active ingredient filgracyim in 0. 8 ml solution for injection . - the other ingredients are sodium hydroxide , glacial acetic
what riluzole zentiva is riluxole zenziva contains a substance called rilusole which belongs to the nervous system . what rilzole zsentiva is used for rilizole zertiva is given to adults with amyotrophic lateral sclerosis ( amy ) motor neurone disease ( ms ). ms affects the nerve cells responsible for muscles , causing weakness , muscle waste and paralysis . ms is caused by the destruction of nerve cells . motor neurones disease may also cause too much glutamate ( a chemical messenger ) in the brain and spinal cord . rilazole zeptiva works
do not take riluzole zentiva - if you are allergic to rilizole or any of the other ingredients of this medicine ( listed in section 6 ). - if any liver disease has been reported . - if your body has increased blood levels of some enzymes of the liver called transaminases . - tell your doctor if you think any of these apply to you . - you are pregnant . warnings and precautions talk to your doctor or pharmacist before taking rilzole zenta : - if there are any liver problems . - contact your doctor immediately if you notice yellowing of your skin or the whites of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . the tablets should be taken by mouth at about the same time each day . your doctor may prescribe a lower dose if necessary . the maximum recommended dose for adults is 12 tablets once a week . if you take more riluzole zentiva than you should contact your doctor , pharmacist or your nearest hospital emergency department . if possible take rilzole zenta with food . if a child swallows some tablets , contact your physician immediately . if
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever ( increase in temperature ). during treatment with riluzole zentiva there may be a decrease in the number of white blood cells . this is seen in a blood sample . white blood cell counts are important for fighting infections . if you have any of the following symptoms : yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling sick or being sick . these may be signs of liver disease ( hepatitis ). your doctor will do regular blood tests before and during treatment
what riluzole zentiva contains the active substance is rilusole . the other ingredients are anhydrous dibasic calcium phosphate , micro crystalline cellulose , anhydrated colloidal silica , magnesium stearate , croscarmellose sodium , hypromellose , macrogol 6000 , titanium dioxide ( e171 ). what rilizole zsentiva looks like and contents of the pack the tablets are white to off - white , round and marked with 50 on one side and rilzole on the other side . the tablets have a diameter of 202 mm . r
emgality contains the active substance galcanezumab , a medicine that blocks the activity of a protein called calcitonin gene ( cgrp ). migraine is a condition in which patients have increased levels of cgrm . emgality is used to treat migraine in adults , adolescents and children aged 4 years and older who have migraines . emigality has been shown to reduce the frequency of migraine headache and improve your quality of life .
do not use emgality if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious cardiovascular disease if you suffer from serious cardiovascular diseases . allergic reactions emg abnorm may cause serious allergic reactions . these reactions may occur within 40 minutes of a serious allergic reaction . if such signs occur , you should contact your doctor immediately . possible side effects see section 4 . children and adolescents emgation is not recommended for children and teenagers under 18 years of age . other medicines and emgals tell your doctor or pharmacist if you or your child
always use emgality exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg of emgally given as an injection under your skin ( subcutaneous injection ). you may be able to inject emgalis yourself if you have been trained by your doctor to do so . your emgali injection will be given to you by a doctor or nurse who is experienced in giving proper training . if you use more emgals than you should if you forget to use emgaality if you miss a dose , inject the missed dose as soon as you
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality may include rash and itching . serious allergic reactions ( rare , may affect up to 1 in 1 , 000 people ) may include : difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , a red rash , raised bumps . other side effects very common side effects ( may affect more than 1 in 10 people ) injection site pain injection site reactions may include red skin , itching
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening , the product may be stored for up to 7 days at room temperature ( up to 30 ). do this medicine if you notice that the solution is not clear or contains particles . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect
what emgality contains the active substance is galcanezumab . each pre - filled pen contains 120 mg of galcaneszumumab in 1 ml solution . the other ingredients are l - histidine , l - ethidine hydrochloride monohydrate , polysorbate 80 , sodium chloride and water for injections . what emgalis looks like and contents of the pack emgally is a solution for injection in a clear glass syringe . the colour is slightly yellow . the syringe is a single - dose pen . emgals is available in packs of 1 , 2 , 3 pre -
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occclusive disease ( when the blood vessels in the liver become damaged ) in adult patients where blood clots are formed and cannot be removed with medicines obtained prior to a stem cell transplantation . defibrorotide works by helping the blood vessel to open and close , which helps to prevent the blood clasts from forming . your doctor has prescribed this medicine for you because you have not been given it before .
do not use defitelio if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ) if you have been taking other medicines to prevent blood clots ( tissue plasminogen activator warnings and precautions talk to your doctor or nurse before using this medicine if you : have a history of bleeding if you experience heavy bleeding if your doctor decides that a blood transfusion is necessary after surgery if you suffer from problems with blood circulation or a constant blood pressure ( see section 1 ) have recently taken other medicines ( medicines to reduce blood clotting ) such as acetylsal
the treatment with defitelio will be started by a doctor who is experienced in the use of stem cells transplantation . it will be given into one of your veins as an ' intravenous infusion ' ( drip ). you will be monitored during this treatment for 21 days to assess your symptoms and for at least 18 months after your last dose of defitelinio . if you miss a dose , tell your doctor or nurse as soon as possible . do not take a double dose to make up for a forgotten dose . if your next dose is due in two weeks , tell the doctor or hospital pharmacist . if it is not
like all medicines , defitelio can cause side effects , although not everybody gets them . stop taking defiteloio and see a doctor immediately if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): low blood pressure common ( might affect up to 1 in every 10 people ) bleeding in general bleeding including the nose bleeding from the brain bleeding from inside the gut vomiting blood bleeding from around the lungs bleeding from blood in the urine and the mouth bleeding from under the skin coagulopathy ( disturbance of blood clotting ) nausea vomiting diarrhoea rash itching fever uncommon ( may
keep this medicine out of the sight and reach of children . do not use defitelio after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do do not defiteloio if you notice that the infusion storage is damaged or if the solution is cloudy . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what defitelio contains the active substance is defibrotide . each ml of solution contains 2 . 5 mg or 200 mg of defibroide . after dilution , each ml solution contains 80 mg of the active ingredient in defibotide . the other ingredients are sodium citrate dihydrate , hydrochloric acid , sodium hydroxide ( for ph - adjustment ), water for injections . see section 2 " defitelsio contains sodium ". what defitELio looks like and contents of the pack defiteloio is a clear , colourless to pale yellow solution for infusion . it is supplied
daklinza contains the active ingredient daclatasvir . hepatitis c is an infectious disease that affects the liver , caused by the hepatitis c virus . this medicine works by stopping the hepatitisc virus from multiplying in your body . it reduces the amount of the virus in your blood . daklinz is used in combination with other medicines to treat hepatitis c infection . the other medicines that you will be taking with daklanza are : - oral , single use , with or without food . - combination with a medicine containing other medicines for hepatitis c infections . the effect of the other medicine may be reduced . if you
do not take daklinza if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ) if you take daclinza by mouth with the following medicines : phenytoin , carbamazepine , oxcarbazepine and phenobarbital used to treat epileptic seizures rifampicin , rifabutin and rifapentine antibiotics used to prevent tuberculosis . dexamethasone , a steroid used to correct allergic and inflammatory diseases . medicines called st . john ' s wort ( hypericum perforatum
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of daklinza is 60 mg once a day . do not take more than this dose once a week . do this if you notice that the medicine has a very unpleasant taste . daklanza may be taken with some other medicines . if you take more daklineza than you should if you have taken more daclinza than your doctor tells you to , talk to your doctor . if possible , take these medicines with a meal . your doctor may increase your daily dose
like all medicines , this medicine can cause side effects , although not everybody gets them . daklinza in combination with sofosbuvir and ribavirin has been associated with the following side effects : very common ( may affect more than 1 in 10 people ): headache fatigue common ( might affect up to 1 in every 10 people ) difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching or tender muscles when taking daklineza in tandem with sofsosbuir or ribavir , the following other side effects have been associated : very commonly ( may affects more than1
what daklinza contains the active substance is daclatasvir . each film - coated tablet contains 30 mg or 60 mg of daclasvir ( as dihydrochloride ). the other ingredients are : tablet core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e171 ), macrogol 400 , indigo carmine aluminum lake ( e132 ), yellow iron oxide ( e172 ) 51 what daklineza looks like and contents of the pack
proquad is a vaccine to prevent measles , mumps , rubella and chickenpox ( varicella ) viruses in adults . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce antibodies against the measles , rubles , rubell and varicelluses . the antibodies help to prevent diseases caused by these viruses . proquad is used to prevent adults from getting measles , measles , or rubella caused by chickenpox . the vaccine is given to infants 12 months of age and older . pro quad is used in children and adolescents ( 3 to 9 years of age ) who
do not receive proquad - if you are allergic to any varicella vaccine , measles , mumps or rubella vaccine , or any of the other ingredients of this vaccine ( listed in section 6 ) - if your doctor has told you that you have neomycin - if any of these apply to you - if the child has a blood disorder or type of cancer that affects the immune system - if treatment with medications that weaken the immunesystem ( e . g . low - dose corticosteroid therapy , asthma or replacement therapy ) - a weakened immune system ( including aids ) - congenital or hereditary immunodeficiency
proquad is given as an injection into the muscle or under the skin ( usually in the thigh or upper arm ). injections should be given into the upper muscle of the thigh area or upper upper arm . if you have a blood clotting disorder or low levels of platelets , the vaccine should not be given under the sun . injecting under the surface of the skin may increase the risk of bleeding and may damage the muscle . proquad should never be given directly into a blood vessel . prorant is given by injection into a vein . adults and adolescents proquad is intended for use in children and adolescents from 9 years of age and older
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions such as hives may occur . if these reactions occur , you may experience difficulty in breathing or swallowing . if you have an allergic reaction , contact your doctor immediately . other side effects that have been reported with proquad are : uncommon ( may affect up to 1 in 100 people ): seizures ( fits ) and a fever rare ( may effect up to1 in 1 , 000 people ): bronchiolitis ( difficulty breathing , cough , unsteadiness with walking ). other side side effects reported with the use of proquad include :
what proquad contains the active substances are : measles virus1 , edmonston strain , 3 . 00 mg mumps virus1 ( jeryllynn™ level b ) strain , 4 . 30 mg rubella virus2 , strain , equivalent to 3 .00 mg varicella virus3 , merck strain , approximately 3 . 99 mg mrc . the other ingredients are : powder sucrose , hydrolysed gelatin , urea , sodium chloride , sorbitol ( e420 ), monosodium glutamate , sodium phosphate , sodium bicarbonate , potassium phosphate , potassium chloride 199 what proquad looks like and contents of
jylamvo is a substance that is absorbed by the body and is an anticancer medicine which reduces unwanted reactions . it is an immunosuppressive agent . by reducing the inflammatory effect jylamve is used to treat rheumatic and skin diseases : active rheumatoid arthritis ( for example , polyarthritic forms of joints ) severe juvenile idiopathic arthritis ( jia ) in children and adolescents 3 years of age and older . it may be used in combination with non - steroidal anti - inflammatory drugs ( nsaids ) to treat inadequate o severe and disabling psoriasis in adults who are
do not use jylamvo if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) if you have a severe kidney impairment if you suffer from a liver impairment if your doctor has told you that you have blood disorders such as bone marrow hypoplasia , leukopenia , thrombocytopenia or significant anaemia 34 if you know that you may have a weakened immune system if you think you have or have ever had a serious infection such as tuberculosis or hiv . if you develop ulcers in the stomach or intestines ( an inflammation of
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . jylamvo can be used for several conditions , which may lead to severe side effects or even death . your doctor will determine the dose you need and will adjust the dose depending on the response to the treatment . rheumatoid arthritis and severe juvenile idiopathic arthritis if you have severe psoriasis or severe psoriatic arthritis , jylimvo may be used as a long - term treatment . jyslamvo is also used
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash or itching , especially affecting your whole body . other possible side effects include breathing problems , feeling of illness , dry , irritating cough , shortness of breath , difficulty or breathing , chest pain ( fever ), spitting or coughing blood , serious peeling or blistering of the skin unusual bleeding ( vomiting blood ), bruising nose bleeds nausea , vomiting , abdominal discomfort , severe diarrhoea mouth ulcers , black or t
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . do store below 25 . store in the original package in order to protect from light . the medicine should be used immediately after preparation . in case of accidental spillage , the product should be disposed of in accordance with local requirements . the following information is intended for the specialist only : - 3 - keep out of reach of child - do not store any unused medicine . - do this after the date printed
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotroxate . - the other ingredients are macrogol 400 , glycerol , orange flavour , sucralose , ethyl parahydroxybenzoate ( e218 ), sodium methyl parahhydroxybenzzoate , citric acid , tri - sodium citrate , purified water ( see section 2 " jylimvo contains ethyl parahydroxy benzoate and sodium methyl parahydrobenzoates "), water for injections , and a brown glass bottle containing 60
what enurev breezhaler is this medicine contains a substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what enurevo breez inhaler is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten , making breathing difficult . this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the lungs . this helps to reduce the effects
do not use enurev breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have kidney problems . - if there is an eye problem called narrow - angle glaucoma ( difficulty passing urine ). warnings and precautions talk to your doctor or pharmacist before using treatment with enurevi breez inhaler . if you have any of these conditions , stop using this medicine and tell your doctor immediately : - tightness of the chest , coughing , wheezing or breath
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the recommended dose of this medicine is one inhaler once a day . you should use this this medicine for 24 hours at a temperature not above 75 ºc . you can use this medicinal product at any time of the day . how to use this product this medicine comes as an inhaler and capsules ( in blisters ) that contain the medicine as inhalation powder . the capsules are provided in separate cartons . the inhaler is for single use only .
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious : uncommon ( may affect up to 1 in 100 people ) irregular heart beat high level of blood sugar ( hyperglycaemia ). typical symptoms are excessive thirst , hunger and frequent urination . rash , itching , hives , difficulty breathing , swallowing , dizziness . allergic reaction including swelling mainly of the tongue , lips , face or throat ( angioedema ). if any of the side effects gets serious , stop taking enurev breezhaler and talk to your doctor immediately . some other side effects (
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each hard capsule contains 63 micrograms glycopirroniumbromide equivalent to 50 microgram glycopyronium . - the delivered dose is delivered into the mouthpiece of the inhaler delivering 44 microgram of glycopyrsronium per inhalation dose . - - the other ingredients are lactose monohydrate and magnesium stearate . what enurelv breez inhaler looks like and contents of the pack enurevan breezer 44 microlitre inhalation powder , hard capsules
riximyo contains the active substance rituximab , a type of protein called a " monoclonal antibody ". it sticks to the surface of a type a white blood cell called " b - lymphocyte ". when ritukimab sticks to this surface , it stops the cell from growing and dividing . riximyo is used for the treatment of several different conditions . ruximyo can be used : a ) non - hodgkin ' s lymphoma this is a disease of the lymph tissue that affects the immune system . it affects a type in the body called " white blood cells "
do not use riximyo if you are allergic to rituximab , other proteins that are derived from ritukimab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe active infection at the moment . if you suffer from a weak immune system . if your doctor has told you that you have severe heart failure or severe uncontrolled heart disease ( granulomatosis , polyangiitis , microscopic polyangiaitis or pemphigus vulgaris ). warnings and precautions talk to your doctor or pharmacist before using rixi . before using ,
your doctor will decide how much riximyo you will receive and how often you will need this treatment . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have any side effects , your doctor may decide to change your dose . rixima is given as a drip ( intra - venous infusion ). medicines given before each riximusyo administration you will be given rixamyo together with other medicines ( premedication ) to reduce the risk of side effects . your doctor will also monitor you during your treatment . if your doctor determines
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate and will generally disappear after a few days of treatment . rarely , some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy or runny nose , vomiting , flushing or palpitations , heart attack , low number
what riximyo contains the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab ( 10 mg / ml ). each 50 ml vials contains 500 mg of the active ingredient in ritiximab , 10 mg per ml . the other ingredients are sodium citrate , polysorbate 80 , sodium chloride , sodium hydroxide and hydrochloric acid ( see section 2 " rixima contains sodium "). what rixamyo looks like and contents of the pack riximusyo is a clear to slightly yellowish solution for infusion . it
topotecan actavis contains the active substance topotecin . topotecaan activ is used to treat adults with small cell lung cancer that has come back after chemotherapy . it is also used to prevent advanced cervical cancer that cannot be controlled by surgery or radiotherapy . in this case topotican actez treatment is combined with medicines containing cisplatin .
do not use topotecan actavis - if you are allergic to topotecaan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using topotocan activ . your doctor may check your blood cell counts if they are too low . your dose of topotican actv may need to be adjusted . - if any kidney problems are serious . your treatment with topotchean actez should be stopped immediately . - tell your doctor if you think any of these apply to you . - topotcan actis may
the dose of topotecan actavis you receive will depend on the disease being treated and on results of blood tests carried out before treatment . the usual dose for treatment of adults small cell lung cancer is 1 . 5 mg per square metre of body surface area for every 5 square metres of body area . this treatment cycle will also include cervical cancer . the dose for adults is 0 . 75 mg per sq metre of surface area , for every 3 square metres that is given . this dose cycle will normally be repeated every three weeks . for cervical cancer , you will be given another anticancer medicines containing cisplatin . cisplin
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious sideeffects : infections ( very common , may affect more than 1 in 10 people ): fever . this is a sign of your general condition . local symptoms may include sore throat , burning sensation , severe stomach pain , fever , diarrhoea and bowel inflammation ( neutropenic colitis ). topotecan actavis may reduce your ability to fight infections . lung inflammation ( rare , may effect up to 1 in 1 , 000 people ): difficulty in breathing , cough and
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the expiratory date refers to the last day of that month . keep the vials in the outer carton in order to protect from light . after reconstitution and dilution chemical and physical in - use stability has been demonstrated for 24 hours at 25 ± 2 and from 2 to 8 when stored in a refrigerator ( 2 to 9 ). the drug product solution for dilution in solutions for infusion ( nacl 0 . 9 %)
what topotecan actavis contains - the active substance is topotecaan . each vial contains 1 mg or 4 mg topototecin ( as hydrochloride ). after reconstitution , 1 ml contains 1 % of the active ingredient of topotan . - the other ingredients are mannitol ( e421 ), tartaric acid , hydrochloric acid and sodium hydroxide . what topotican actis looks like and contents of the pack topottecan acti is supplied in glass vials with grey bromobutylic stopper and aluminium seals with plastic flip -
the active substance of rivastigmine hexal is rivustigmine . rivastersigmine belongs to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson ' s disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivasterigmine works by blocking the enzymes that break down acetylchloroline : acetylCHolinescerase and butyrylcholinesternase . by
do not take rivastigmine hexal - if you are allergic to rivasta , the active substance in rivostigminehexal , or any of the other ingredients of this medicine ( listed in section 6 ). - if a previous skin reaction ( allergic contact dermatitis ) has been severe . warnings and precautions talk to your doctor or pharmacist before taking rivstigmine Hexal . if any of these apply to you , tell your doctor before taking this medicine . - if your doctor has told you that you have irregular or slow heartbeat . - you have an active stomach ulcer . - difficulties in
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take . treatment usually starts with a low dose . depending on how you respond to treatment , the highest dose may be 6 . 0 mg twice a day . your doctor may adjust your dose depending on your weight . taking this medicine take rivasta hexal every day for as long as your health allows . if you take more rivasteigminehexal than you should if you have taken more r
like all medicines , this medicine can cause side effects , although not everybody gets them . you may experience side effects more often when you start your medicine or when your dose is increased . the side effects listed below are very common ( may affect more than 1 in 10 people ). feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ) diarrhoea common ( might affect up to 1 in every 10 people ) anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling or feeling confused decreased appetite nightmares uncommon ( may affects up to1 in 100 people
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what rivastigmine hexal contains 64 the active substance is rivasta hydrogen tartrate . the other ingredients are hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ), titanium dioxide ( e171 ), shellac . each rivastsigminehexal 1 . 5 mg capsule contains 1 . 25 mg of rivostigmine . each vial of each ritastigmin hexal 3 mg capsule releases 3 mg of the active ingredient in each riastigme hex
cabometyx is a cancer medicine that contains the active substance cabozantinib . it is used to treat kidney cancer ( renal cell carcinoma ) or liver cancer that has spread to other organs . it can be given alone or in combination with a specific anticancer medicine containing sorafenib . how cabometyx works cabometx blocks the action of proteins called receptor tyrosine kinases ( rtks ), which are involved in the development of new blood vessels . these proteins can be present in high amounts in cancer cells . cabomety is used in adults .
do not take cabometyx 45 if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking cabomety if you have high blood pressure , have an aneurysm ( enlargement or weakening of a blood vessel wall ) or a tear in a blood valve wall , have diarrhoea , have recent had significant bleeding , have had surgery within the last month , have undergone surgical procedures , or dental surgery , have inflammatory bowel disease ( e . g . crohn ' s disease , ulcerative
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . you should take this tablet at the same time each day . your doctor may increase your dose depending on how you respond to your treatment . this will help reduce the risk of serious side effects . your treatment with cabometyx will usually be started by a doctor who is experienced in the treatment of patients over 60 years of age . you can take cabometometyx with or without food . it is best to take cabometricyx at least 2 hours before or 1
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with cabometyx and other medicines : tell your doctor straight away if your side effects become severe or persistent . if you notice any of the following serious side effects you may need urgent medical treatment : symptoms include pain in the abdomen ( nausea ), vomiting , constipation and fever . these may be signs of a gastrointestinal perforation ( a hole in the stomach or intestine ). severe or uncontrollable bleeding , with symptoms such as vomiting blood , black stolls , bloody urine , headache , coughing up blood , swelling , pain
what cabometyx contains the active substances are cabozantinib and malate . cabometx 20 mg : each tablet contains cabozatinib ( s ) and malates . each tablet of 20 mg contains cab ozantinab . cabobometyx 40 mg : one tablet contains Cabozanthinib (s ) and / or malate and /or 40 mg contains Caboxantinob . each tablets of 60 mg contain cabozANTinib . the other ingredients are microcrystalline cellulose , lactose anhydrous , hydroxypropyl cellulose ( e460 ), cro
pemetrexed hospira is a medicine used in the treatment of cancer . pemetrexED hospira will be given to you in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . pemrexedospira will also be given in combination to cisplin for the initial treatment of patients with advanced stage of lung cancer . your doctor will determine the best course of pemetemetrexes hospira if you have lung cancer at an advanced
do not use pemetrexed hospira - if you are allergic ( hypersensitive ) to pemetreed or any of the other ingredients of this medicine ( listed in section 6 ). - if breast - feeding is not recommended during treatment with pemetretted hospir . - if your child has recently received or is about to receive a vaccine against yellow fever . warnings and precautions talk to your doctor or pharmacist before using pemetezed hospire if you have or have had problems with your kidneys . before you receive pemeted hospiral , your doctor will check before each infusion that : you have sufficient amounts of
the dose of pemetrexed hospira is 500 mg for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your whole body . your doctor will use this body surface area to work in exactly the right way for you . your dose and duration of treatment will depend on your blood cell counts and on your general condition . your healthcare professional will have mixed the pemetreed hospir powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before it is given to you . pemetretted hospire will be given to your doctor by
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever or signs of infection ( common ): if you have a temperature of 38ºc or greater , sweating or other signs of early signs of an infection ( since you may have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and may lead to death . if you get chest pain ( common ) or a fast heart rate ( common ). if you develop pain , redness , swelling or sores in your mouth ( common ), allergic reaction ( uncommon ). if
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiratory date refers to the last day of that month . this medicine does not require any special storage conditions . reconstituted and infusion solution : chemical and physical in - use stability of the product has been demonstrated for 24 hours at 2ºc - 8ºc . the reconstitution solution should be used immediately . parenteral medicines : if discolouration occurs prior to administration , the product should be discarded . this product
what pemetrexed hospira contains the active substance is pemetreed . pemetaled hospira 100 mg : each vial contains 100 milligrams of pemetereed ( as pemetretrexed disodium hemipentahydrate ). pemetoled hospira 500 mg : one vial of 500 milligram of pememetrexED ( as peemetrexede disodium emipenthydrate ) contains 1 , 000 milliggrams of pererexed . after reconstitution , the solution contains 25 mg / ml of petrexed ( without further dil
ganfort contains two active substances called bimatoprost and timolol which work together to reduce pressure in the eye . bimAToprost belongs to a group of medicines called prostamides , which work by blocking a prostaglandin analogue . timolole belongs to medicines called beta - blockers . what ganfort looks like and contents of the pack ganint is a clear , watery liquid that is injected into the eye by your eye . it is used in adults , adolescents and children aged one year and above . the eye is the clear , moisture - free liquid that helps to protect the
do not use ganfort eye drops : - if you are allergic to bimatoprost , timolol or beta - blockers or any of the other ingredients of this medicine ( listed in section 6 ) - if your child has respiratory problems such as asthma or severe chronic obstructive bronchitis - if he / she has severe lung disease - if the child has wheeziness or difficulty in breathing - if they have long - standing cough - if his / her child has heart problems suchas low heart rate or heart block - if their child has had heart failure warnings and precautions the following are reasons why this medicine may
always use ganfort exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to use treatment the bottle is for single use only . the bottle should be put into a neck pouch . 5 . 1 . wash your hands . do not touch your head . 2 . pull down your eyelid , which is closed by a small pocket . 3 . gently squeeze the bottle into your eye . during treatment , 4 . gently pull down the lid of your eye ( picture 2 ). gently squeeze your eye out . 5 ). tilt your eye back , pointing down with a finger . gently press
like all medicines , ganfort can cause side effects , although not everybody gets them . the drops can cause them . side effects of ganart ( multi - dose or single - dose ) are : very common side effects ( may affect more than 1 in 10 people ) the eye redness . common side effect ( may affects up to 1 in 9 people ) 100 the eye burning , itching , stinging , irritation of the conjunctiva ( the transparent layer at the back of the eye ), sensitivity to light , eye pain , sticky eyes , dry eyes , feeling of something in the eye , small breaks in the surface of
keep this medicine out of the sight and reach of children . do not use ganfort after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . ganf is for single use only . if you notice that the solution is not clear or contains particles , you should throw it away in a safe place . do this after 4 weeks . do away with the container . do no throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away
what ganfort contains - the active substance is bimatoprost ( 0 . 3 mg / 0 . 5 ml ) timolol ( 5 mg / ml ) and timolole maleate ( 6 . 8 mg / l ). - the other ingredients are benzalkonium chloride ( a preservative ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate , purified water , hydrochloric acid and sodium hydroxide . what ganFort looks like and contents of the pack ganf is a clear to slightly yellow , round , clear , colourless to
gefitinib mylan contains the active substance gefitinib . this protein is designed to kill cancer cells by blocking their growth and spread . gefitoninib melan is used to treat adults with non - small cell lung cancer . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan if you are allergic to gefitoninib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking gefnitinib melan if : you have any other lung problems you have some lung problems that may need medical attention . gefinib yourlan may cause problems with your liver . gekitin ib mylan is not recommended for use in children under 18 years of age . other medicines and gefilitinib tell your doctor if you take , have recently taken or might
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 250 mg tablet once a day . you can take antacids on an empty stomach ( see section 2 " gefitinib mylan contains lactose "). take the tablet at least 1 hour before or 2 hours after food . you should take gefnitinib melan at about the same time each day . if you have trouble swallowing the tablet whole , talk to your doctor . do not take any other liquids . the tablet can be taken with or without food
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : allergic reaction with symptoms such as swollen face , lips , tongue or throat , difficulty to swallow , hives , nettle rash , difficulty breathing , serious breathlessness , sudden worsening breathlessness with a cough or fever . these may be signs of an inflammation of the lungs called ' interstitial lung disease '. uncommon ( may affect up to 1 in 100 people ) gefitinib may cause severe skin reactions affecting your entire body . the
what gefitinib mylan contains - the active substance is gefinib . each film - coated tablet contains 250 mg of gefib . - the other ingredients are lactose monohydrate , microcrystalline cellulose , crospovidone ( type a ), povidon ( k30 ), sodium laurilsulfate , magnesium stearate . - coating : polyvinyl alcohol , macrogol 4000 , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide red ( e 172 ). what gefitoninib melan looks like and contents of the
reblozyl contains the active substance luspatercept which is used to treat myelodysplastic syndromes ( mds ). mds is a group of many different blood and bone marrow disorders in which red blood cells become abnormal . signs and symptoms include a low red blood cell count and anaemia which cannot be controlled with red bloodcell transfusions . reblozey is used in adults to treat anaemia in adults with mds who cannot be treated with red cell transfusions , or who are unable to receive erythropoietin therapies ( e . g . beta - thalassa
do not take reblozyl if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be pregnant ( see pregnancy section ). warnings and precautions talk to your doctor before taking this medicine if you have thalassaemia ( a condition where your spleen removed ) or have had a blood clot . your doctor may recommend hormone replacement therapy if you had a previous blood clot and / or preventive measures ( including medicines used to prevent a blood clot ). if any of these apply to you , tell your doctor . if you suffer from high blood
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will carry out blood tests before you start using reblozyl . reblzyl is given as an injection under the skin . the usual dose is one injection . the injections should be given every two weeks . the recommended dose is 1 . 0 mg / kg of body weight . your dose may be adjusted by your doctor . your physician may adjust this dose depending on your blood pressure . use in children and adolescents rebl ozyl is used in the treatment of myelodysplastic
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor immediately if you experience difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , or in parts of the body , with blurred vision . these may be symptoms of a stroke . blood clots swelling in the area around the eyes , face , lips , mouth or tongue throat allergic reactions with rashes 36 reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after reconstitution , reblozyl may be stored at room temperature ( up to 8 ) for up to 25 hours when stored at 2 8 . do away with any unused medicinal product or waste material . do this after the date of opening of the vials . do throw away any medicines via wastewater or household waste . these
what reblozyl contains the active substance is luspatercept . each ml of solution contains 25 mg or 75 mg of luspaterscept . after reconstitution , each mlof solution contains 50 mg of the active ingredient luspatecept . the other ingredients are excipients , citric acid monohydrate , sodium citrate 80 , sucrose , hydrochloric acid ( for ph adjustment ), sodium hydroxide ( for pct adjustment ). what rebl ozyl looks like and contents of the pack reblazyl is a white to off - white powder . reblosyl 25 mg / 75
fotivda contains the active substance tivozanib , a protein kinase inhibitor . tivzanib works by stopping the growth of the cancer by stopping it from spreading . it stops the growth and spread of cancer cells by blocking new blood vessels . fotivd is used in adults with advanced kidney cancer when other treatments ( alpha or interleukin - 2 ) have not worked or have not helped to stop your disease .
do not take fotivda - if you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you are taking st . john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor before taking fotiveda : - if any of these apply to you , or if you have any other concerns about your blood pressure . your doctor may need to adjust your dose of a medicine before you start taking fothivda . your blood will be
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of fotivda is 1340 mg once a day ( 21 capsules per day ). this means that you take 7 capsules in the morning and 7 capsules per night ( 24 capsules per 4 hours ). if you take more fotvda than you should if you have taken too many capsules , you may experience unacceptable side effects . severe side effects may occur during fotiva therapy . the usual dose of the fotive medicine is 890 mg once daily ( 21 capsule per day ),
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure ( this side effect can occur in more than 1 in 10 people ) tell your doctor immediately if you have high bloodpressure . symptoms may include severe headaches , blurred vision , shortness of breath , changes in your mental state , feeling anxious , confused or disorientated . your doctor may want to monitor your blood pressure more closely while you are taking fotivda . high blood hypertension may be treated with a medicine to control your high blood blood pressure . if you take more fotvda than you should if
what fotivda contains the active substance of fotive is tivozanib . each tablet contains 890 mg of tivzanib ( as tiv ozanib hydrochloride monohydrate ). the other ingredients are : tablet core : 890mg tivuzanib , mannitol ( e421 ), magnesium stearate , gelatin , titanium dioxide ( e171 ), indigo carmine ( e132 ), yellow iron oxide ( e172 ), propylene glycol ( for strong ammonia solution ), titanium dioxide , tartrazine aluminium lake ( e133 ), shellac , propyleneglycol
stribild contains two active substances : elvitegravir , an antiretroviral medicine known as an integrase inhibitor cobicistat , a booster ( pharmacokinetic enhancer ) of the activity of elvitesgravira emtricitabine , an antiviral medicine called a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir disoproxil , an antitroviral medication called a truncotide reverse transcriptases inhibitor ( rtti ). stribild is given as a single tablet regimen for the treatment of human immunodeficiency virus ( h
do not take stribild - if you are allergic to elvitegravir , cobicistat , emtricitabine , tenofovir , ten ofovir disoproxil or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking stribil . during treatment , you should tell your doctor if you have ever taken any medicine containing tenofovegravira disoprocessil . your doctor may also check your kidney function and may change your dose of these medicines . tell your physician if you : - are taking
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents 12 to less than 18 years of age : take the tablet once a day at about the same time each day . the recommended dose is 35 mg taken by mouth once a morning . swallow the tablet whole with a glass of water . you can take your tablet with or without food . your doctor may change the dose of your medicine or interrupt the treatment if you take medicines ( such as oral supplements , antacids , laxatives containing minerals , magnesium , aluminium , calcium , iron , zinc
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . when treating hiv infection , it is not always possible to tell whether unwanted effects are caused by stribild or by the hick disease itself . serious side effects tell your doctor immediately lactic acidosis ( excess lacticacid in the blood ) is a common
what stribild contains the active substances are elvitegravir , cobicistat , emtricitabine and tenofovir disoproxil . each stribil film - coated tablet contains 150 mg elvitesgravira , 150 mg cobicista , 200 mg emtracitabrine and 245 mg tenofovegravor disoprocessil ( as 300 mg ten ofovir desoproxel fumarate ) or 136 mg ten Ofovir . the other ingredients are croscarmellose sodium , hydroxypropyl cellulose , lact
zyprexa contains the active substance olanzapine . zyprexa belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , a condition with symptoms of excitement or euphoria . zzyprex has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olan zapine treatment
do not take zyprexa - if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching , a swollen face , swollen lips or shortness of breath . - if your doctor has told you that you have eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). warnings and precautions talk to your doctor or pharmacist before taking zypoxa . zypitxa is not recommended for use in elderly patients with dementia as it may have serious side
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . zyprexa tablets should be taken once a day . you should take zyxa between 5 and 20 mg once a morning . if your symptoms do not improve after this time , contact your doctor . swallow the tablets whole with a glass of water . do not chew or crush them . you can take zkyprexa with or without food . you may take your zypitxa tablets with or just after food . it is important that you take your tablets at the same time each day . z
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue ; blood clots in the veins ( a side effect which may affect upto 1 in 100 people ) especially in the legs ( symptoms include swelling , pain , and redness in the leg ), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if you notice any of these symptoms seek medical advice immediately ; a combination of fever , faster breathing , sweating ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . zyprexa does not require any special storage conditions . do this if you notice any change in the appearance of the tablets . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what zyprexa contains the active substance is olanzapine . each zypxa tablet contains 2 . 5 mg , 5 mg or 7 . 5mg , 10 mg , 15 mg or 20 mg of olanza . the other ingredients are lactose monohydrate , hyprolose , crospovidone , microcrystalline cellulose , magnesium stearate , hypromellose , titanium dioxide ( e171 ), carnauba wax . the different zypyxa tablet strengths are : - zypi 2 .5 mg , 7 . 75 mg and 10 mg - shellac
what prolia is prolia contains denosumab , a protein ( monoclonal antibody ) that is similar to another protein that is produced naturally in the body . it is used to prevent bone loss in adult patients with osteoporosis when treatment is not suitable . prolia helps to make bone stronger by making it easier for bone to break . it reduces the amount of oestrogen that is made up in the bones after the menopause . when oestrogens level drops , bones become thin and fragile . osteopORosis is caused by a lack of testosterone . when osteoporaosis is not treated
do not use prolia if you have low calcium levels in the blood ( hypocalcaemia ) if you are allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using prolia . if you think any of these apply to you , tell your doctor before using this medicine . if any of them apply to your child , tell the doctor or nurse before using it . warnings and symptoms talk to the doctor before starting prolia : if you develop a skin infection with symptoms such as a swollen , red area of skin , usually
what prolia is prolia contains one pre - filled syringe of 60 ml . it is given to you by your doctor or nurse , or by a doctor or other healthcare professional , for a maximum of 6 weeks . it can be given as a single injection under the skin ( subcutaneous ) in the front of your thighs , abdomen or upper arm . if you are injecting prolia yourself , you may be asked to wear stickers to help you remember to use it . you should also take calcium and vitamin d supplements while you are using prolia . how prolia works prolia will be given to your doctor by a healthcare
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking prolia and tell your doctor straight away if you develop skin infections ( cellulitis ). if you have any of these symptoms while taking prolix : swollen , red area of skin , usually in the leg , which feels hot and tender . symptoms may include fever . stop using prolia if you experience pain in the mouth and / or jaw , swelling or non - healing of sores in themouth or jaw ( discharge , numbness , feeling of heaviness or loosening of a tooth ), as these could be signs of bone damage in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . your pre - filled syringe may be removed from the refrigerator and left at room temperature ( not above 25 ) for a single period of maximum three months . after this period , the injection may be stored either at room temperatures ( not below 25 ) or at room
what prolia contains - the active substance is denosumab . each ml of solution contains 1 mg or 60 mg of denosumaab ( corresponding to 60 mg / ml ). - the other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prolia looks like and contents of the pack prolia is a clear to slightly yellow solution for injection in a pre - filled syringe with a needle guard .
what ambirix is ambirox is a vaccine for adults and adolescents from 1 to 15 years of age . it is used to treat two diseases : hepatitis a and hepatitis b : infection with the hepatitis a virus , which causes the liver to become swollen and inflamed . the virus can also cause faeces , serum or saliva . symptoms are usually mild to moderate and occur within 3 to 6 weeks of infection . if you feel sick , have a fever , aches or pains , or feel very tired , dark urine , pale faececes or yellowish skin or eyes ( jaundice ). the severity and type
you must not be given ambirix if you are allergic to ambirax or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue . if you have an allergic response to any vaccine . if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor or nurse before you are given ambira if you : have hepatitis a or hepatitis b diseases . have a severe infection with a high temperature . the vaccine should be given at the same time each day . have or
your doctor or nurse will give you ambirix as an injection into a muscle ( usually in the upper arm ). ambirux will be given into a vein . the injection will be injected into the thigh muscle . you will receive a total of two injections . the injections will be administered within 12 months . if you miss an injection , make another one as soon as possible . if it is more than six months since the missed one , make a new one as early as possible and then make another as soon possible . you may be able to go back to your regular schedule within 12 weeks of the missed injection . if the second injection
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering , swelling of the eyes and face , difficulty in breathing or swallowing , a sudden drop in blood pressure and loss of consciousness . other side effects reported in clinical trials with ambirix were : common ( may affect up to 1 in 10 people ): headache loss of appetite feeling tired or irritable pain or redness where
what ambirix contains 26 the active substance is hepatitis a virus . 1 ml solution contains 720 micrograms of elisa units ( equivalent to hepatitis b surface antigen ). 20 the other ingredients are human diploid ( mrc ), cells , aluminium hydroxide , hydrated in 0 . 05 ml , saccharomyces cerevisiae , aluminium phosphate in 0. 4 ml , sodium chloride and water for injections . what ambirax looks like and contents of the pack suspension for injection in a pre - filled syringe . ambirood is a white , slightly milky liquid . ambarix is available in packs
what bexsero is bex sero is a meningococcal group b vaccine . what bexero is used for bex serumo is given to adults , adolescents and children from 2 years of age with disease caused by the neisseria meningitidis group b bacteria . these bacteria cause infections ( such as meningitis , inflammation of the brain and spinal cord ) and sepsis ( blood poisoning ). the vaccine works by helping your body to produce its own protection ( antibodies ) against the disease .
do not use bexsero if you are allergic to any of the ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before using bex sero if : you have a severe infection with a high temperature . vaccination may be delayed if you have such a minor infection such as a cold . your doctor will decide whether vaccination is needed . you have haemophilia a or any other problem that may prevent your blood from clotting properly . you are treated with blood thinners ( anticoagulants ) or treatment that strengthens your immune system ( eculizumab ).
your doctor or nurse will give you bexsero at the following dose : the recommended dose is 5 mg injected into a muscle ( usually in the thigh or upper arm ). injections will be given at least 2 weeks apart . the interval between injections will not be longer than 2 weeks . if you miss a scheduled injection , make another one as soon as possible . if it is more than 1 month since the missed injection , your doctor will give the vaccine an additional injection ( booster ). the first injection will be postponed until 2 weeks after the missed dose . the intervals between injections should not exceed 1 month . if the intervalbetween injections is
like all vaccines , this vaccine can cause side effects , although not everybody gets them . stop using bexsero and see a doctor immediately if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): pain / tenderness at the injection site , redness of the skin at the site of injection , swelling of theskin at the place of injection site hardness at the area of the injection , red or white skin at site of the injected injection . if any of these side effects occur , stop using this vaccine and tell your doctor immediately . common ( might affect up to 1 in every
what bexsero contains the active substances are recombinant neisseria meningitidis group b nhba fusion protein 1 , 2 , 3 50 micrograms recombinant nisseria maningitidas group b noada protein 1 and 2 3 50micrograms reconstituted with recombinant neoisseria meingitis group b fhbp fusion protein 2 and 3 50 micromoleg al3 + recombinant noisseria meningitidis type b f hbp fusionprotein 1 , 3 , 50 microramoleg . the other ingredients are : outer membrane vesicles (
what nitisinone mdk is nitisinfone is a medicine used to treat a rare disease called hereditary tyrosinemia ( hty ) in adults , adolescents and children aged 1 year and above . in this disease your body does not make enough of the amino acid tyrosine ( amino acids are substances that are naturally present in the body ). nitisino reduces the amount of tyrosinine and the harmful substances that can be produced . this medicine helps to remove tyrosrine from your body by lowering the amount low tyrosines and phenylalanine ( another amino acid ).
do not take nitisinone mdk - if you are allergic to nitisinfone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking this medicine . pregnancy and breast - feeding nitis inone md k may affect the eyes . during nitisarinone treatment , red eyes may occur . if you notice red eyes , tell your doctor immediately . your doctor may recommend an eye examination . eye problems may be due to inadequate dietary control . see section 4 for more information . your healthcare professional will monitor you closely during the treatment and take blood
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . treatment with this medicine will be started by a doctor who is experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended dose is 1 capsule for every kg of body weight taken orally once a day . the dose may be increased to 20 capsules once a daily . in this patient population , the dose is based on body weight . swallow the capsules whole with a small amount of water or formula diet . if you take more nitisinone mdk than you should if you accidentally
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening , use within 2 hours at a temperature not above 25 . do away with the blister before use . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what nitisinone mdk contains the active substance is nitisino . nitishinone mdky 2 mg : each hard capsule contains 2 mg nitisine . nisinone MDk 5 mg : one hard capsule releases 5 mg nisine . each hard capsules releases 10 mg nitesinone . the other ingredients are : capsule content : gelatin , titanium dioxide ( e171 ), black iron oxide ( e172 ), shellac glaze . what nitisinnone mdks looks like and contents of the pack nitisinfone md k capsules are 15 . 7 mm long , hard gelatin capsules imprinted
docetaxel accord contains the active substance docetaxal . docetxel belongs to the group of anti - cancer medicines called taxoids . docel accord has been prescribed by your doctor for the treatment of breast cancer , special forms of lung cancer ( non - small cell lung cancer ), prostate cancer , gastric cancer and head and neck cancer : for the diagnosis of advanced breast cancer : docetixel could be administered either alone or in combination with doxorubicin , trastuzumab or capecitabine . for the prevention of early breast cancer with or without lymph node involvement , doc
do not use docetaxel accord - if you are allergic ( hypersensitive ) to docetxel or any of the other ingredients of docetixel accord ( listed in section 6 ) - if white blood cells are low - if your liver is not working properly - if there is a severe liver disease warnings and precautions before you are given docetAXel accord , you will have blood tests to check that you have enough blood cells and sufficient liver function to receive docetacord . white blood cell disturbances may occur . tell your doctor immediately if you experience : - fever or infections . tell the doctor immediately of abdominal
docetaxel accord will be given to you by a doctor or nurse . the dose will depend on your weight and your general condition . your doctor will calculate your body surface area in square meters ( m² ) and will determine the dose you should receive . method and route of administration docetaxele accord will usually be given by infusion into one of your veins . the infusion will last approximately one hour during which you will be in the hospital . frequency of administration you should usually receive your infusion once every 3 weeks . your dose may be adjusted by your doctor based on your blood tests and yourgeneral condition . in particular , doc
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord are reduction in the number of red blood cells and white blood cells , alopecia , nausea , vomiting , sores in the mouth , diarrhoea and tiredness . the severity of adverse events of docel accord may be increased when docetxel is given in combination with other chemotherapeutic agents . during the infusion at the hospital the following allergic reactions may occur :
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store below 25 . store in the original package in order to protect from light . do away with the vial once it has been opened . after dilution , the medicine should be transferred from the infusion bag to the infusion vial and used within 6 hours ( at 25 ). do not freeze . for infusion , the infusion solution should be used immediately . non - pvc bags may be stored for
what docetaxel accord contains - the active substance is docetxel . each ml of concentrate for solution for infusion contains 20 mg docetel . 1 ml of the concentrate contains 20mg docetixel . 4 ml of solution for injection each ml ( 0 . 5 ml concentrate contains 80 mg docel ). 8 ml ( 1 . 5ml concentrate contains 160 mg docotaxel ). - the other ingredients are polysorbate 80 , ethanol anhydrous ( see section 2 " docetacord contains ethanol an hydrous "), citric acid anhydrated ( see also section 2 ) what doc
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the brain . this medicinal product works by reducing the activity of the nervous system , such as the brain , which is involved in learning and memory . this helps to reduce impulsive and hyperactive behaviour . this medication is used to treat ' attention deficit hyperactivity disorder ' ( adhd ) in adults who are not adequately responsive to current stimulation or who are unable to take current medication to control adhd symptoms . the medicine is used together with a treatment programme consisting of psychological therapy , educational therapy and social therapy . intuniv
do not take intuniv if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking this medicine if you have low or high blood pressure . heart problems tell your doctor if you suffer from heart problems . you may have fainted recently if you had thoughts or feelings of suicide or any other psychiatric conditions ( withdrawal symptoms ). increased heart rate or highblood pressure should not be a problem for you . if you take this medicine with food , drink or alcohol , talk to a doctor or go to a hospital straight away
your treatment will be overseen by a doctor experienced in the treatment of adolescent behavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . your doctor will start your treatment with 1 tablet once daily . your dose will be gradually increased during treatment . the dose may be adjusted to : - 0 . 05 mg / kg bodyweight once daily depending on your response to treatment . - 1 tablet twice daily for 7 days . your daily dose of intuniv will be adjusted during 7 days after you start taking intun
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , you should take your medicine and continue to follow your doctor ' s instructions . serious side effects tell your doctor straight away if you notice any of the following serious side side effects : feeling drowsy or feeling dizzy ( hypotension ), slow heart beat ( bradycardia ), feeling faint , loss of concentration ( syncope ), a serious withdrawal side effect with high blood pressure . symptoms may include headaches , feeling confused , nervousness , agitation and tremors ( hypertensive encephalopathy ). if any of these side
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister pack after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . the tablets should be used within the first week of opening the blister pack . do this if you notice any change in the appearance of the tablets . do away with the tablets if you see any change to the appearance or appearance of them . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no
what intuniv contains the active substance is guanfacine hydrochloride . each prolonged - release tablet contains 1 mg guanFacine . each extended - release dose contains 2 mg guinfacine . the 3 mg prolonged - releases dose contains guanine hydroxychloride , and the 4 mg prolonged release dose increases to guanfuine . what intuniver looks like and contents of the pack intunive is a white to off - white , round tablet with " gsi " debossed on one side and " gs " debottled on the other side . intuniva is available
ecalta contains the active substance anidulafungin and is used to treat adults and children from 1 to 18 years old with fungal infection of the blood or other internal organs ( invasive candidiasis ). the infection is caused by fungal cells called candida that are cut off and live in the blood . ecalta belongs to a group of medicines called echinocandins . these medicines are used to prevent serious fungal infections caused by the lack of fungal cell walls . ecalda is used when fungalcells have incomplete or defective cell walls , which may make them fragile and unable to grow .
do not use ecalta if you are allergic to anidulafungin , other echinocandins , caspofungin acetate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before using ecaltra if you have liver function problems . your doctor may decide to reduce the dose you receive , or stop your treatment , or give you anaesthetics . your treatment with ecaltfa may need to be delayed or stopped if you experience an allergic reaction such as itching , wheezing or blotchy skin . if you develop an
the treatment will be given to you by a doctor or nurse . the recommended dose is 200 mg / 100 mg given once a week . the dose is 1 dose in children and adolescents ( aged 1 to 18 years ) of 3 . 0 mg / 200 mg given every other week . this dose is given as 1 . 5 mg / week . your doctor will decide the dose that is right for you . the doctor will work out the right dose for you based on the patient ' s weight . ecalta is given by slow infusion ( a drip into a vein ) over a period of 1 . 75 to 3 hours . the loading
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects : - threatening allergic reactions , including difficulty breathing or wheezing , or if you have an existing rash . ecalta can cause serious sideeffects , including convulsion ( seizure ), flushing , rash , pruritis ( itching ), hot flush , hives , sudden contraction of the muscles , wheezezing or coughing , or difficulty of breathing other side effects very common side effects ( may affect more than 1 in 10 people ): - low blood potassium ( hypok
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiratory date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . the reconstituted solution should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 8 . the infusion solution should not be stored above 25 for longer than 48 hours .
what ecalta contains - the active substance is anidulafungin . each vial of powder contains 100 mg of anidulinafungan . - the other ingredients are mannitol , polysorbate 80 , tartaric acid , sodium hydroxide and hydrochloric acid . what ecaltfa looks like and contents of the pack ecaltava is supplied as a box containing 1 vial containing 100 mg concentrate for solution for infusion . the powder is white to off - white .
adynovi contains the active substance rurioctocog alfa pegol , which is a copy of pegylated human coagulation factor viii ( hcvviii ). the human coaggulation factor iii is produced naturally in the body . factor v iii is necessary for the blood to form clots and stop bleedings . in patients with haemophilia a , factor v viii is not produced in the blood . adynovi is used for the treatment and prevention of bleeding in adults and adolescents 12 years of age and older and for children and adolescents with haemaophilia b , an inherited
do not use adynovi - if you are allergic to rurioctocog alfa pegol or octocog aluminium or any of the other ingredients of this medicine ( listed in section 6 ). - if your child is allergic to any of these active substances . warnings and precautions talk to your doctor or pharmacist before using adynov : - if the child has had an anaphylactic reaction ( a severe , sudden allergic reaction ) to adyno . allergic reactions may include rash , 95 hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing
treatment with adynovi will be started by a doctor experienced in the treatment of haemophilia a . adynov is used for treatment of bleeding in adults . adnovi is used as the replacement therapy for patients who have had adynocococ or who have not had a life - long treatment . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . dosage and prevention of bleeding the usual dose of adynova is 40 mg or 50 mg once every 2 weeks . to treat bleeding , your doctor will calculate your body weight and adjust the factor viii
like all medicines , this medicine can cause side effects , although not everybody gets them . sudden allergic reactions ( anaphylactic ) may occur within minutes of the injection . early symptoms of allergic reactions may include rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing , tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . if severe symptoms of difficulty in breath or fainting occur , prompt emergency treatment is needed . patients who have received previous treatment with factor viii ( more than 150 days of treatment ) inhibitor antibodies (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . the powder vial may be stored at room temperature ( up to 30 ) for a maximum of 3 days . do this medicine if it is stored at a room temperature not above 30 and it is not used within 3 days or it is discarded . after 3
what adynovi contains the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains nominally 250 , 500 , 1000 or 2000 iu of ruricoctocag alfa pepegol . the solvent vial is provided with 5 ml sterilised water for injections . the other ingredients are mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride dihydrates , tris ( hydroxymethyl ) aminomethane
rekovelle contains follitropin delta , a follicle stimulating hormone that belongs to a group of hormones called gonadotropins . gonadotropicins are involved in female fertility and are present in assisted reproduction programs , including in vitro fertilisation ( ivf ) and intracytoplasmic sperm injection . they work by helping the ovaries produce many egg sacs .
do not use this medicine if any of the following apply to you . if you are not sure , talk to your doctor or pharmacist before using rekovelle . warnings and precautions talk to the doctor or nurse before using this medicine : if you have a tumour in the uterus , ovaries , breasts , pituitary gland or hypothalamus . if your womb has enlarged ovaries or cysts on your ovaries . if any member of your family has polycystic ovarian disease ( bleeding from the vagina at an early menopause ). if you suffer from malformations of the sexual organs . if there is a
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the rekovelle dose will be given as your first treatment cycle . your doctor will tell you how much anti - Müllerian hormone to take . your ovaries will be stimulated by stimulation with gonadotropins in your blood . your dose will depend on your body weight . your physician will ask you to take a blood sample during the last 12 months to measure how much rekole you should take . the dose will vary depending on how you respond to treatment . your bodyweight will be checked
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects caused by hormones that are used to treat infertility have been reported . this medicine may cause a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ). symptoms include pain , discomfort and swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain and difficulty breathing . if you experience any of these symptoms , seek medical advice straight away . a side effect that may affect up to 1 in 10 people is headache . nausea ( ovarianhyperstimulation systrome ) pelvic pain and discomfort ( ovarian origin tiredness
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store at room temperature ( up to 25 ) for a single period of up to 3 months . after this period , the product may be stored at room temperatures ( up up to 28 ) for up to a maximum of 25 days . after the end of the treatment any unused solution must be discarded . do this to protect the
what rekovelle contains the active substance is follitropin delta . each multidose cartridge contains 12 mg of follitroin delta in 0 . 36 millilitre of solution . after dilution , each ml of solution contains 33 . 3 mg of the active ingredient follitrotin deltain each millilitere of solution , corresponding to 12 mg / ml . the other ingredients are phenol , polysorbate 20 , l - methionine , sodium sulphate decahydrate , disodium phosphate dodecahydrated , concentrated phosphoric acid , sodium hydroxide and water for injections
the active substances of revinty ellipta are fluticasone furoate and vilanterol . each inhalation of revindy elliptoe contains flutica furoates 92 mg and vilterol 22 mg . each inhale of flutic asone firoate 184 mg and / or vilancerol 22mg is equivalent to 92 / 22 mg of the active substances . chronic obstructive pulmonary disease ( copd ) in adults and adolescents ( 12 years of age and older ) the combined dose of revipta is 184 mg / 22mg . asthma in adults ( 12 to less than
do not take revinty ellipta : if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking revintchy ellipta . if you have liver disease , tell your doctor straight away if you notice any of these side effects . if your doctor determines that you have moderate or severe liver disease . the lower strength of revintty ellipta 92 / 22 mg / m2 is recommended for patients with heart problems , high blood pressure , tuberculosis ( tb ) of
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . asthma the recommended dose for asthma is one inhalation twice a day ( one inhalational dose each day ). the dose is one tablet twice a morning ( one inhale each day ) with fluticasone furoate and one 22 mg tablet each day ( two inhaled doses each day ), with vilanterol . copd the recommended starting dose for copd is one and a half tablets twice a daily ( one oral dose each morning , with flilitasonef
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you experience any of the following symptoms while taking ellipta , stop taking this medicine and contact your doctor immediately : skin rash , hives , redness swelling , sometimes of the face or mouth ( angioedema ) feeling very wheezy or coughing , having difficulty in breathing , feeling weak or light headed ( which may lead to collapse or loss of consciousness ) immediate breathing difficulties immediate breathing problems stop taking revinty ellipta and
what revinty ellipta contains the active substances are fluticasone furoate and vilanterol . each 92 micrograms inhalation delivers 92 microlitres of flutic as a 22 microgram per inhalation dose , vilancerol and trifenatate . each 184 microgram inhalation provides 184 microlitre of flritasonefuroate as a 23 microgramper inhalation dosage , vilterol and and triffenatatate respectively . the other ingredients are lactose monohydrate ( see section 2 " revintchy ellipta is for inhalation use
atripla contains three active substances that are used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), emtricitabine , a nucleosides reverse transcript enzyme inhibitor ( tnrtis ), tenofovir , aucleotide reverse transcriptases inhibitor ( rtti ). these active substances are all used together in combination with antiretroviral medicines . they work by interfering with the normal working of an enzyme ( reverse transcriptatase ) that is essential for the virus to multiply
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet taken by mouth once a day . take atripla on an empty stomach once a morning , at about the same time each day . the dose may be adjusted by your doctor from 1 to 2 tablets per day . some side effects such as dizziness and drowsiness may occur . if you take more atripola than you should if you accidentally take too many atripa tablets , contact your doctor immediately . if possible , take your tablets with you .
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects lactic acidosis ( excess lacticacid in the blood ) is rare ( may affect up to 1 in 1 , 000 people ). if you experience any of the following serious side effect , stop taking atripla and seek medical help immediately :
what atripla contains the active substances are efavirenz , emtricitabine and tenofovir disoproxil . each atripera film - coated tablet contains 600 mg efavairenz and 200 mg emtracitabin and 245 mg tenofvir disopicroxil ( as fumarate ). the other ingredients are croscarmellose sodium , hyprolose , magnesium stearate , microcrystalline cellulose , sodium laurilsulfate ( see section 2 " atriplea contains sodium "). the tablet film coating
orgalutran contains the active substance ganirelix . it belongs to a group of medicines called anti - gonadotrophin . it is a synthetic version of the natural gonadonrophin releasing hormone ( gnrh ). when gonadocrophins are released , they help to control the growth and release of gonadotroprophins . they are involved in the development and releaseof gonadocytes ( a type of follicle stimulating hormone ). gonadrophins play an important role in the growth of follicles in the ovaries . follicles are small round sacs that contain the egg cells .
do not use orgalutran - if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). - if hypersensitive to gonadotrophin releasing hormone ( gnrh ). - you have agnrh analogue . - if your doctor has told you that you have or have had a moderate or severe kidney or liver disease . - you are pregnant . warnings and precautions talk to your doctor or pharmacist before using orgaluchran allergic reactions . if you develop an active allergic condition , your doctor may recommend additional monitoring and treatment . allergic reactions : allergic reactions are
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . orgalutran is only used in women who are able to use assisted reproduction techniques ( i . e . in vitro fertilisation ( ivf ), ovarian stimulation , follicle stimulating hormone ( corifollitropin ), on day 2 or day 3 of each cycle . orgdalutran should be injected under the skin ( subcutaneously ) every 5 to 6 weeks . orgallutran must not be used in fsh patients . the preparation is made using different injection sites . daily treatment with
like all medicines , this medicine can cause side effects , although not everybody gets them . if you have a side effect , tell your doctor immediately . very common ( may affect more than 1 in 10 people ) local skin reactions ( including redness and swelling ). the local reaction usually disappears within 4 hours . uncommon ( may effect up to 1 in 100 people ) headache nausea ( malaise ). rare ( may affects up to1 in 10 , 000 people ) allergic reactions ( rash facial swelling difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat , difficulty in breathing or swallowing ( angio
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and syringe after exp . the exp date refers to the last day of that month . syringes should be clear , colour - free solutions . do this to protect from light . do away with any unused syringe after first opening . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what orgalutran contains - the active substance is ganirelix . each vial contains 0 . 5 ml of acetic acid . - the other ingredients are mannitol and water for injections ( for the ph ) and sodium hydroxide . - acetic acids are excipients . what orgaluitran looks like and contents of the pack orgaluchran is a clear , colourless aqueous solution for subcutaneous administration . the solution is supplied in a glass vial with the needle . it is supplied as a clear to slightly opalescent , dry natural rubber / latex . org
what blitzima is blitzima contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a type a white blood cell called b - lymphocyte . when ritukimab sticks to this surface , the cell dies . what blitzima used for blitzima can be used in adults with : a ) non - hodgkin ' s lymphoma this is an disease of the lymph tissue that affects the immune system . it affects a type in the body called b lymphocytes . blitzima may be used alone or in combination
do not use blitzima - if you are allergic to rituximab , other proteins that are derived from ritukimab or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a severe active infection . - if he / she has a weak immune system . - warnings and precautions talk to your doctor or pharmacist before using blitzima if you have severe heart failure or severe uncontrolled heart disease . - granulomatosis , polyangiitis , microscopic polyangis or pemphigus vulgaris . warnings and risks talk to the doctor or nurse before
how blitzima is given your doctor will decide how much blitzima you will receive and for how long . always use this treatment exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor may decide to change the dose of this medicine , or stop it altogether if you experience any side effects . how blitzima will be given blitzima comes as a drip ( intravenous infusion ). medicines given before each blitzima administration you will be treated with blitzima together with other medicines ( pre - medication ) to reduce the risk of side effects and to improve the effectiveness of your treatment . for
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate and will generally disappear after a few days of treatment . rarely , some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy or runny nose , vomiting , flushing or palpitations , heart attack , low number
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . do away with the vials after first opening . do this if you notice any particles in the solution . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help
what blitzima contains - the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab in 10 ml . each 50 ml vials contains 500 mg of the active ingredient in ritiximab ( 10 mg / ml ). - the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what blitzima looks like and contents of the pack blitzima is a clear , colourless solution for infusion . it is supplied in 2 glass vials , each containing 50 ml . pack size of 1 vial
roactemra contains the active substance toilizumab , a type of monoclonal antibody ( a type in the body ) that attaches to a specific target in the brain . this target is found in the cells of the body and helps to reduce the inflammation in your body . roactemrea can cause symptoms such as pain and swelling in your joints . roactorra reduces the damage to the cartilage and bone in the joints caused by the disease . roACTemra is used to treat moderate to severe active rheumatoid arthritis , an autoimmune disease that can occur when previous therapies did not work well
do not use roactemra if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active , severe infection . during the infusion with roactiemra , you may experience allergic reactions such as chest tightness , wheezing , severe dizziness , light - headedness , swelling of the lips or skin rash . during and after the infusion , tell your doctor if you develop any of these . infection tell your healthcare professional if you get infections or feel unwell . roactema may cause your body ' s ability to fight infections .
the doctor or nurse will give you roactemra by infusion into a vein ( intravenous infusion ). your doctor or a nurse will decide on the correct dose based on your body weight . the treatment will be started by a doctor or another healthcare professional . the recommended dose of roactlemra is 8 mg / kg body weight once a day for 4 weeks . your doctor will decide how many weeks you should receive roactiemra . the usual dose is 4 mg /kg body weight twice a day . your dose will be worked out by your doctor . the maximum recommended dose is 8mg / kg of body weight three times
like all medicines , roactemra can cause side effects , although not everybody gets them . the following side effects have been reported in the post marketing setting in patients treated with roactemnra : very common side effects ( may affect more than 1 in 10 people ) allergic reactions , including difficulty with breathing , chest tightness , light - headedness , rash , itching , hives , swelling of the lips , tongue or face . serious infections , including fever and chills , which may travel through the mouth and skin blisters and stomach ache signs and symptoms of liver toxicity . rare side effects these may affect up to 1
keep this medicine out of the sight and reach of children . do not use after the expiry date which is stated on the carton and the vial after exp . the expirability of the product does not require any special storage conditions . do this medicine after the first opening of the vials . do away with the vals . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what roactemra contains the active substance is tocilizumab . each 4 ml vial contains 80 mg of tociluzumab in 20 ml . each 10 ml vials contains 200 mg of of tocizumumab ( 20 mg / ml ). each 20 ml vray contains 400 mg of the active substances in tocilixumab 20 mg . the other ingredients are sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphate dihydrate and water for injections . what roactemetra looks like and contents of the pack roact
what onbrez breezhaler is onbrezer contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . these relax the muscles in the walls of the small air passages in the lungs . what onbreez breez inhaler is used for onbrezezhalcer is used to treat breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways relax , making breathing difficult . this medicine works by relaxing these muscles in your lungs . it helps to open the air passages wider and makes it
do not use onbrez breezhaler - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). - if your asthma is not controlled with onbreez breez inhaler . - if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor or pharmacist before using onbrezer : - if there are any signs of heart problems such as epilepsy , thyroid gland problems , thyrotoxicosis ( diabetes ), or if you have any other medical conditions requiring treatment with on brez breezer . tell your physician immediately if
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is one 150 microgram capsule twice a day . your doctor may increase your dose to 300 microgram twice a week depending on how you respond to the treatment . your inhaler will be used 24 hours after you last inhaled it . onbrez breezhaler is supplied as an inhaler and capsules ( in blisters ) containing the medicine . the medicine is inhalation powder . the onbreez breez inhaler inhaler contains the medicine as inhalationpowder . the capsules
what onbrez breezhaler contains - each onbrex breez inhaler 150 mg capsule contains 150 mg indacaterol ( as indacathol maleate ). - the other ingredients are lactose and the capsule is made of gelatin . - eachonbrez bronzhalER 300 mg capsule delivers 300 mg indiacaterol , as indiacathol femaleate . - the ingredients are : lactose , lactose amd the capsule contains gelatin . what onbreez breezer looks like and contents of the pack onbrezy breezker 300 mg capsules are white to off - white ,
clopidogrel hcs contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelelet medicinalproducts reduce the chances of blood clots forming ( a process called thrombosis ). clopIDogrel clcs is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis , which can lead to atherostrombotic events
do not take clopidogrel hcs - if you are allergic to clopidineogrel or any of the other ingredients of this medicine ( listed in section 6 ). - if a medical condition is currently causing bleeding such as a stomach ulcer or bleeding within the brain . - if severe liver disease is a problem . if any of these apply to you , tell your doctor before taking clopridogrel clcs . warnings and precautions take special care with clopIDogrel hexa if any part of you is at risk of bleeding such : - if your child has a medicalcondition that puts you at risk
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clubidogl hcs ( 4 tablets of 75 mg ) once at the start
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel hcs contains the active substance is clopidoogrel . each film - coated tablet contains 75 mg of clopidaogrel ( as hydrochloride ). the other ingredients are ( see section 2 ' clopide hcs contain hydrogenated castor oil '): tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenatedcastor oil . tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc
fetcroja contains the active substance cefiderocol . it is an antibiotic medicine that belongs to a group of antibiotics called cephalosporins . antibiotics are used to fight bacteria that cause infections . fetcroja is used to treat infections caused by bacteria that you have not previously been able to fight with other antibiotics .
do not use fetcroja if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to other antibiotics ( e . g . cephalosporins ). if this applies to you , tell your doctor before using fetcroj . if you have had a severe allergic reaction to certain antibiotics ( such as penicillins or carbapenems ). if severe skin peeling or swelling of the hands , face , feet , lips , tongue or throat that may cause difficulty swallowing or breathing stop using fetroja and tell your
this medicine is given by a doctor or nurse as an infusion ( a drip ) into a vein . it is usually given every 3 weeks . it may be given every 2 weeks . your doctor will decide how often you should receive fetcroja treatment . your dose will be decided by your doctor . it depends on how you respond to treatment and on how well you tolerate it . your infection will be treated . you should not feel any pain during the fetcrora infusion . it will be given into a separate vein . patients with kidney problems if you have kidney problems , your doctor may decide to reduce your dose of fetcroJA .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects you may need urgent medical treatment : severe allergic reaction ( sudden swelling of your lips , face , throat or tongue , a severe rash or other severe skin reactions , difficulty swallowing or breathing ). this reaction may lead to diarrhoea , stools , blood or mucus . treatment may be stopped or medicines given to slow bowel movement may cause this reaction . other side effects include : very common side effects ( may affect more than 1 in 10 people ): feeling
what fetcroja contains - the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg cefide . - the other ingredients are sucrose , sodium chloride and sodium hydroxide . what fetcroJA looks like and contents of the pack fetcrojoe is a white to off - white powder for concentrate for solution for infusion . it is supplied in packs containing 10 vials .
depocyte is used to treat lymphomatous meningitis . lymphomatinous menenitis is a condition in which tumour cells accumulate in the membranes of the brain and spinal cord . depocyte is prepared by biotechnology and is used in adults . lymphoma tumour cell growth is not caused by any other treatment .
do not take depocyte - if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking depocyte . - if your child has a meningeal infection . - severe neurological side effects have been reported with depocyte , with symptoms affecting the nervous system such as convulsions , pain , numbness , tingling , blindness and visual disturbances . if your doctor suspects that your child may have these symptoms , stop taking depocytes and contact your doctor . - taking any dexamethasone tablets
treatment of cancer in a hospital or clinic is under the supervision of a doctor experienced in the care of patients . depocyte is prepared by injection in a lumber sac . depocytes is given as two injections ( 1 ml and 5 ml ) of dexamethasone in the morning and 5 mg in the evening . each depocyte dose will be monitored by your doctor to detect any side effects . the recommended dose of depocyte for adults is based on body weight and temperature . the dose is 22 mg / kg given once daily for 30 days . before withdrawing depocyte from the vial , you should take proper precautions to avoid exposure
like all medicines , this medicine can cause side effects , although not everybody gets them . you may experience side effects more often during your treatment . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) very common : affects 1 or 10 users per 10 , very common not known ( frequency cannot be estimated from the available data ) very rare : affects less than 1 users in 10 , not known : frequency cannot been estimated from available data very common adverse events
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . depocyte should be stored in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . after preparation , depocyte must be used within 4 hours . do this if you notice that the solution is discoloured or contains particles . do discard the vial containing depocyte . do do not throw away any medicines via wastewater or household waste . ask your pharmacist
what depocyte contains - the active substance is cytarabine . one ml of suspension contains 10 mg cytarbine . each 5 ml vial contains 50 mg cytabine ( as besilate ). - the other ingredients are cholesterol , triolein , dioleoylphosphatidylcholine , dipalmitoylophosphatylglycerol , sodium chloride and water for injections . what depocyte looks like and contents of the pack depocyte is a solution for injection . it is supplied in a 5 ml glass vial as a single injection . depocyte can be divided
what bemrist breezhaler is bemist breez inhaler contains two active substances called indacaterol and mometasone furoate . indacasterol belongs to a group of medicines called bronchodilators . it relaxes the muscles in the lungs , making it easier for air to get in and out of the lungs . mometsone fruate belongs to the group of medicine called corticosteroids and belongs to an anti - steroidal group called steroids . corticostromes reduce the swelling and irritation ( inflammation ) in the small airways in the lungs
do not use bemrist breezhaler - if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor thinks you may be allergic . - if any of these apply to you , tell your doctor before using bemist breez inhaler . warnings and precautions talk to your doctor or pharmacist before using this medicine : - if : - you have heart problems - you experience an irregular or fast heartbeat - you suffer from thyroid gland problems - if the patient has diabetes - you drink alcohol excessively - you
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . bemrist breezhaler capsules should be swallowed whole with water . the medicine should be inhaled immediately after a meal . do not chew or crush the capsules . if your asthma does not improve or your symptoms get worse , contact your doctor . how bemist breez inhaler is for inhalation use . be mrist breezezhalER is for use in adults only . you should use bemrid breezcaler as an inhaler and capsules . the inhaler contains the
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious . tell your doctor immediately if you experience any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives . allergic reaction uncommon ( may effect up to 1 in 100 people ): swelling of either the tongue or lips , face or throat ( angioedema ). other side effects other sideeffects include the following listed below : very commonly ( may affects more than1 in 10 users ): sore
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store in the original blister in order to protect from light . do this after the first use . do away with the capsules if you notice that the blister is damaged or shows signs of tampering . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the
what bemrist breezhaler contains the active substances are indacaterol ( as acetate ) and mometasone furoate . bemist breez inhaler 125 micrograms / 62 . 5 microgram inhaled in a single inhalation each contains 173 microgram indacate and 150 microgram of indacatedol ( corresponding to 80 microgram mometsone furyate ). the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is 125 microlitres ( equivalent to 173 microlitre ) indacatersol acetate and 160 microgramm
zyllt contains clopidogrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). zyllt is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis , which can lead to atherostrombotic events ( such as stroke , heart attack , or
do not take zyllt - if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor thinks you may have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . - if any of these apply to you , tell your doctor before taking zylltt . warnings and precautions talk to your doctor or pharmacist before taking the zylltic if : you have a risk of bleeding such a medicalcondition that puts you at risk of internal bleeding ( such as - a stomach ache ). you have ever
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of zllt ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended starting
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what zyllt contains the active substance is clopidogrel . each film - coated tablet contains 75 mg of clopridogrel ( as hydrogen sulphate ). the other ingredients are : tablet core : lactose ( see section 2 under ' zyllts contains lactose '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the film - coating . tablet coating : hypromellose , titanium dioxide ( e171 ), red iron oxide ( e172 ), talc and propylene glycol in thefilm - coating what zyllT
lamivudine teva contains the active substance lamivudin . lamivudaine tevas is used to treat long term ( chronic ) hepatitis b infection in adults . lamvudineteva is an antiviral medicine that works by stopping the hepatitis b virus from multiplying . it belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis ). hepatitis b is a virus that infects the liver . long term (" chronic " infection can lead to liver damage . lamlivudine seva works by reducing the amount of hepatitis b in your body . this results in a reduction in
do not take lamivudine teva - if you are allergic to lamivuda or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 28 lamivuine tevas , like other similar medicines , can cause serious side effects , especially if you have liver disease such as hepatitis c . if you become overweight , your doctor may need to change your dose . your doctor will do blood tests before you start your medication . see section 4 for more information . warnings and risks talk to your doctor before taking lamivuxine tev if your hepatitis is getting worse . before you take lamvel
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage your doctor lamivudine teva is used to treat your hepatitis b infection . it is important that you take it every day , as long as your infection is getting better . it does not matter whether you take the tablets whole or in equal doses . your doctor will tell you how many tablets to take . if you have any questions about how to take lamivuda teva , ask your doctor . lamivuxine tella can be taken with or without food . if your kidneys are not
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects of lamivudine teva are related to other conditions linked to hepatitis b . the following side effects have been reported during therapy for ' hepatitis b ' in clinical trials : tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort , pain , nausea , vomiting , diarrhoea , and increases in liver enzymes . these are signs that the liver is not working properly . these may be signs that your muscles are not working normally . allergic reaction ( rare , may affect up to 1 in 1 , 000 people
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . lamivudine teva should not be put back in the refrigerator after first opening . do this to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what lamivudine teva contains - the active substance is lamivuine . each film - coated tablet contains 100 mg of lamivubine . - the other ingredients are microcrystalline cellulose , sodium starch glycolate , magnesium stearate . tablet film - coating : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( e172 ), iron oxide red ( e 172 ). what lamivUDine teeva looks like and contents of the pack orange , biconvex film - coat : 32 lamivuxine tevas
nespo is an anti - anaemic ( means that your anaemia is not caused by any other medicine ). anaemia occurs when your blood does not contain enough red blood cells . the symptoms can include fatigue , weakness and shortness of breath . nespo works by inhibiting the natural hormone erythropoietin . erythroietin works by blocking the growth of your kidneys and so makes your bone marrow produce more red blood cell cells . it is also used to reduce the production of darbepoetin alfa . chronic renal failure ( symptomatic anaemia ) chronic renal fail is caused by
do not use nespo : if you have high blood pressure or are taking other medicines . if you are allergic to nespos ( darbepoetin alfa ) or r - huepo . warnings and precautions talk to your doctor or pharmacist before using nesp : if your child has high bloodpressure and is taking medicines to treat sickle cell anaemia . if your baby has epileptic fits ( seizures ). if your newborn has convulsions or fits . if he / she has liver disease . if the child is taking drugs to treat anaemia or has an allergy to latex . the needle
your doctor will carry out blood tests before you start using nespo to check your haemoglobin level . the usual starting dose is 10 mg . your doctor will then increase your dose to a haemogl level of 10 mg every 12 hours using the pre - filled syringe ( intravenous ) provided in the package leaflet . if you have chronic renal failure , your doctor may increase your starting dose to one vial of nespos every 12 weeks . a single injection should be given under the skin or into a vein ( intravenously ). your doctor should check your anaemia regularly . the dose of nnespo given
like all medicines , nespo can cause side effects , although not everybody gets them . the following side effects have been reported with nespos : 471 common ( may affect up to 10 in 100 people ): high blood pressure ( hypertension ) fluid retention ( oedema ) uncommon ( may effect up to 1 in 100 , 000 people ): blood clots ( thrombosis ) pain in the area injected rash , redness and swelling of the skin rare ( may affects up to1 in 10 , 000 users ): serious allergic reactions sudden life - threatening allergic reactions ( anaphylaxis ) swelling of any of the face
keep out of the reach and sight of children . do not use nespo after the expiry date which is stated on the carton and on the syringe label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep nespos in the original package in order to protect from light . before you start using nespen , your syringe may be removed from the refrigerator and left at room temperature ( not above 30 ) for a single period of up to 7 days . do this at the same time each day . do it at the
what nespo contains the active substance is darbepoetin alfa . each ml of solution for injection is a pre - filled syringe containing 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 , 500 micrograms . each pre -filled syringe contains the inactive substance darbasoetine alfa ( e321 ). the other ingredients of nespos are sodium phosphate monobasic , sodium phosphate dibasic ( e507 ), sodium chloride , polysorbate 80 and water for injections . what nespol
macugen is a solution for the eye that contains the active substance pegaptanib . this medicine works by stopping abnormal formation of new blood vessels in the eye . macugen is used for the treatment of adults with macular degeneration . in this disease , vision loss is caused by damage to a part of the retina called the macula ( the macular part of your eye ). macula is the macule that lines the front part of an eye called the amd . abnormal blood vessels grow in the retina and form in the maculula . these new blood structures bleed and leak fluid causing the maculas to bulge ,
do not use macugen : if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active or suspected infection in or around the eye . warnings and precautions talk to your doctor or pharmacist before using macugen . if you think you have or have had an infection or bleeding in the eye , stop using macug injection and contact your doctor immediately . if any of these occur , tell your doctor straight away . if the following symptoms occur , contact your ophthalmologist immediately : eye pain or increased discomfort worsening eye redness blurred or decreased vision increased
mugen will be given to you by a doctor or nurse . injections of macugen will usually be given by a single injection into the eye . the recommended dose is 6 to 9 injections per week . the injection will be injected into the vitreous part of the eye ( the front part of your eye ). macugen is not to be used in combination with antibiotic eye drops . your doctor will clean your eye and may give you some local anaesthetic (umbing medicine ) to reduce any pain you may have after the injection . if you are allergic to antibiotic eyedrops , your doctor may decide to treat you with antibiotic treatment to prevent
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction ) angioedema of which symptoms include breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting , rapid pulse , stomach cramps , nausea , vomiting and diarrhoea . the frequency of these side effects is not known . an infection in the internal portion of the eye has been reported in patients receiving macugen treatment . the symptoms are described in section 2 under " warnings and precautions " and in section 4 . if you experience any of these
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do use the medicine if you notice any change in the appearance of the capsules . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what macugen contains - the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegaptenib in 90 ml of solution . - the other ingredients are sodium chloride , monobasic sodium phosphate monohydrate , dibasicodium phosphate heptahydrate , sodium hydroxide , hydrochloric acid ( for ph adjustment ) and water for injections . see section 2 . what macugen looks like and contents of the pack macugen solution for injection in a single dose pack is supplied as a pouch . each pack contains a pre -filled syringe of
palifermin belongs to a group of medicines called escherichia coli . palifermin works by blocking the growth of epithelial cells in the mouth and digestive tract and in the tissues of the skin . paliflate is a substance produced by biotechnology in the body and is very similar to the natural chemical in the food we eat . palfermin is used to treat oral mucositis ( soreness , dryness or inflammation of the mouth ) as an additional side effect that may be associated with treatments for your blood cancer . if your bloodcancer is not being treated with chemotherapy , radiotherapy or autologoushemat
do not use kepivance if you are allergic to palifermin , escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). children and adolescents do not give this medicine to children under 18 years of age . other medicines and kepipivance tell your doctor or pharmacist if you have recently taken or might take any other medicines . kepivalance may be taken with heparin . if you recently taken heparrin , tell your physician . pregnancy and breast - feeding kepvelance is not recommended if you plan to become pregnant . if pregnant ,
how kepivance is given your doctor will decide how much kepvance you will receive and for how long . your doctor or nurse will decide the dose you will be given . your dose will depend on your condition and your general condition of cancer treatment . the usual dose of kepovance is 60 mg per kilogram body weight . your healthcare professional will give you kepvelance as an intravenous injection into a vein . how kepivanance is administered kepervance is used in adults . you will first be given kepavance three days before chemotherapy ( chemotherapy and radiotherapy ) and then
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ): side effects include skin rash , itching and redness ( pruritus and erythaema ), an increase in the thickness in the mouth or tongue , change in colour of the mouth , generalised swelling ( oedema ), swelling of hands , ankles or feet , pain , fever and aching joints ( arthralgia ), altered taste , decrease in lipase and amylase levels , and increase in levels of digestive enzymes in the blood . most of these effects occur within
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg of paliferin . - the other ingredients are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid . what kepivismance looks like and contents of the pack kepiverance is a white powder for concentrate for solution for injection . each pack contains 6 vials .
cinacalcet accordpharma contains the active ingredient cinacalcitepine which reduces the levels of calcium and phosphorous in the blood . it is used to treat problems with organs called parathyroid glands . parathyroids are four small glands in the neck , near the thyroid gland . cinocalcate accordphara is used : to treat secondary hyperparathyroidism in adults with serious kidney disease who are not on dialysis or who are unable to swallow food . to reduce the amount of waste products that can be made from parathyrosin , to reduce calcium in the bloodstream
do not take cinacalcet accordpharma - if you are allergic to cinacealcut or any of the other ingredients of this medicine ( listed in section 6 ). - if there are low levels of calcium in your blood . your doctor will check your blood calcium levels regularly before and during treatment with cinocalcordpharma . warnings and precautions talk to your doctor or pharmacist before taking cinicalcvet accordpha : - if any of these apply to you , tell your doctor before taking this medicine . - if your doctor has told you that you have a history of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cinacalcet accordpharma must be taken orally with or without food . you should take cinaccalcate accordpharmat with or shortly after food . the tablets should be taken with regular blood samples . your doctor will decide on the dose that is best for you . treatment of secondary hyperparathyroidism the usual starting dose of cinocalcite accordphara is 30 mg once a day ( one tablet in
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : numbness or tingling around the mouth , muscle aches or cramps , seizures , as these may indicate that your calcium levels are too low ( hypocalcaemia ). swelling of the face , lips , mouth , tongue or throat which may cause difficulty in swallowing or breathing ( angioedema ). very common ( may affect more than 1 in 10 people ): nausea and vomiting . if you notice any of these side effects seek medical advice immediately . common ( might affect up to 1 in every 10
what cinacalcet accordpharma contains - the active substance is cinocalcep . each film - coated tablet contains 30 mg , 60 mg or 90 mg of ciniacalcip ( as hydrochloride ). - the other ingredients are cellulose , microcrystalline - crospovidone - magnesium stearate , hypromellose , titanium dioxide ( e171 ), triacetin , indigo carmine aluminum lake ( e132 ), iron oxide yellow ( e172 ). what cinacealcelcet cordpharma looks like and contents of the pack c
jentadueto contains two active substances called linagliptin and metformin . linaglptin belongs to a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) metformrin belongs to the class of substances called biguanides . they work together to lower blood sugar levels in adult patients with a type of diabetes called ' type 2 diabetes mellitus '. this medicine works by reducing the amount of insulin produced by the body . this medicine can be used alone or with certain other medicines used to treat diabetes ( such as sulphonylureas or emp
do not take jentadueto - if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have severely reduced kidney function . - if any of these apply to you , tell your doctor before taking jentadoueto . warnings and precautions talk to your doctor or pharmacist before taking this medicine : - if : you have severe reduced kidneyfunction - if this is the case - if the level of uncontrolled diabetes ( severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoe
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jentadueto should be taken with or without food . if you currently take metformin or individual tablets containing linagliptin or metforman , take the tablet before you take this medication . if this medicine is not suitable for you , or you are having an upset stomach , take it with food . the recommended dose is one 5 mg linaglptin tablet once a day with food , and one 2 , 000 mg metformine hydrochloride tablet once daily . if your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms need immediate medical attention . stop taking jentadueto and contact a doctor immediately if you experience any of the following symptoms : low blood sugar ( hypoglycaemia ) trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change and confusion . hypoglycasemia is a very rare ( may affect up to 1 in 10 , 000 people ) but very serious side effect . jentodueto plus sulphonylurea may cause the combination jentadenuetoplus insulin to stop
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . blister : store in the original package in order to protect from light . do this medicine if you notice any visible sign of tampering . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what jentadueto contains - the active substances are linagliptin and metformin hydrochloride . each jentadinueto 2 . 5 mg / 850 mg film - coated tablet contains 2 . 25 mg linaglioptin and 850 mg metformformin Hydrochloride , respectively . - each jentinueto 1 . 5mg / 1 , 000 mg film film - coating contains 2. 5 mg linagoptin and 1 ,000 mg met formin hydroxychloride ( respectively ). - the other ingredients are arginine , copovidone , magnesium stearate , maize starch
edurant contains the active substance rilpivirine . edurant is used to treat human immunodeficiency virus ( hiv ) infection in adults , adolescents and children aged 12 years and older who are already infected with hiv medicines . edhurant is indicated for the use in combination with non - nucleoside reverse transcriptase inhibitors ( nnrtis ) to reduce the amount of hiv in the blood . edaurant is also used in combination of hik medicines in adults and adolescents aged 12 months and older infected with either hiv or ntris . your doctor will discuss with you
do not take edurant : if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking edurent if you : are taking any of any of , or have recently taken any of : any of these : - any of a combination of any combination of the following medicines : carbamazepine , oxcarbazepine or phenobarbital or phenytoin ( medicines used to treat some bacterial infections such as tuberculosis ) - omeprazole , esomeprazole or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults ( 18 years of age and older ) the recommended dose of edurant is one tablet once a day . the dose may be adjusted by your doctor . do not take more than one tablet a day if you have to take rifabutin . this is because edurants contains rifabeutin and it is not recommended to take edurent with food . if you take more edurutant than you should if you accidentally take too many tablets , contact your doctor immediately .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have : headache , nausea , difficulty falling asleep , insomnia , dizziness , changes in your routine liver tests ( transaminase ), increase in cholesterol and pancreatic amylase in your blood , abnormal dreams , rash , stomach pain , depression , tiredness , vomiting , drowsiness , decreased appetite , sleep disorders , stomach discomfort , depressed mood , dry mouth 36 low white blood cell and / or platelet count , decrease in haemoglobin in your bloodstream ( triglycerides , lipase , bilirubin
what edurant contains the active substance is rilpivirine . each tablet contains rilpaline hydrochloride . each film - coated tablet of edurants contains rrilpiviraine hydro chloride equivalent to 25 mg ril pivirrine . the other ingredients are : tablet core : lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose , magnesium stearate . tablet coating : lactate monohydrate . tablet coat : hypromellose 2910 ( e464 ), tal
avandamet tablets are a combination of two different medicines called rosiglitazone and metformin . these two medicines are used to treat type 2 diabetes . type 2abetes usually develops in adulthood when your body does not make enough insulin to control the level of sugar in your blood or where your body is not able to use the insulin it produces effectively . rosigslitazONE and met formin work together by helping your body make better use of the insulin that your body produces . this helps lower your blood sugar . avandamvet is also used as a sulphonylurea ( a type of
follow all the doctor ' s instructions carefully , even if they differ from the general information contained in this leaflet . check with your doctor or pharmacist if you are not sure . your doctor may need to change your dose of avandamet . if you : - are allergic ( hypersensitive ) to rosiglitazone , metformin or any of the other ingredients of avANDamet ( listed in section 6 ) - have had a heart attack - have severe angina - have heart failure - have experienced heart failure in the past - have suffered severe breathing difficulties - have liver disease - have diabetic keto
always take avandamet tablets exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 2 mg rosiglitazone ( equivalent to 1000 mg metformin ). this dose is taken once a day , at least 1 hour apart , at about the same time each day . if you have to take a daily dose of 8 mg , the maximum dose is 4 mg rosciglitasone ( corresponding to 1000mg metforman ). thisdose is taken twice a day at about about thesame time each morning , at approximately the same place each
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions to avandamanet include raised and itchy rash ( hives ) swelling mainly of the face or mouth ( angioedema ), with difficulty in breathing collapse . if you get any of these symptoms , stop taking avandandamnet and seek medical advice straight away . lactic acidosis ( build up of lactic acids in the blood ( lacticacidosis is a common side effect in patients taking metformin , especially in patients with severe kidney disease ). symptoms of lact acidosis include rapid breathing ,
keep out of the reach and sight of children . do not use avandamet after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do this if you notice any change in the appearance of the tablets . do away with the blister or the blister after you have taken them . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what avandamet contains the active substances are rosiglitazone and metformin . avandamanet tablets come in different strengths . each tablet contains 1 mg rosIGlitazon ( 500 mg ) metforman . each 2 mg tablet contains rosigslitazona ( 500mg ) met formin . each 3 mg tablet contain 2 mg roSiglitizone ( 1000 mg ) meetformin and each 4 mg tablet containing rosigllitazione ( 1000mg ) meet formin ). the other ingredients are sodium starch glycollate , hypromellose , microcry
clopidogrel mylan contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelelet medicinalproducts reduce the chances of blood clots forming ( a process called thrombosis ). clopIDogrelmylan is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis , which can lead to atherostrombotic events
do not take clopidogrel mylan 31 if you are allergic to clopipidogel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking clopridogrelmylan . warnings and precautions talk to your doctor or pharmacist before taking any of your medicines : if you think any of this applies to you ( or you are not sure ), talk to the doctor
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clubidogl mylan ( 4 tablets of 75 mg ) once at the start
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel mylan contains the active substance is clopidoogrel . each film - coated tablet contains 75 mg of clopidaogrel ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 ' clopridogrel Mylan contains hydrogenatedcastor oil '), polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc and macrogl 3000
doptelet belongs to a group of medicines called thrombopoietin receptor agonists . doptelet is used to treat chronic liver disease with low platelet count ( thromboocytopenia ), in adults , adolescents and children . it is used in a medical procedure to reduce the risk of bleeding . it works by reducing the number of platelets in the blood . platelets are blood cells that help the blood to clot and stop bleeding .
do not use doptelet : - if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor thinks that you may have a risk of blood clots in the veins or arteries . warnings and precautions talk to your doctor or pharmacist before using doptelelet : if you have a history of bloodclots , as this medicine may increase the risk of having blood clops in your family . if you suffer from cancer . if your child is taking the contraceptive birth control pill or hormone replacement therapy . if he or she has recently had
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will decide the dose you need to take during your procedure . the recommended dose is 5 mg once a day . your dose may be increased or decreased by up to 8 mg once daily . your physician will tell you the dose of doptelet to take . the usual dose of either doptelets 20 mg , 40 mg or 60 mg once per day is 5 tablets once a morning . your platelet counts may be reduced by taking this medicine at least 10 to 13 days before your planned medical procedure
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with doptelet : very common ( may affect more than 1 in 10 people ): feeling tired uncommon ( may effect up to 1 in 100 people ): low red blood cell count ( anaemia ) blood clot in the portal vein ( a blood vessel that transports blood from the liver to the intestines ) upper abdominal pain , swelling bone pain muscle aches and fever reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaf
what doptelet contains - the active substance is avatrombopag . each film - coated tablet contains avatormbopaga maleate equivalent to 20 mg avatrambopg . - the other ingredients are lactose monohydrate ( see section 2 ' doptelets contains lactose '), microcrystalline cellulose , crospovidone type b [ e ], silica , colloidal anhydrous , magnesium stearate . - film - coating : vinyl alcohol , talc , macrogol 3350 , titanium dioxide ( e171 ), iron oxide yellow ( e172 ). what
rapiscan belongs to a group of medicines called ' coronary vasodilators '. it works by helping to widen the heart arteries , thus increasing heart rate and helping to relax the muscles of the heart . rapiscan is used for the following types of heart scan : ' myocardial perfusion imaging '. the scan uses a radioactive substance called a ' radiopharmaceutical '. these images are taken using the muscles in the heart using a readmill . a scan contains a small amount of radiopharma that is injected into your body through a vein . your doctor will give you images of the inside of the head of the baby
do not take rapiscan if you have slow heart rate , high degree heart block , sinus node disease or a pacemaker that does not work properly , chest pain ( unstable angina ), or if you are not sure , talk to your doctor before taking rapiscin if you suffer from low blood pressure ( hypotension ) or heart failure if you think you may be allergic to regadenoson or any of the other ingredients of rapiscen ( listed in section 6 ). warnings and precautions talk to you doctor before you take rapican if any of these apply to you : if you : have a recent serious heart
rapiscan will be given to you by a doctor or nurse who is experienced in the treatment of your heart and blood pressure . it will be injected into a vein ( intravenously ) in a maximum of 400 ml . the recommended dose is a 5 ml solution the injection will be administered over a period of 5 to 10 minutes . the dose will depend on your weight and your general condition . your doctor will also give you an injection of sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection ( intravenous ) over a minimum of 5 minutes . if you are given more rapiscan than you should if you
like all medicines , rapiscan can cause side effects , although not everybody gets them . the side effects usually occur within a few days of the rapiscin injection and usually disappear within 30 days of any treatment . tell your doctor immediately if you notice any of the following side effects : sudden stopping of the heart , which may be signs of damage to the heart ( heart block ), a disorder of theheart ' s electrical signal , rapid heart beat low blood pressure , fainting , mini strokes , weakness of the face and inability to speak . rapiscans may cause a stroke ( cerebrovascular accident ), an allergic reaction
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping to relax the blood vessels in your penis , allowing blood to flow into your penis when you get sexually excited . viagra will only help you to get an erection if you are sexually stimulated . viag is a treatment for adult men with erectile dysfunction or impotence . this is when a man cannot get , or keep a hard , erect penis suitable for sexual activity .
do not take viagra - if you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you are taking medicines called nitrates , which could lead to a dangerous fall in your blood pressure . these medicines are used to treat angina pectoris ( " chest pain "). if you have not taken any of these medicines , tell your doctor . - if the doctor has prescribed nitric oxide donors such as amyl nitrite , which may lead to an increased risk of a dangerous drop in yourblood pressure . - when taking
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 50 mg once a day . take viagra film - coated tablets with a glass of water . do not take viaga orodispersible tablets with food . take your daily dose at about the same time each day . viagra is for oral use . swallow the tablet whole with a drink . do this with a light meal . do it at about about the time you usually take viagus . viag may help you to get an erection if you continue to take it , even
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported with viagra are usually mild to moderate . if you experience any of the following side effects while taking viagra : an allergic reaction ( may affect up to 1 in 100 people ). symptoms include sudden wheeziness , difficulty in breathing , dizziness and swelling of the eyelids , face , lips or throat . if this happens , chest pains may progress to a semi - sitting position . you may need to take nitrates to control your chest pain . prolonged and sometimes painful erections ( may occur rarely , may affect upto
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of sildenedafil ( as the citrate salt ). - the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate , hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake ( e132 ). what viagra looks like and contents of the pack viagra film - coated tablets have a rounded - diamond shape and are marked with "
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate dopamine receptors in the brain . stimulation of the dopamine receptors triggers nerve impulses in thebrain that help to control body movements . sifrol is used to : treat the symptoms of primary parkinson ' s disease in adults . it can be used alone or in combination with levodopa . treat parkinson '. the symptoms are moderate to severe primary restless legs syndrome .
do not take sifrol - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking sifol . - if your doctor has told you that you have any medical conditions or symptoms that could be associated with kidney disease . - hallucinations ( seeing , hearing or feeling things that are not there ). most hallucinations are visual . - dyskinesia ( abnormal , uncontrolled movements of the limbs ). in patients with advanced parkinson ' s disease , levodopa may cause dyskineia . talk to
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of sifrol for parkinson ' s disease is 3 tablets taken once a day . during the first week , the usual starting dose is 1 tablet of sufrol 0 . 088 mg ( 0 . 264 mg / kg ) once a morning . this will be increased to 1 tablet once a half a day with sifol 0 .088 mg ( 1 . 264 μg / kg ). this will usually be increased until your symptoms are controlled . the usual maintenance dose is one tablet once
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common ( may affect more than 1 in 10 people ) common ( might affect up to 1 in 100 people ) uncommon ( may affects up to1 in 1 , 000 people ) rare ( may effect up to one in 10 , 000 patients ) not known ( frequency cannot be estimated from the available data ) if you have parkinson ' s disease , tell your doctor straight away if you notice any of the following side effects : - dyskinesia ( abnormal , uncontrolled movements of the
what sifrol contains the active substance is pramipexole . each tablet contains 0 . 088 mg , 0 . 18 mg , or 0 . 35 mg , in 0 . 7 ml of solution . the other ingredients are pramipxole 0 . 125 mg , 1 mg , 2 mg , 3 mg , 4 mg , 5 mg , 6 mg , 8 mg , 10 mg , 20 mg , 30 mg , 40 mg , 50 mg , 60 mg , 100 mg , 90 mg , 200 mg , 300 mg , 400 mg , and 500 mg . the tablet coating contains mannitol , maize starch ,
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye . allergic conditions occur in some parts of the body , including the eye , but the allergic reaction may be more severe . allergic conjutivitis may occur with some materials ( allergens ) that may cause allergic reactions , such as itching , redness and swelling . if you notice any of these on the surface of your eye , tell your doctor immediately . do not try to cover it with any other contact lenses . if any of the above apply to you , do not use emadine and talk to your doctor .
do not use emadine - if you are allergic to emedastine or any of the other ingredients of this medicine ( listed in section 6 ). - if your child is more than 3 years old . warnings and precautions talk to your doctor or pharmacist before using emadin : - if the active substance in emadmine is benzalkonium chloride . emadino is not recommended in children less than 6 years old as it has not been studied in clinical trials . - if any of these apply to your child , tell your doctor . - emadrine should not be used if your baby has kidney or liver
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use adults use one drop twice a day ( morning and evening ) in the affected eye . this medicine is for use in both eyes . use in children and adolescents use in adults and adolescents ( 12 years of age and older ) and adolescents weighing at least 1 kg . children and teenagers use in adolescents and children aged 2 years and above . adults use in all age groups . children 1 year of age use in the recommended dose for children and adolescent use in adult use the emadine bottle is
like all medicines , this medicine can cause side effects , although not everybody gets them . the drops can cause them . common side effects ( may affect up to 1 in 10 people ) effects in the eye : eye pain , itchy eye and eye redness . uncommon side effects in adults ( may effect up to1 in 100 people )effects in the back of the eye ( corneal disorder ): abnormal eye sensation , increased tear production , tired eyes , eye irritation , blurred vision , corneural staining , dry eye . general side effects : headache , difficulty sleeping , sinus headache , bad taste , rash . generalside
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do this to protect from light and infections . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what emadine contains the active substance is emadastine in 0 . 5 ml solution . the other ingredients are difumarate , benzalkonium chloride , trometamol , sodium chloride , hypromellose , purified water , hydrochloric acid , sodium hydroxide to maintain acidity levels and ph levels . what emadrine looks like and contents of the pack emadINE is a liquid ( a solution ) supplied in a 5 ml or 10 ml plastic ( drop - bottle ) bottle with a screw cap . not all pack sizes may be marketed .
levetiracetam is an antiepileptic medicine ( a medicine used to treat seizures in epilepsy ). levetir acetam actavis is used : on its own in adults and adolescents from 16 years of age with newly diagnosed epilepsy , to treat a certain form of epilepsy . epilepsy is a condition where the patients have repeated fits ( seizures ). levevetirateam is used for the epilepsy form in which the fits initially affect only one side of the brain , but could thereafter extend to larger areas on both sides of the head ( partial onset seizure with or without secondary generalisation ). levestiracetamer has
do not take levetiracetam actavis - if you are allergic to leveturacetam , pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking levetiraacetamactavis - tell your doctor if you have kidney problems - tell the doctor if any slow down in the growth or unexpected puberty development of your child has been reported in patients taking anti - epileptics . levetiaracetam actsavis may cause thoughts of harming or killing themselves . tell your family or carer if you notice
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . levetiracetam actavis is taken twice a day , once in the morning and once inthe evening . monotherapy dose in adults and adolescents from 16 years of age and older : the usual dose is 1 , 000 mg once a day . your doctor may increase your dose to 3 , 000mg once a daily depending on how you respond to levetvetiram acta . your daily dose is 2 tablets of 1 , 500 mg once daily . your dose may be increased or decreased depending on
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor or the nearest emergency department immediately if you experience : weakness , feel light - headed or dizzy or have difficulty breathing , as these may be signs of a serious allergic ( anaphylactic ) reaction . swelling of the face , lips , tongue and throat ( quincke ' s oedema ). flu - like symptoms and a rash on the face followed by an extended rash with a high temperature and increased levels of liver enzymes seen in blood tests . reduction in a type of white blood cell ( 56 - eosinoph
what levetiracetam actavis contains the active substance is levetviracetam . levetiraacetamactavis 250 mg : each tablet contains 250 mg of levetvetirateam . each tablet of leveriracetamine actavis 500 mg : one tablet contains 500 mg of the active ingredient levetiroacetam. levetmiracetam accord 750 mg : every tablet contains 750 mg of strength levetirusacetam the other ingredients are : levetieracetam amide , crospovidon , povidone , silica colloidal anhydrous , magnesium stearate
incruse ellipta contains the active substance umeclidinium bromide , which belongs to a group of bronchodilators . incruse ellipta is used to treat adults with chronic obstructive pulmonary disease ( copd ). copd is a long - term condition in which the airways in your lungs become blocked , leading to breathing difficulties . difficulties in breathing can also result in tightening of the muscles around the airway . this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the lungs . this helps to control your breathing difficulties and
do not use incruse ellipta 27 if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine if you have asthma . incruruse ellipta should not be used in patients with asthma . if you suffer from heart problems . if your doctor has told you that you have an eye problem called narrow - angle glaucoma ( an enlarged prostate , difficulty passing urine , or a blockage in your bladder ). if you know that you suffer severe liver problems . immediate breathing
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . do not use incruse ellipta if you notice any change in the appearance of the inhaler . if you have symptoms of this medicine , such as a sudden attack of breathlessness or wheezing , seek medical advice immediately . if this attack does not go away , you may need a quick - acting reliever inhaler ( such as salbutamol ). the
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are uncommon ( may affect up to 1 in 100 people ). if you experience any of the following symptoms while taking incruse ellipta , stop taking this medicine and seek medical help immediately : itching skin rash , hives and redness 29 common side effects ( may effect up to1 in 10 people ): faster heart beat painful and frequent urination these may be signs of a urinary tract infection . common cold infection of nose , throat cough , feeling of pressure , pain in the cheeks and forehead these may indicate inflammation of the sin
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the inhaler after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the inhalcer in the sealed tray in order to protect from light . after first opening of the tray , the inhalard should be used within 6 months . once the tray has been opened , the seal should be replaced . once opened , use the inhalER within 30 . do away with the inhalator
what incruse ellipta contains - the active substance is umeclidinium bromide . each single inhalation provides a delivered dose of 55 micrograms umechinium . each adult should receive a delivered doses of 65 microgramms umecidinIUM bromides . - the other ingredients are lactose monohydrate ( see section 2 under ' incrusemellipta contains lactose '), magnesium stearate . what incrusey ellipta looks like and contents of the pack incrute ellipta is an inhalation powder . the ellipta inhaler is supplied in a
what nucala is nucal contains the active substance mepolizumab , a monoclonal antibody . this is a type of protein that recognises and attaches to a specific target in the body . what nucalan is used for nucale is used to treat severe asthma in adults , adolescents and children aged 6 years and older . severe asthma affects many eosinophils ( a type white blood cell that helps the airways to open ) and affects the lungs . in eosinaophilic asthma , the most common form of asthma nucalo is used in adults to prevent asthma attacks .
do not use nucala if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine if you have worsening asthma 58 if you experience asthma - related side effects , your doctor may decide to reduce the dose of nucal or stop nucalan . if your asthma does not respond to nuca treatment , your physician may decide that you should not continue nuclatin treatment . allergic and injection site reactions medicines of this type ( monoclonal antibodies ) can cause severe allergic reactions
nucala is given under the skin ( subcutaneous injection ). adults and adolescents 12 years of age and older : the recommended dose is 100 mg once a week . children and adolescents 1 year of age or older : your doctor will decide the dose that is right for you . the pre - filled pen is for single use only . your doctor may decide to change the dose of nucala depending on how you respond to treatment . if you miss a dose of vucala , tell your doctor as soon as possible . if it is almost time for the next dose , skip the missed dose and go back to your regular schedule
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions may occur very commonly ( may affect more than 1 in 10 people ) after the injection . sometimes symptoms can be severe . symptoms can include chest tightness , cough , difficulty breathing fainting , dizziness , feeling lightheaded ( due to a drop in blood pressure ), swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor immediately if you experience a reaction similar reaction to any of the following reactions that may occur with
keep out of the reach and sight of children . do not use nucala after the expiry date which is stated on the carton and on the pre - filled pen after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the nucalo pre -filled pen in the outer carton in order to protect from light . after first opening , use within 7 days . do away with the pre pre - fill pen once you have established the date of opening . do discard the pre / filled pen if it has been stored for more than 7
what nucala contains - the active substance is mepolizumab . each 1 ml ampoule contains 100 mg of mepolzumab - the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate , polysorbate 80 , edta disodium dihydrate and water for injections . what nucal looks like and contents of the pack nucale is supplied as a pack containing 1 ampoules , a multipack containing 3 ampouls , each containing 1 vial .
what ninlaro is ninlar is a cancer medicine that contains the active substance ixazomib , a ' proteasome inhibitor '. what it is used for ninlara is used to treat a cancer of the bone marrow called multiple myeloma . ixezomib works by stopping cell survival and slowing down the number of myelomas cells . it works by blocking the action of a lot of proteins called proteasomes . what ninlalo is used in adults and children ninlare is used when multiple myelooma is first diagnosed in patients , and it is given to you in combination with
do not take ninlaro if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking ninlar . if you take more ninlara than you should if you have taken more than the recommended dose , or if you think you may have taken too many tablets , contact your doctor immediately . if any of these apply to you , tell your doctor . if possible , stop taking the medicine and contact your nearest hospital straight away . if your doctor thinks you may be at increased risk of bleeding , or have
you must always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one capsule of one capsule . if you have multiple myeloma , your doctor will tell you how many capsules of this medicine to take . the dose of ninlaro that you take will depend on your condition and your condition . the amount of lenalidomide and dexamethasone you take once a day for the first 4 weeks . the usual dose of one dose of the combination of ninluaro is once capsule of lenlamide and one capsule dexam
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ): low platelet counts ( thrombocytopenia ) nose bleeds that can easily bruise nausea , vomiting , diarrhoea numbness or tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs or feet (> peripheral oedema ) skin rash that may become itchy all over the body rare side effects these may affect up to 1 in 1 , 000 people : severe skin rashes , red to purple bumps (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the blister tightly closed in order to protect from light . do store below 30 . do discard the capsule if you notice any damage to the pack . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what ninlaro contains the active substance of ninlar is 2 . 3 mg ixazomib . each capsule contains 2 .3 mg ikazomab . each hard capsule contains 3 . 3mg ixezomib citrate . the other ingredients are : capsule shell : microcrystalline cellulose , magnesium stearate , talc . the capsule shell contains gelatin , titanium dioxide ( e171 ), red iron oxide ( e172 ), shellac , propylene glycol , potassium hydroxide , black iron oxide . what ninlara looks like and contents of the pack the capsule is white
do not use palforzia if you are allergic to peanuts ( arachis hypogaea ) or any of the other ingredients of palfORzia ( listed in section 6 ). children and adolescents from 4 to 17 years of age should not receive treatment for peanut allergy because the medicine contains traces of peanut ( desensitisation ). palfiorzia is not intended to cause allergic reactions . palforbzia should not be used in children and young people with food allergies . if you have any further questions on the use of pforzias , ask your doctor or pharmacist .
do not take palforzia - if you are allergic to peanut or soya - if your asthma is getting worse - if there is a problem swallowing - if this is a sign of long term problems with your digestive system - if it is a severe mast cell disorder - if severe or life - threatening anaphylaxis occurs within 60 days of treatment with your palfORzia . warnings and precautions talk to your doctor or pharmacist before taking palforsia . the symptoms of peanut allergy may occur during treatment with palfiorzia , but only after an allergic reaction has occurred . during treatment , p
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and duration of allergy if allergic reactions ( anaphylaxis ) occur , your doctor will decide how many days you should take palforzia and how long you should continue treatment with palfourzia . initial doseescalation and up - dosing steps are given at the end of this leaflet . your doctor may instruct you to follow these treatment steps . the initial dose doseescalations and up dosing phases are given in steps . if you take more palforbzia
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with palforzia : severe allergic reactions if you have any of the following symptoms after taking palfORzia , stop taking the medicine and seek medical help immediately : trouble breathing , throat tightness , feeling offulness , trouble swallowing or speaking - changes in voice , dizziness or fainting severe stomach cramps , pain , vomiting , diarrhoea , severe flushing and itching of the skin palforsia may cause problems with the stomach and digestive system ( eosinophilic o
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine if you notice any hard lumps of powder or if the solution is discoloured . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what palforzia contains the active substance is palforbzia 0 . 5 mg / 1 mg / 10 mg / 20 mg . the other ingredients are microcrystalline cellulose , colloidal anhydrous silica and magnesium stearate palfiorzia 100 mg / 5 mg oral powder in capsules for opening microcrycrystallrine cellulose ( e460 ), colloidal Anhydroussilica and and magnesium strearatepalforza 300 mg / 6 mg oralpowder in sachet microcrystine celluloses ( e463 ), colloid anhydrated silica , and
zerene belongs to a group of substances called benzodiazepine - related medicinal products . it contains hypnotic actions . zerene is used to treat sleeping problems in adults . it is used during treatment of adults who have problems sleeping .
you should not be given zerene : if you have hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients of zerenea sleep apnoea syndrome ( for short periods ) if you suffer from severe kidney or liver problems if you are suffering from myasthenia gravis ( very weak , tired muscles , severe breathing and chest problems ). children and adolescents zeren is not recommended for use in children and teenagers under 18 years of age . therefore , zerenes should not have any effect on this age group . undesirable effects are not known . if you take any medicine , including
always take zerene exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 10 mg once a day . if you have difficulty falling asleep , take your capsule straight away . if your doctor tells you to take a different dose , you should not take more than the dose recommended . if the dose is 65 mg once daily . if a dose is higher than the recommended dosage , you may take a dose of 5 mg once every day . for mild to moderate liver problems , take the dose as recommended . do not take a double dose to make up for a forgotten
like all medicines , zerene can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any other changes in your health . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) uncommon : 1 to 5 users in 1 , 000 very rare : 1 in 10 , 000 not known ( frequency cannot be estimated from the available data ) very rare ( affects less than 1 users in 10, 000 ) very very rare cases ( affects fewer than 1 patient in 10 000 )
what zerene contains - the active substance is zaleplon 5 mg . - the other ingredients are microcrystalline cellulose , pregelatinised starch , silicon dioxide ( e171 ), sodium lauryl sulphate , magnesium stearate . - printing ink : shellac , lecithin , simethicone , yellow iron oxide ( e172 ). what zeren looks like and contents of the pack zerenea 5 mg is an intensely dark blue powder in a glass vial with a light brown cap . zerenes 5 mg are available in blisters containing 7 , 10 or 14
